Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

  • Главная
  • Biphenyls and fluorenes as imaging agents in alzheimer's disease

Biphenyls and fluorenes as imaging agents in alzheimer's disease

Номер патента: EP1553985A2
Опубликовано: 20-07-2005
Автор(ы): Hank.F. Kung, Mei Ping. Kung, Zhi-Ping Zhang
Принадлежит: University of Pennsylvania Penn

Реферат: This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits.

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease

Номер патента: US09422286B2. Автор: Anuj Sharma,Jason Schultz,Liviu Mirica. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2016-08-23.

Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Номер патента: US09833458B2. Автор: William E. Klunk,Chester A. Mathis, Jr.,Yanming Wang. Владелец: University of Pittsburgh. Дата публикации: 2017-12-05.

AMYLOID-BINDING THIOFLAVIN DERIVATIVES, METHOD OF in vivo DETECTION OF AMYLOID DEPOSIT AND METHOD OF DIAGNOSTICS OF ALZHEIMER'S DISEASE

Номер патента: RU2324686C2. Автор: Яньмин ВАН,Уильям Э. КЛАНК,Честер Э. Мл. МАТИС,Уиль м Э. КЛАНК. Владелец: Юнивесити Оф Питсбэг. Дата публикации: 2008-05-20.

Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Номер патента: CA2419420C. Автор: William E. Klunk,Chester A. Mathis, Jr.,Yanming Wang. Владелец: University of Pittsburgh. Дата публикации: 2011-08-02.

Imidazopyridine derivatives and their use as agents for diagnosis of alzheimer's disease

Номер патента: IL198995A. Автор: . Владелец: Nihon Mediphysics Co Ltd. Дата публикации: 2012-10-31.

Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders

Номер патента: WO2008134618A3. Автор: David R Elmaleh,Timothy Shoup,Alan J Fischman. Владелец: Alan J Fischman. Дата публикации: 2008-12-24.

(hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease

Номер патента: WO2004094384A2. Автор: VARGHESE John,Ruth Tenbrink,Roy Hom,Shon Pulley,Jose Aquino,John A. Tucker. Владелец: Pharmacia & Upjohn Company LLC. Дата публикации: 2004-11-04.

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Номер патента: CA2486869C. Автор: Gerardo M. Castillo,Alan D. Snow,Beth P. Nguyen,Lesley Larsen,Stephen D. Lorimer,Virginia J. Sanders,Thomas P. Lake,Rex T. Weavers,David S. Larsen,David L. Coffen (Deceased). Владелец: ProteoTech Inc. Дата публикации: 2011-09-13.

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Номер патента: US20090069432A1. Автор: Gerardo M. Castillo,Alan D. Snow,Beth P. Nguyen,Lesley Larsen,Stephen D. Lorimer,Virginia J. Sanders,Thomas P. Lake,Rex T. Weavers,David S. Larsen,David L. Coffen,Chrlotte Coffen. Владелец: ProteoTech Inc. Дата публикации: 2009-03-12.

New compounds for the treatment of alzheimer's disease

Номер патента: US20240327427A1. Автор: Jian Jin,Bin Zhang,Aiqun Li,Eric E. Schadt,Minghui Wang,Zhenyu Yue,Lap Ho,Lihuai QIN,Vahram HAROUTUNIAN,Xianxiao ZHOU,Husnu Umit KANISKAN,Kristen J. BRENNAND. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2024-10-03.

Compounds to treat Alzheimer's disease

Номер патента: US20030013881A1. Автор: VARGHESE John,Andrea Gailunas,Roy Hom,Shumeye Mamo,Jay Tung,Lawrence Fang. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2003-01-16.

Targeting lysosomal lipid in alzheimer's disease

Номер патента: WO2024197271A1. Автор: Zibo Li,JR. Leon G. COLEMAN,Alexandra BARNETT,Saradhi KALARI,Xinrui Ma. Владелец: The University of North Carolina at Chapel Hill. Дата публикации: 2024-09-26.

Nlrp3 inflammasome small-molecule inhibitor for treatment of alzheimer's disease

Номер патента: EP4289830A1. Автор: Ho Chul Shin,Jee Yeon SEO,Muhammad Haseeb,Sangdun Choi,Javaid NASIR,Yasmeen FARZANA,Jae Kyung Heo. Владелец: Ajou University Industry Academic Cooperation Foundation. Дата публикации: 2023-12-13.

Therapeutic preparation and preventive preparation for treating alzheimer's disease

Номер патента: RU2560171C2. Автор: Каору НАКАО,Наохиро ЯМАДА,Йохей МИЯМОТО. Владелец: Торэй Индастриз, Инк.. Дата публикации: 2015-08-20.

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Номер патента: US09808541B2. Автор: William E. Klunk,Chester A. Mathis, Jr.,Yanming Wang. Владелец: University of Pittsburgh. Дата публикации: 2017-11-07.

Application of the piperazin derivatives for treatment of the alzheimer's disease and the alzheimer's type dementia with disturbed ventricular calcium signaling

Номер патента: RU2676100C1. Автор: Елена Александровна Попугаева,Дарья Павловна Чернюк,Илья Борисович Безпрозванный. Владелец: федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ"). Дата публикации: 2018-12-26.

Malonamide derivatives as gamma-secretase inhibitors for treatment of alzheimer's disease

Номер патента: RU2402538C2. Автор: Александр Флор,Вольфганг ВОСТЛЬ,Роланд ЯКОБ-РОЭТНЕ. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2010-10-27.

Nlrp3 inflammasome small-molecule inhibitor for treatment of alzheimer's disease

Номер патента: US20240132458A1. Автор: Ho Chul Shin,Jee Yeon SEO,Muhammad Haseeb,Sangdun Choi,Javaid NASIR,Yasmeen FARZANA,Jae Kyung Heo. Владелец: Ajou University Industry Academic Cooperation Foundation. Дата публикации: 2024-04-25.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: US20200071312A1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2020-03-05.

Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease

Номер патента: US10584120B1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2020-03-10.

Pyrimidine derivatives for treatment of alzheimer's disease

Номер патента: EP2312946A1. Автор: Sean P. Ahearn,Alexey A. Rivkin,Stephanie M. Chichetti. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-04-27.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: CA3109623A1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2020-03-05.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3

Номер патента: EP1458394A1. Автор: Philip Edwards,Stefan Berg,Sven Hellberg,Ratan Bhat. Владелец: AstraZeneca AB. Дата публикации: 2004-09-22.

Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3

Номер патента: US20090312322A1. Автор: Philip Edwards,Stefan Berg,Sven Hellberg,Ratan Bhat. Владелец: AstraZeneca AB. Дата публикации: 2009-12-17.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3

Номер патента: EP1458394B1. Автор: Philip Edwards,Stefan Berg,Sven Hellberg,Ratan Bhat. Владелец: AstraZeneca AB. Дата публикации: 2008-10-22.

Compounds for treatment of alzheimer's disease

Номер патента: US09517232B2. Автор: Harry Ralph Howard,Dennis Michael Godek. Владелец: Medi Synergics LLC. Дата публикации: 2016-12-13.

Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders

Номер патента: US20230295125A1. Автор: Jonnie R. Williams, SR.. Владелец: Miralogx LLC. Дата публикации: 2023-09-21.

Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders

Номер патента: EP4228628A1. Автор: Jonnie R. Williams. Владелец: Miralogx LLC. Дата публикации: 2023-08-23.

7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease

Номер патента: EP3894411A1. Автор: Hasane Ratni,Beat Frei. Владелец: F Hoffmann La Roche AG. Дата публикации: 2021-10-20.

Methods and drug products for treating alzheimer's disease

Номер патента: US20160000769A1. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2016-01-07.

Methods and drug products for treating alzheimer's disease

Номер патента: EP2665479A1. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2013-11-27.

Methods and drug products for treating alzheimer's disease

Номер патента: WO2012096873A9. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals, Inc.. Дата публикации: 2013-09-12.

Methods and drug products for treating alzheimer's disease

Номер патента: US20170319565A1. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2017-11-09.

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

Номер патента: US09868725B2. Автор: Minoru Nakamura,Shinkichi Suzuki,Masami Yamada,Makoto Kamata,Hiroki Sakamoto,Takahiro Sugimoto. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2018-01-16.

Methods and drug products for treating alzheimer's disease

Номер патента: US09724339B2. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2017-08-08.

Novel pyrimidine derivatives and their application in therapy, as well as application of pyrimidine derivatives in manufacturing medication for prevention and/or treatment of alzheimer's disease

Номер патента: RU2433128C2. Автор: Карин СТААФ,Стефан БЕРГ,Ларс АНДЕРССОН,Эрван АРЗЕЛЬ,Джереми БАРРОУЗ,Свен ХЕЛЛЬБЕРГ,Фернандо ХУЭРТА,Торбен ПЕДЕРСЕН,Тобиас РЕЙН,Дидье РОТТИЧЧИ,Доминика ТУРЕК. Владелец: Астразенека Аб. Дата публикации: 2011-11-10.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: WO2020047360A8. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2021-09-10.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: AU2019333295A1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2021-03-04.

1, 3, 4, 5-Tetrahydro-2H-Pyrido[4,3-B]Indole Derivatives For The Treatment, Alleviation Or Prevention Of Disorders Associated With Tau Aggregates Like Alzheimer's Disease

Номер патента: AU2021203340A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2021-06-24.

1, 3, 4, 5-tetrahydro-2H-pyrido(4,3-b)indole derivatives for the treatment, alleviation or prevention of disorders associated with Tau aggregates like Alzheimer's disease

Номер патента: AU2019205087A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2020-07-02.

Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrahydrofurans acting as mixed sigma-1 / muscarinic ligands

Номер патента: US20150073046A1. Автор: Alexandre Vamvakides. Владелец: Individual. Дата публикации: 2015-03-12.

Compounds for the treatment of alzheimer's disease

Номер патента: AU2021366268A9. Автор: Ryoichi Kimura,Michael Houghton,James A. Nieman,D. Lorne Tyrrell,Bing Bai,Wen FU,Jack Jhamandas,Alexandr BELOVODSKIY,Mostofa HENA,Appan Srinivas Kandadai,Kamlesh Kumar Sahu. Владелец: University of Alberta. Дата публикации: 2024-08-01.

Indazole derivatives for treatment of alzheimer's disease

Номер патента: EP1983981A1. Автор: Peter Hunt,Alan Nadin,Ian Churcher,Carmel B. Nanthakumar,Peter Brian Simpson,Richard Jelley,Hedaythul Choudhury,Neil Wilkie. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2008-10-29.

Pi-extended acedan derivatives, their application for two-photon microscopy imaging, and their application for two-photon microscopy imaging of amyloid-beta plaque in an alzheimer's disease animal model

Номер патента: US09658235B2. Автор: Ki Hean Kim,Dokyoung KIM,Hyunsoo Moon,Kyo Han Ahn,Hye Gun RYU. Владелец: Academy Industry Foundation of POSTECH. Дата публикации: 2017-05-23.

Compositions and methods for treating Alzheimer's disease

Номер патента: US09427438B2. Автор: John Jahangir ALAM. Владелец: EIP PHARMA LLC. Дата публикации: 2016-08-30.

Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds

Номер патента: US20050054732A1. Автор: Kazuo Koyama,Yasuhiro Nakagami,Isao Kaneko,Shinji Marumoto,Masaki Meguro,Tomiichiro Oda. Владелец: BTG International Ltd. Дата публикации: 2005-03-10.

Preventives or remedies for alzheimer's disease or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Номер патента: CA2468948C. Автор: Kazuo Koyama,Yasuhiro Nakagami,Isao Kaneko,Shinji Marumoto,Masaki Meguro,Tomiichiro Oda. Владелец: BTG International Ltd. Дата публикации: 2012-04-17.

Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease

Номер патента: US5565323A. Автор: Corinna Herrnstadt,W. Davis Parker. Владелец: MitoKor Inc. Дата публикации: 1996-10-15.

Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders

Номер патента: AU2021361997A9. Автор: Jonnie R. Williams. Владелец: Miralogx LLC. Дата публикации: 2024-02-08.

ARYL-ISOXAZOL-4-YL-IMIDAZO[1,2-a]PYRIDINE SUITABLE FOR TREATING ALZHEIMER'S DISEASE THROUGH GABA RECEPTORS

Номер патента: RU2426732C2. Автор: Бернд БЮТТЕЛЬМАНН,Хеннер КНУСТ,Бо ХАН,Эндрю ТОМАС. Владелец: Ф. Хоффманн-Ля Рош Аг. Дата публикации: 2011-08-20.

Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease

Номер патента: EP1828151A2. Автор: Alexander Flohr,Wolfgang Wostl,Roland Jakob-Roetne. Владелец: F Hoffmann La Roche AG. Дата публикации: 2007-09-05.

2, 3, 4, 5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: CA2524640C. Автор: Guido Galley,Robert Alan Goodnow, Jr.,Jens Uwe Peters. Владелец: F Hoffmann La Roche AG. Дата публикации: 2011-10-11.

Pharmaceutical agents for the treatment of alzheimer's disease

Номер патента: CA2217513C. Автор: Joseph G. Lombardino,Leland D. Loose,Ethan S. Weiner. Владелец: Pfizer Ltd. Дата публикации: 2002-02-05.

Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrahydrofurans acting as mixed sigma-1 / muscarinic ligands

Номер патента: WO2014155138A1. Автор: Alexandre Vamvakides. Владелец: Alexandre Vamvakides. Дата публикации: 2014-10-02.

1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer's disease

Номер патента: CA3086759A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2019-07-11.

Triazole derivatives for treatment of alzheimer's disease

Номер патента: EP2378879A1. Автор: Christian Fischer,Hua Zhou,Matthew Christopher,Benito Munoz,Adam J. Schell,Chaomin Li,Joey Methot,Rachel N. Maccoss,Sean P. Ahearn,William Colby Brown,Alexey A. Rivkin,Stephanie Chichetti,Andrew Rosenau,Sam D. Kattar. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-10-26.

Compounds for the treatment of alzheimer's disease

Номер патента: CA3199261A1. Автор: Ryoichi Kimura,Michael Houghton,James A. Nieman,D. Lorne Tyrrell,Bing Bai,Wen FU,Jack Jhamandas,Alexandr BELOVODSKIY,Mostofa HENA,Appan Srinivas Kandadai,Kamlesh Kumar Sahu. Владелец: University of Alberta. Дата публикации: 2022-04-28.

1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer’s disease

Номер патента: NZ765495A. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2024-02-23.

Methods of Treating Alzheimer's Disease

Номер патента: US20230070758A1. Автор: Xue Hua,William Walker,Hans J. MOEBIUS,Leen Kawas,Kevin Church. Владелец: Athira Pharma Inc. Дата публикации: 2023-03-09.

Alzheimer's disease treatment and methods

Номер патента: US20240091376A1. Автор: Peter Butzloff. Владелец: Pharmzandia Corp. Дата публикации: 2024-03-21.

Alzheimer's disease treatment and methods

Номер патента: EP4301696A1. Автор: Peter Butzloff. Владелец: Pharmzandia Corp. Дата публикации: 2024-01-10.

Extracellular vesicles for the diagnosis of alzheimer's disease

Номер патента: WO2024108311A1. Автор: Stephen Pasternak,Hon LEONG. Владелец: Stephen Pasternak. Дата публикации: 2024-05-30.

Methods of treating alzheimer's disease

Номер патента: AU2022312384A1. Автор: Xue Hua,William Walker,Hans J. MOEBIUS,Leen Kawas,Kevin Church. Владелец: Athira Pharma Inc. Дата публикации: 2024-01-04.

Furosemide analogues and compositions and uses thereof for treatment of alzheimer's disease

Номер патента: US20220259167A1. Автор: Zhiyu Wang,Donald Fredric WEAVER,Lisa DOYLE,Laura VILLAR,Prachi S. VILEKAR. Владелец: UNIVERSITY HEALTH NETWORK. Дата публикации: 2022-08-18.

Methods of treating alzheimer's disease

Номер патента: CA3222480A1. Автор: Xue Hua,William Walker,Hans J. MOEBIUS,Leen Kawas,Kevin Church. Владелец: Athira Pharma Inc. Дата публикации: 2023-01-19.

Methods of treating alzheimer's disease

Номер патента: EP4370131A1. Автор: Xue Hua,William Walker,Hans J. MOEBIUS,Leen Kawas,Kevin Church. Владелец: Athira Pharma Inc. Дата публикации: 2024-05-22.

Terphenyl derivatives for treatment of alzheimer' s disease

Номер патента: CA2649845C. Автор: Yan Zhang,Francis Wilson,Andrew Cansfield,Svenja Burckhardt,Jess Taylor,Mihiro Sunose,Valerie Reader,Chih Yung Ho,Jeremy Major,Richard John Harrison,Alison Reid,Kathryn Smelt,Cyrille Boussard,Remedios Hernadez-Perni,Adeline Leformal. Владелец: Ortho McNeil Janssen Pharmaceuticals Inc. Дата публикации: 2014-09-16.

Alpha-(N-sulphonamido)acetamide derivatives as beta-amyloid inhibitors used for treating Alzheimer's Disease and Down's syndrome

Номер патента: NZ533603A. Автор: John E Macor,Lawrence R Marcin,Joanne J Bronson,Yonghua Gai,Carl P Bergstrom,Michael F Parker,Katharine E Mcelhone,Robert A Mate. Владелец: Bristol Myers Squibb Co. Дата публикации: 2007-02-23.

Compounds to treat Alzheimer's disease

Номер патента: NZ538542A. Автор: VARGHESE John,Ruth E Tenbrink,James P Beck,Barbara Jagodzinska,Andrea Gailunas,Roy Hom,John N Freskos,Lawrence Y Fang,Shon R Pulley,Michael Maillard. Владелец: Elan Pharm Inc. Дата публикации: 2006-09-29.

Compounds to treat alzheimer's disease

Номер патента: NZ547529A. Автор: . Владелец: Pharmacia & Upjohn Co Llc. Дата публикации: 2008-04-30.

Peptide for treatment of alzheimer's disease

Номер патента: RU2678987C2. Автор: Александр Александрович Колобов,Владимир Михайлович Шпень,Елена Артуровна КАМПЕ-НЕММ,Роман Данилович ДЕЙКО,Сергей Юрьевич Штрыголь. Владелец: Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА". Дата публикации: 2019-02-05.

Peptide with treatment action against alzheimer's disease

Номер патента: RU2626972C2. Автор: Александр Николаевич Самохин,Наталья Викторовна Бобкова,Ольга Марковна Вольпина,Анна Владимировна Камынина,Дмитрий Отарович Короев,Татьяна Данииловна Волкова,Маргарита Павловна Филатова. Владелец: Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН). Дата публикации: 2017-08-02.

Adeno-associated virus vector for alzheimer's disease treatment, its application for reception of therapeutic agents, and also method of alzheimer's disease treatment by means of given vector

Номер патента: RU2335542C2. Автор: Хидео ХАРА,Такеси ТАБИРА. Владелец: Нэшнл Инститьют Оф Байомедикал Инновэйшн. Дата публикации: 2008-10-10.

Identification of genes involved in alzheimer's disease using drosophila melanogaster

Номер патента: US20020174446A1. Автор: Dalia Cohen,Mary Konsolaki,Felix Freuler,Susan Zusman,Uwe Dengler,Alyce Finelli,Mischa Reinhardt. Владелец: Individual. Дата публикации: 2002-11-21.

BIVALENT MULTIFUNCTIONAL LIGANDS TARGETING Aβ OLIGOMERS AS TREATMENT FOR ALZHEIMER'S DISEASE

Номер патента: WO2012012257A3. Автор: Shijun Zhang,Tai Liang Guo. Владелец: Virginia Commonwealth University. Дата публикации: 2012-05-31.

Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease

Номер патента: US09845352B2. Автор: Eva Kontsekova,Michal Novak,Branislav Kováce{hacek over (c)}h,Norbert {hacek over (Z)}ilka. Владелец: Axon NeuroScience SE. Дата публикации: 2017-12-19.

Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease

Номер патента: US09828421B2. Автор: Eva Kontsekova,Michal Novak,Branislav Kováce{hacek over (c)}h,Norbert {hacek over (Z)}ilka. Владелец: Axon NeuroScience SE. Дата публикации: 2017-11-28.

Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease

Номер патента: US09518101B2. Автор: Eva Kontsekova,Norbert ZILKA,Michal Novak,Branislav Kovacech. Владелец: Axon NeuroScience SE. Дата публикации: 2016-12-13.

Alzheimer's disease treatment with tacrine metabolites

Номер патента: WO1992022534A1. Автор: Roger Michael Marchbanks. Владелец: Roger Michael Marchbanks. Дата публикации: 1992-12-23.

Alzheimer's disease treatment with tacrine metabolites

Номер патента: US5767126A. Автор: Roger Michael Marchbanks. Владелец: Individual. Дата публикации: 1998-06-16.

Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders

Номер патента: CA2975059C. Автор: Frederico Nuno Castanheira Aires Da Silva,Sofia Volker Cörte-Real,Vera Luísa SANTOS NEVES,Pedro Manuel CORREIA CANHÃO,Tiago FLEMING OUTEIRO,Miguel Augusto RICO BOTAS CASTANHO,Soraia Rafaela Santiago de Oliveira. Владелец: Technophage Investigacao e Desenvolvimento em Biotecnologia SA. Дата публикации: 2023-02-21.

Humanized tau antibodies in Alzheimer's disease

Номер патента: AU2020227007B2. Автор: Eva Kontsekova,Branislav Kovacech,Rostislav SKRABANA,Michael Novak. Владелец: Axon NeuroScience SE. Дата публикации: 2024-05-30.

Modulators of expression and function of lrp in alzheimer's disease

Номер патента: WO1997004794A1. Автор: Bradley T. Hyman,Dudley K. Strickland,Rudolph E. Tanzi,Maria Z. Kounnas,Robert D. Moir. Владелец: The American National Red Cross. Дата публикации: 1997-02-13.

Biomolecules involved in alzheimer's disease

Номер патента: CA2986826C. Автор: Malcolm Andrew Ward,Ian Hugo Pike,Vikram MITRA,Claire Louise RUSSELL. Владелец: Electrophoretics Ltd. Дата публикации: 2023-11-28.

Methods for treating alzheimer's disease

Номер патента: AU2021249050A1. Автор: Wilfred Jefferies,Chaahat SINGH. Владелец: Individual. Дата публикации: 2022-11-17.

Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease

Номер патента: US09738709B2. Автор: Jeffrey A. Kuret,Kristen E. Funk,Jyanyu Austin Yang,Stefani Thomas. Владелец: University of Maryland at Baltimore. Дата публикации: 2017-08-22.

Invention of protein pi4kiiia and related membrane protein complex in treatment of alzheimer's disease

Номер патента: RU2724493C2. Автор: Лэ ЧЖАН,Сяо ЧЖАН,Хайянь ЛЮ,Ян ХЭ,Фуде ХУАН,Венан ВАН,Лисян ЦЗЯН,Тонг ЧЖУ,Юдон ЧЖОУ,Ванго ВЭЙ. Владелец: Цзянсу Нуо-Бета Фармасьютикал Текнолоджи Ко., Лтд.. Дата публикации: 2020-06-23.

Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents

Номер патента: EP4321165A3. Автор: Hitoshi Okazawa. Владелец: Tokyo Medical and Dental University NUC. Дата публикации: 2024-08-21.

Use of stat4 inhibitors for prevention and treatment of alzheimer's disease

Номер патента: US20230233595A1. Автор: Jerry L. Nadler,Patric K. Stanton. Владелец: New York Medical College. Дата публикации: 2023-07-27.

Application of zn7mt3 and its derivatives in the prevention and treatment of alzheimer's disease

Номер патента: US20180371061A1. Автор: Wei Xu,Xiangshi TAN,Daofeng XIANG,Yingxuan TAN,Yueru ZHANG. Владелец: Liaocheng City Orient Biomedical Technology Co Ltd. Дата публикации: 2018-12-27.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20230312662A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-10-05.

Tau vaccine for the treatment of alzheimer's disease

Номер патента: US20230302127A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-09-28.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20230295254A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-09-21.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20240343769A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-10-17.

Methods of treating alzheimer's disease

Номер патента: RU2720468C2. Автор: Роберт Грэхэм. Владелец: Дженентек, Инк.. Дата публикации: 2020-04-30.

Method of treating alzheimer's disease

Номер патента: RU2385161C2. Автор: БАРРИО Мануэль САРАСА. Владелец: Араклон Байотек, С.Л.. Дата публикации: 2010-03-27.

Methods of using gm6 in diagnosing and treating alzheimer's disease

Номер патента: WO2018119018A1. Автор: Pui-Yuk Dorothy Ko,William Swindell. Владелец: Genervon Biopharmaceuticals, LLC. Дата публикации: 2018-06-28.

New targets for diagnosing and treating alzheimer's disease and use thereof

Номер патента: EP4450973A1. Автор: Shisong Jiang,Wenshu LU,Aili Jian,Renying ZHU. Владелец: Shanghai Jw Inflinhix Co Ltd. Дата публикации: 2024-10-23.

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: US09505739B2. Автор: Craig A. Coburn,Hao Wu,Shawn J. Stachel,Thomas G. Steele. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2016-11-29.

Methods of treating alzheimer's disease

Номер патента: RU2724190C2. Автор: Майкл Уорд,Уилльям ЧО,Мишель ФРИЗЕНХАН,Роберт ПОЛ. Владелец: Дженентек, Инк.. Дата публикации: 2020-06-23.

Therapeutic Agent For Alzheimer's Disease

Номер патента: US20090246170A1. Автор: Hitoshi Iwasaki,Mamoru Hasegawa,Makoto Inoue,Hiroto Hara,Yumiko Tokusumi,Toshiaki Tabata. Владелец: Dnavec Corp. Дата публикации: 2009-10-01.

3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of alzheimer's disease

Номер патента: US20230159503A1. Автор: Ping Xiang,Jinming Gao,Bo REN,Jiangjiang Tang,Zhaoyuan Bian,Lanfang Huang. Владелец: NORTHWEST A&F UNIVERSITY. Дата публикации: 2023-05-25.

3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease

Номер патента: US11680062B2. Автор: Ping Xiang,Jinming Gao,Bo REN,Jiangjiang Tang,Zhaoyuan Bian,Lanfang Huang. Владелец: NORTHWEST A&F UNIVERSITY. Дата публикации: 2023-06-20.

INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

Номер патента: EP2454599A1. Автор: Michael Thomas Heneka,Markus Peter Kummer. Владелец: Rheinische Friedrich Wilhelms Universitaet Bonn. Дата публикации: 2012-05-23.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: WO2012111021A1. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council Of Scientific & Industrial Research (An Indian Registered Body Incorporated Under The Registration Of Societies Act (Act Xxi Of 1860). Дата публикации: 2012-08-23.

Marker peptide for alzheimer's disease

Номер патента: US20110014635A1. Автор: Kazuo Yamamoto,Toshiharu Suzuki,Masaki Nishimura,Yoichi Araki,Haruyasu Yamaguchi,Naomi Miyagi. Владелец: Individual. Дата публикации: 2011-01-20.

Human PEM as a target for birth contol and treatment of Alzheimer's disease

Номер патента: US20020048764A1. Автор: Bertram Weiss,Bernard Haendler,Christoph Geserick. Владелец: Schering AG. Дата публикации: 2002-04-25.

Human PEM as a target for birth control and treatment of Alzheimer's disease

Номер патента: US6825329B2. Автор: Bertram Weiss,Bernard Haendler,Christoph Geserick. Владелец: Schering AG. Дата публикации: 2004-11-30.

Biomarkers and treatments of alzheimer’s disease and mild cognitive impairment

Номер патента: ZA202201230B. Автор: Eva Kontsekova,Norbert ZILKA,Michal Novak,Branislav Kovacech. Владелец: Axon NeuroScience SE. Дата публикации: 2024-09-25.

Assay method for Alzheimer's disease

Номер патента: US09453069B2. Автор: David M. Holtzman,Ronald Demattos,Kelly R. Bales,Steven M. Paul,David J. Cummins. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2016-09-27.

Methods of treating alzheimer's disease with apo a-1 milano

Номер патента: WO2012109469A2. Автор: Prediman K. Shah. Владелец: CEDARS-SINAI MEDICAL CENTER. Дата публикации: 2012-08-16.

Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents

Номер патента: EP4321165A2. Автор: Hitoshi Okazawa. Владелец: Tokyo Medical and Dental University NUC. Дата публикации: 2024-02-14.

Multiepitope vaccine for the treatment of alzheimer's disease

Номер патента: US20230355729A1. Автор: Robin Barbour,Wagner Zago,Gene Kinney. Владелец: Individual. Дата публикации: 2023-11-09.

Multi-epitope vaccine for the treatment of Alzheimer's disease

Номер патента: US11945849B2. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-04-02.

ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Номер патента: US20230364210A1. Автор: Robin Barbour,Wagner Zago,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-11-16.

Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g

Номер патента: AU2024201051A1. Автор: Hans-Peter Schwarz,David M. Gelmont,Julia Singer,Sandor Fritsch. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2024-03-14.

Diagnostic test and treatment/prevention of alzheimer's disease

Номер патента: EP3142708A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical Inc. Дата публикации: 2017-03-22.

Diagnostic Test and Treatment/Prevention of Alzheimer's Disease

Номер патента: US20160206714A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical Inc. Дата публикации: 2016-07-21.

Diagnostic test and treatment/prevention of alzheimer's disease

Номер патента: WO2015175898A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical, Inc.. Дата публикации: 2015-11-19.

Multi-epitope vaccine for the treatment of Alzheimer's disease

Номер патента: US11965005B2. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-04-23.

Multi-epitope vaccine for the treatment of Alzheimer's disease

Номер патента: US11952406B2. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-04-09.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20230322876A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-10-12.

Application of elapidae snake postsynaptic neurotoxin monomer molecule in treatment of alzheimer's disease

Номер патента: EP4046648A1. Автор: Hyatt QI,Zhankai QI. Владелец: Qi Zhankai. Дата публикации: 2022-08-24.

Tau vaccine for the treatment of alzheimer's disease

Номер патента: WO2022031342A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Limited. Дата публикации: 2022-02-10.

Method of treating alzheimer's disease

Номер патента: RU2526155C2. Автор: БАРРИО Мануэль САРАСА. Владелец: Араклон Байотек, С.Л.. Дата публикации: 2014-08-20.

Inhibitors of two sites of binding acetylcholinesterase for treatment of the alzheimer's disease

Номер патента: RU2325379C2. Автор: ПАДИЛЬЯ Мигель МЕДИНА,УЭРТА Ана ФУЭРТЕС,ДИАС Исабель ДОРРОНСОРО,ГОРДИЛЬО Диана АЛОНСО,ПАЛОМЕРО Эстер ГАРСИА,ХИЛ Ана МАРТИНЕС,МОНТЕ МИЛЬЯН Мария ДЕЛЬ,ЭХЕА Паола УСАН,АРРЬЕТА Лаура РУБИО,Сусана МОРАЛЕС-АЛСЕЛАЙ,АУСТРИА Селия ДЕ,МОНТЕ МИЛЬЯН Мари ДЕЛЬ,АУСТРИА Сели ДЕ. Владелец: Неурофарма, С.А.. Дата публикации: 2008-05-27.

Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease

Номер патента: US5589154A. Автор: Stephen Anderson. Владелец: Rutgers State University of New Jersey. Дата публикации: 1996-12-31.

2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: CA2714058A1. Автор: Craig A. Coburn,Hong Zhu,Philippe G. Nantermet,Hemaka A. Rajapakse,Keith P. Moore,Shawn J. Stachel,Ivory D. Hills,Samuel L. Graham. Владелец: Individual. Дата публикации: 2009-09-03.

Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: CA2667071A1. Автор: Philippe G. Nantermet,M. Katharine Holloway,Shaun R. Stauffer,Keith P. Moore. Владелец: Keith P. Moore. Дата публикации: 2008-04-17.

Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease

Номер патента: US7291454B2. Автор: Jack R Wands,Suzanne De La Monte. Владелец: General Hospital Corp. Дата публикации: 2007-11-06.

N-terminal truncated protofibrils/oligomers for use in therapeutic and diagnostic methods for alzheimer's disease and related disorders

Номер патента: CA2765602C. Автор: Lars Lannfelt,Paer Gellerfors,Karin Tegerstedt,Linda Soederberg. Владелец: BioArctic AB. Дата публикации: 2021-05-25.

DNA sequence useful for the detection of Alzheimer's disease

Номер патента: US5220013A. Автор: Barbara Cordell,Phyllis A. Ponte. Владелец: Scios Nova Inc. Дата публикации: 1993-06-15.

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: EP2063889A2. Автор: Craig A. Coburn,Wenjin Yang,Melissa S. Egbertson,Bruce Fahr,Wanli Lu,James C. Barrow,Lou Anne Neilson,Shaun R. Stauffer,Jenny M. Wai. Владелец: Sunesis Pharmaceuticals Inc. Дата публикации: 2009-06-03.

Identification of novel benzothiazones as tau-sh3 interaction inhibitors for the treatment of alzheimer's disease

Номер патента: WO2023250002A1. Автор: Mark J. Suto,Corinne E. Augelli-Szafran,Vibha Pathak,Erik D. Roberson. Владелец: THE UAB RESEARCH FOUNDATION. Дата публикации: 2023-12-28.

Scyllo-inositol in combination with immunotherapeutics for the treatment of alzheimer's disease

Номер патента: WO2024054416A1. Автор: Phillip Frost,Antonio Cruz,John K. CHOE. Владелец: Eirgen Pharma, Ltd.. Дата публикации: 2024-03-14.

Therapeutic agent for alzheimer's disease

Номер патента: US20210162069A1. Автор: Fuyuki Mitsuyama. Владелец: Individual. Дата публикации: 2021-06-03.

Methods for diagnosing and treating alzheimer's disease by administering an anti-angiogenic agent

Номер патента: US20140294726A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Individual. Дата публикации: 2014-10-02.

Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease

Номер патента: EP1153036A1. Автор: Rudolph E. Tanzi,Dora M. Kovacs,Aleister J. Saunders. Владелец: General Hospital Corp. Дата публикации: 2001-11-14.

Gene therapy for alzheimer's disease

Номер патента: EP3976637A1. Автор: Jie Shen,Raymond J. KELLEHER III. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2022-04-06.

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: EP2091328A2. Автор: Shaun R. Stauffer,Ivory D. Hills,Ashley Nomland. Владелец: Merck and Co Inc. Дата публикации: 2009-08-26.

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: US20100069419A1. Автор: Shaun R. Stauffer,Ivory D. Hills,Ashley Nomland. Владелец: Individual. Дата публикации: 2010-03-18.

Methods for diagnosing and treating alzheimer’s disease

Номер патента: AU2020204610A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2020-07-30.

Methods for diagnosing and treating alzheimer's disease

Номер патента: US20170224792A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Dara L. Dickstein. Дата публикации: 2017-08-10.

Methods for diagnosing and treating alzheimer's disease by administering an angiogenic agent

Номер патента: EP2734221A1. Автор: Kaan E. Biron,Dara L. Dickstein,Dr. Wilfred Jefferies. Владелец: Dickstein Dara L. Дата публикации: 2014-05-28.

Methods for diagnosing and treating alzheimer's disease

Номер патента: US20210100881A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2021-04-08.

Methods for diagnosing and treating alzheimer’s disease

Номер патента: AU2022202855A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2022-05-19.

Methods for diagnosing and treating Alzheimer's disease

Номер патента: US11925678B2. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2024-03-12.

Methods for diagnosing and treating alzheimer’s disease

Номер патента: AU2020204610B2. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2022-05-26.

Methods for diagnosing and treating Alzheimer's disease

Номер патента: US10792347B2. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Alternative Extracts Inc. Дата публикации: 2020-10-06.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3

Номер патента: EP1458711A1. Автор: Stefan Berg,Sven Hellberg,Ratan Bhat,Philip AstraZeneca Wilmington EDWARDS. Владелец: AstraZeneca AB. Дата публикации: 2004-09-22.

Therapeutic agent for alzheimer's disease

Номер патента: EP3804766A1. Автор: Fuyuki Mitsuyama. Владелец: Individual. Дата публикации: 2021-04-14.

Compounds for treatment of alzheimer's disease

Номер патента: EP2349308A1. Автор: Arun K. Ghosh. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2011-08-03.

Method for treating alzheimer's disease by targeting mapt gene

Номер патента: EP4179082A1. Автор: Tetsuya Yamagata,Iain Robert Thompson,Talha AKBULUT. Владелец: Modalis Therapeutics Corp. Дата публикации: 2023-05-17.

Compositions and methods for treating alzheimer's disease

Номер патента: US20240238355A1. Автор: William L. Klein,Diana Jerusalinsky,Sergio T. Ferreira,Maria Clara Selles,Adriano S. Sebollela. Владелец: Universidade Federal do Rio de Janeiro UFRJ. Дата публикации: 2024-07-18.

Trpc3 as a therapeutic target for alzheimer’s disease

Номер патента: US20240099277A1. Автор: Catherine Kaczorowski,Sarah M. Neuner,Kristen M.S. O'Connell. Владелец: Jackson Laboratory. Дата публикации: 2024-03-28.

Compound and method for treatment of alzheimer's disease

Номер патента: EP4087860A1. Автор: Jan Johansson. Владелец: ALPHABETA AB. Дата публикации: 2022-11-16.

Biomarkers for alzheimer's disease treatment

Номер патента: EP4367516A1. Автор: Robert Gordon,David Verbel,Pallavi SACHDEV,Michael Irizarry,Larisa Reyderman,Akihiko Koyama,June Kaplow,Lynn Kramer,Shobha DHADDA,Chad SWANSON,Michio KANEKIYO,Seiichi HAYATO,Ishani LANDRY. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2024-05-15.

Combined therapy for treating Alzheimer's disease

Номер патента: US11793775B2. Автор: Feng-Shiun Shie,Ih-Jen Su. Владелец: Merry Life Biomedical Company Ltd. Дата публикации: 2023-10-24.

Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain

Номер патента: US10344065B2. Автор: Nan-Shan CHANG,Yu-Min Kuo. Владелец: National Cheng Kung University NCKU. Дата публикации: 2019-07-09.

Compounds for alzheimer's disease

Номер патента: WO2006041874A3. Автор: Mark B Anderson,Yevgeniya Klimova,Kenton Zavitz,Jon Adam Willardsen,Warren S Weiner,Rachel Slade,Ruth J Walton,Robert J Halter,Ashantai J Yungai. Владелец: Ashantai J Yungai. Дата публикации: 2007-01-25.

Methods and compositions for treating alzheimer's disease

Номер патента: WO2003086300A3. Автор: Dudley Strickland,Bradley T Hyman,William G Rebeck,Ayae Kinoshita,Christa Whelan. Владелец: Christa Whelan. Дата публикации: 2004-01-22.

Regional tau imaging for diagnosing and treating alzheimer's disease

Номер патента: AU2023216231A1. Автор: Ilke TUNALI,Vikas KOTARI,Sergey SHCHERBININ,Sudeepti Suresh SOUTHEKAL. Владелец: Eli Lilly and Co. Дата публикации: 2024-08-01.

Method of Treating Cognitive Decline and Synaptic Loss Related to Alzheimer's Disease

Номер патента: US20090016995A1. Автор: Gary W. Arendash,Douglas W. Ethell. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2009-01-15.

Compositions and methods for treating alzheimer's disease

Номер патента: US20200289589A1. Автор: William L. Klein,Diana Jerusalinsky,Sergio T. Ferreira,Maria Clara Selles,Adriano S. Sebollela. Владелец: Universidade Federal do Rio de Janeiro UFRJ. Дата публикации: 2020-09-17.

Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy

Номер патента: US20230277687A1. Автор: Gloria Gonzalez-Aseguinolaza,Ralph Michael Linden,Diego Sucunza Guibert,Jose Luis Lanciego Perez. Владелец: Consorcio Centro de Investigacion Biomedica en Red MP. Дата публикации: 2023-09-07.

Novel blood cell biomarker for late onset alzheimer's disease

Номер патента: US20200333339A1. Автор: Christopher Wheeler. Владелец: Cedars Sinai Medical Center. Дата публикации: 2020-10-22.

Methods for treating alzheimer's disease

Номер патента: US20240270830A1. Автор: Karen SMIRNAKIS,Patrick Ryland BURKETT,Kimberly UMANS. Владелец: Biogen MA Inc. Дата публикации: 2024-08-15.

Liposomes displaying a glycan ligand for cd33 and their use in the treatment of alzheimer's disease

Номер патента: US20240238442A1. Автор: Matthew Macauley,Abhishek BATTACHERJEE,Arjun Singh BAINS,Gour DASKHAN. Владелец: University of Alberta. Дата публикации: 2024-07-18.

Modulating bone morphogenic protein (bmp) signaling in the treatment of alzheimer's disease

Номер патента: US20240102022A1. Автор: Robert C. Jones,Michael F. Clarke,Jane ANTONY,Elizabeth Yang Chen,Felicia Reinitz. Владелец: CZ Biohub SF LLC. Дата публикации: 2024-03-28.

Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain

Номер патента: US20190161525A1. Автор: Nan-Shan CHANG,Yu-Min Kuo. Владелец: National Cheng Kung University NCKU. Дата публикации: 2019-05-30.

Novel blood cell biomarker for late onset alzheimer's disease

Номер патента: EP3345000A1. Автор: Christopher Wheeler. Владелец: Cedars Sinai Medical Center. Дата публикации: 2018-07-11.

Methods for treating alzheimer's disease

Номер патента: EP4426349A2. Автор: Tianle Chen,Laura NISENBAUM,Raj RAJAGOVINDAN. Владелец: Biogen MA Inc. Дата публикации: 2024-09-11.

Methods for treating Alzheimer's disease

Номер патента: AU2024216442A1. Автор: Brendon Phillip BOOT,Jeffrey Joseph Sevigny,Leslie Lugene Williams. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2024-10-17.

Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy

Номер патента: US09994589B2. Автор: Robert Boyd. Владелец: Amicus Therapeutics Inc. Дата публикации: 2018-06-12.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: US09968618B1. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-05-15.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: US09918992B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-03-20.

Combination therapies for the treatment of alzheimer's disease and related disorders

Номер патента: US09913847B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-03-13.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: US09855276B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-01-02.

Optical method for detecting Alzheimer's disease by systemic administration of curcumin

Номер патента: US09839699B2. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Michal Schwartz,Daniel L. Farkas. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2017-12-12.

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

Номер патента: US09512191B2. Автор: Nazneen Dewji,S. Jonathan Singer. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2016-12-06.

Immunotherapeutic compositions for the treatment of alzheimer'S disease

Номер патента: US09498522B2. Автор: Stephen Grimes,Peter Blackburn. Владелец: MERCIA PHARMA Inc. Дата публикации: 2016-11-22.

Compositions for reducing Aβ 42 production and their use in treating alzheimer's disease (AD)

Номер патента: US09464053B2. Автор: Venkateswarlu Akella,Uday Saxena,Anji Reddy Kallam. Владелец: KAREUS THERAPEUTICS SA. Дата публикации: 2016-10-11.

3,5-diarylazaindoles as DYRK1A protein inhibitors for the treatment of cognitive deficiencies associated with Down's syndrome and with Alzheimer's disease

Номер патента: US09447093B2. Автор: Kevin Cariou,Stephanie Gourdain,Jean Maurice Delabar,Nathalie Janel,Julien Dairou,Clement Denhez,Robert Dobb,Fernando Rodrigues Lima. Владелец: Universite de Reims Champagne Ardenne URCA. Дата публикации: 2016-09-20.

Active immunization for treatment of alzheimer's disease

Номер патента: US6905686B1. Автор: Dale B. Schenk. Владелец: Neuralab Ltd. Дата публикации: 2005-06-14.

Nucleic acids for diagnosing and modeling Alzheimer's disease

Номер патента: US5455169A. Автор: Michael J. Mullan. Владелец: Alzheimers Institute of America Inc. Дата публикации: 1995-10-03.

Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics

Номер патента: US6710226B1. Автор: Dale B. Schenk. Владелец: Neuralab Ltd. Дата публикации: 2004-03-23.

Assay method for alzheimer's disease

Номер патента: CA2457145C. Автор: David M. Holtzman,Ronald Demattos,Kelly R. Bales,Steven M. Paul,David J. Cummins. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2010-12-21.

Alzheimer's disease treatment method comprising a beta-amyloid peptide

Номер патента: CA2524571C. Автор: Manuel Sarasa Barrio. Владелец: Araclon Biotech SL. Дата публикации: 2017-01-10.

Tricyclic indole derivatives and their use in the treatment of alzheimer's disease

Номер патента: EP1620438A1. Автор: Emmanuel Hubert GlaxoSmithKline DEMONT,Sally GlaxoSmithKline REDSHAW,Daryl Simon GlaxoSmithKline WALTER. Владелец: Glaxo Group Ltd. Дата публикации: 2006-02-01.

Use of a peptide for the production of antibodies for the treatment of alzheimer's disease

Номер патента: IL171651A. Автор: . Владелец: Univ Zaragoza. Дата публикации: 2011-11-30.

Methods for diagnosing and treating alzheimer's disease

Номер патента: CA2250075C. Автор: Barbara A. Gilchrest,Mina Yaar. Владелец: Boston University. Дата публикации: 2008-06-10.

Intranasal immunotherapy for the treatment of alzheimer's disease

Номер патента: EP4236988A1. Автор: Kalipada PAHAN. Владелец: RUSH UNIVERSITY MEDICAL CENTER. Дата публикации: 2023-09-06.

Intranasal immunotherapt for the treatment of alzheimer's disease

Номер патента: US20240018231A1. Автор: Kalipada PAHAN. Владелец: RUSH UNIVERSITY MEDICAL CENTER. Дата публикации: 2024-01-18.

Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease

Номер патента: US20120114669A1. Автор: Sungmin Song,Yong-Keun Jung. Владелец: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION. Дата публикации: 2012-05-10.

Application of PI4KIIIA protein and related membrane protein complex in treating alzheimer's disease

Номер патента: US11766420B2. Автор: YANG He,Tong Zhu,Le Zhang,Xiao Zhang,Haiyan Liu,Yudong Zhou,Fude HUANG,Wenan WANG,Wanguo Wei,Lixiang Jiang. Владелец: Jiangsu Nuo-Beta Pharmaceutical Technology Co Ltd. Дата публикации: 2023-09-26.

Methods for the treatment and diagnosis of alzheimer's disease and traumatic brain injuries

Номер патента: EP3307392A1. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Universite Pierre et Marie Curie Paris 6. Дата публикации: 2018-04-18.

Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries

Номер патента: US10857239B2. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Universite Pierre et Marie Curie Paris 6. Дата публикации: 2020-12-08.

Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain Injuries

Номер патента: US20210069346A1. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Universite Pierre et Marie Curie Paris 6. Дата публикации: 2021-03-11.

Agglutination of gangliosides for treating alzheimer's disease

Номер патента: US20200017578A1. Автор: Eugene Ponomarev,Marina Dukhinova,Tatyana Veremeyko,Andrew L.M. Chan. Владелец: Chinese University of Hong Kong CUHK. Дата публикации: 2020-01-16.

Method of treating alzheimer's disease with expanded natural killer cells

Номер патента: WO2024036005A1. Автор: Sang Woo Park,Yong Man Kim,Paul Y. Song. Владелец: LOOTS, Eli. Дата публикации: 2024-02-15.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease

Номер патента: US8946261B2. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2015-02-03.

Methods for treating Alzheimer's disease

Номер патента: AU2021282448A1. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2022-01-06.

Application Of PI4KIIIA Protein And Related Membrane Protein Complex In Treating Alzheimer's Disease

Номер патента: US20240173287A1. Автор: YANG He,Tong Zhu,Le Zhang,Xiao Zhang,Haiyan Liu,Yudong Zhou,Fude HUANG,Wenan WANG,Wanguo Wei,Lixiang Jiang. Владелец: Jiangsu Nuo-Beta Pharmaceutical Technology Co Ltd. Дата публикации: 2024-05-30.

Cd33 antibody compositions for treating alzheimer's disease

Номер патента: WO2024092001A1. Автор: David A. Scheinberg,Yue-ming LI,Wan Fung Eitan WONG,Manish MALVIYA,Kristen VOGT,George LIAO. Владелец: Memorial Hospital for Cancer and Allied Diseases. Дата публикации: 2024-05-02.

Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy

Номер патента: US20190010238A1. Автор: Thomas Wisniewski,Allal BOUTAJANGOUT. Владелец: New York University NYU. Дата публикации: 2019-01-10.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: EP2675790A1. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2013-12-25.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: WO2012111021A8. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. Дата публикации: 2013-07-25.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: US20130324573A1. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2013-12-05.

Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease

Номер патента: US20120192294A1. Автор: Michael Thomas Heneka,Markus Peter Kummer. Владелец: Rheinische Friedrich Wilhelms Universitaet Bonn. Дата публикации: 2012-07-26.

Methods of treating alzheimer's disease

Номер патента: WO2015120233A1. Автор: Robert Paul,Michael Ward,William Cho,Michel Friesenhahn. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2015-08-13.

Compositions and uses thereof for the treatment or prevention of alzheimer's disease

Номер патента: WO2013020723A1. Автор: Remi Palmantier,Daniel Larocque,Pascale Tribout-Jover. Владелец: GLAXOSMITHKLINE BIOLOGICALS S.A.. Дата публикации: 2013-02-14.

Immunological methods and compositions for the treatment of Alzheimer's disease

Номер патента: US20030232758A1. Автор: Joanne Mclaurin,Peter St. George-Hyslop. Владелец: Hospital for Sick Children HSC. Дата публикации: 2003-12-18.

Novel compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy

Номер патента: CA3008266A1. Автор: Robert Boyd. Владелец: Amicus Therapeutics Inc. Дата публикации: 2017-06-22.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: AU2013334874A1. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2015-05-14.

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

Номер патента: CA2760519C. Автор: Nazneen Dewji,S. Jonathan Singer. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2020-10-27.

Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease

Номер патента: CA2212058A1. Автор: Gerard Raphael Dawson. Владелец: Individual. Дата публикации: 1996-08-29.

Transgenic non-human mice expressing Flag-APP-C100 protein develop alzheimer's disease brain morphology and behavior

Номер патента: US5849999A. Автор: Rachael L. Neve,Joanne Berger-Sweeney. Владелец: Wellesley College. Дата публикации: 1998-12-15.

Prevention and treatment of alzheimer's disease by genome editing using the crispr/cas system

Номер патента: CA2948429A1. Автор: Jacques P. Tremblay,Pierre Chapdelaine,Joël ROUSSEAU. Владелец: UNIVERSITE LAVAL. Дата публикации: 2015-11-12.

Gamma secretase modulators for the treatment of alzheimer ' s disease

Номер патента: EP2257542A1. Автор: William J. Greenlee,Robert G. Aslanian,Anandan Palani,Hongmei Li,Zhaoning Zhu,Jr. Robert D. Mazzola,Xianhai Huang,Jun Qin,Pawan Dhondi,Zhiqiang Zhao,Dmitri A. Pissarnitski. Владелец: Schering Corp. Дата публикации: 2010-12-08.

Optical method for the detection of alzheimer's disease

Номер патента: CA2735869C. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Michal Schwartz,Daniel L. Farkas. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2020-08-18.

3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease

Номер патента: US5356912A. Автор: Per Sauerberg,Frank Watjen,Preben H. Olesen,Jens W. Kindtler,Lone Nielsen. Владелец: Novo Nordisk AS. Дата публикации: 1994-10-18.

Methods of treating alzheimer's disease

Номер патента: CA2938466C. Автор: Robert Paul,Michael Ward,William Cho,Michel Friesenhahn. Владелец: Genentech Inc. Дата публикации: 2021-11-02.

Agents inhibiting kallikrein-8 for use in the prevention or treatment of alzheimer's disease

Номер патента: EP3353214A1. Автор: Arne HERRING,Kathy KEYVANI. Владелец: Universitaet Duisburg Essen. Дата публикации: 2018-08-01.

Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease

Номер патента: CA2212058C. Автор: Gerard Raphael Dawson. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2008-05-13.

Multiepitope vaccine for the treatment of alzheimer’s disease

Номер патента: TW202227464A. Автор: 羅賓 巴柏,吉因 金尼,瓦格奈 薩果. Владелец: 愛爾蘭商歐薩爾普羅席納有限公司. Дата публикации: 2022-07-16.

Neural thread protein gene expression and detection of Alzheimer's disease

Номер патента: US5948888A. Автор: Jack R. Wands,Suzanne De La Monte. Владелец: General Hospital Corp. Дата публикации: 1999-09-07.

Truncated memapsin 2 for use for treating alzheimer's disease

Номер патента: WO2007021886A3. Автор: Deborah Downs,Jordan Tang,Wan Pin Chang. Владелец: Wan Pin Chang. Дата публикации: 2007-08-09.

Brain penetrant amylin receptor based peptides for alzheimer's disease

Номер патента: CA2967616A1. Автор: Wen FU,Jack Jhamandas,Rania Soudy,Kamaljit Kaur,David Mactavish,Aarti Patel. Владелец: University of Alberta. Дата публикации: 2018-03-19.

High dose treatments for alzheimer's disease

Номер патента: US20240076358A1. Автор: Jillian SMITH,Janice SMITH,Geoff KERCHNER. Владелец: Genentech Inc. Дата публикации: 2024-03-07.

Peptoids and methods for treating alzheimer's disease

Номер патента: US20160376311A1. Автор: Melissa Moss,Shannon Servoss,James Phillip Turner, JR.. Владелец: University of Arkansas. Дата публикации: 2016-12-29.

Methods of delaying or preventing the onset of alzheimer's disease using crenezumab

Номер патента: WO2023245008A1. Автор: Nan Hu,Eric Reiman,Kaycee Michelle Sink,Shehnaaz SULIMAN,Carole HO,Pierre Tariot,Jessica LANGBAUM. Владелец: Banner Health. Дата публикации: 2023-12-21.

Diagnostic drug and diagnostic method for alzheimer's disease

Номер патента: AU2019318888A1. Автор: Atsushi Ono,Masakazu Hashimoto,Yasuhiro Teranishi,Maki Hashimoto,Masanori Kusumoto,Shoji KASHIWABARA. Владелец: Sumitomo Pharma Co Ltd. Дата публикации: 2021-03-18.

Dlgap2 as a therapeutic target for and alzheimer's disease and age-related cognitive decline

Номер патента: US20210321594A1. Автор: Catherine Kaczorowski,Sarah M. Neuner. Владелец: Jackson Laboratory. Дата публикации: 2021-10-21.

Compositions and methods for treating alzheimer's disease

Номер патента: US11873321B2. Автор: Yi Zhou,Xin-Yuan Fu. Владелец: Generos Biopharma Ltd. Дата публикации: 2024-01-16.

Diagnosis and treatment of alzheimer's disease

Номер патента: US20150177261A1. Автор: Kaj Blennow,Jonas Nilsson,Henrik Zetterberg,Adnan Halim,Göran Larson,Gunnar Brinkmalm,Erik Portelius. Владелец: Individual. Дата публикации: 2015-06-25.

Methods for treating alzheimer's disease

Номер патента: WO2023081194A3. Автор: Tianle Chen,Laura NISENBAUM,Raj RAJAGOVINDAN. Владелец: Biogen MA Inc.. Дата публикации: 2023-10-26.

Compounds for use in the treatment of alzheimer's disease

Номер патента: WO2013042053A3. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2013-07-18.

Compounds for use in the treatment of alzheimer's disease

Номер патента: EP2758077A2. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2014-07-30.

Targeting TGF-beta as a Therapy for Alzheimer's Disease

Номер патента: US20110136892A1. Автор: Richard A. Flavell,Terrence C. Town. Владелец: YALE UNIVERSITY. Дата публикации: 2011-06-09.

Compounds for use in the treatment of alzheimer's disease

Номер патента: US20140220041A1. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2014-08-07.

Compounds for use in the treatment of alzheimer's disease

Номер патента: WO2013042053A2. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2013-03-28.

Compounds for use in the treatment of Alzheimer's disease

Номер патента: US9365647B2. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2016-06-14.

Neuroactive steroid for the treatment of alzheimer's disease

Номер патента: AU2022291395A1. Автор: Albert Jean Robichaud,Michael C. Quirk,James J. Doherty,Aaron Michael KOENIG. Владелец: Sage Therapeutics Inc. Дата публикации: 2024-01-04.

Peptide therapeutics for treating alzheimer's disease and related conditions

Номер патента: EP3802568A1. Автор: Heloise Anne Pereira,Anne Kasus-Jacobi,Amanda J. STOCK. Владелец: University of Oklahoma . Дата публикации: 2021-04-14.

Biomarkers for alzheimer's disease treatment

Номер патента: CA3225302A1. Автор: Robert Gordon,David Verbel,Pallavi SACHDEV,Michael Irizarry,Larisa Reyderman,Akihiko Koyama,June Kaplow,Lynn Kramer,Shobha DHADDA,Chad SWANSON,Michio KANEKIYO,Seiichi HAYATO,Ishani LANDRY. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2023-01-12.

Neuroactive steroid for the treatment of alzheimer's disease

Номер патента: CA3223179A1. Автор: Albert Jean Robichaud,Michael C. Quirk,James J. Doherty,Aaron Michael KOENIG. Владелец: Sage Therapeutics Inc. Дата публикации: 2022-12-15.

Neuroactive steroid for the treatment of alzheimer's disease

Номер патента: EP4351588A1. Автор: Albert Jean Robichaud,Michael C. Quirk,James J. Doherty,Aaron Michael KOENIG. Владелец: Sage Therapeutics Inc. Дата публикации: 2024-04-17.

Biomarkers for alzheimer's disease treatment

Номер патента: AU2022307687A1. Автор: Robert Gordon,David Verbel,Pallavi SACHDEV,Michael Irizarry,Larisa Reyderman,Akihiko Koyama,June Kaplow,Lynn Kramer,Shobha DHADDA,Chad SWANSON,Michio KANEKIYO,Seiichi HAYATO,Ishani LANDRY. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2024-01-04.

Compound and method for treatment of alzheimer's disease

Номер патента: US20230002458A1. Автор: Jan Johansson. Владелец: ALPHABETA AB. Дата публикации: 2023-01-05.

Methods for the treatment of alzheimer's disease and compositions therefore

Номер патента: EP1565202A2. Автор: Larry Alexander Gaither,Dalia Cohen. Владелец: Novartis Pharma Gmbh. Дата публикации: 2005-08-24.

Astrocyte Interleukin-3 Reprograms Microglia and Limits Alzheimer`s Disease

Номер патента: US20240148832A1. Автор: Rudolph E. Tanzi,Cameron McAlpine,Filip K. Swirski. Владелец: General Hospital Corp. Дата публикации: 2024-05-09.

Methods for treating alzheimer's disease

Номер патента: WO2023196470A1. Автор: Stephanie CHERQUI,Priyanka Mishra. Владелец: The Regents of the University of California. Дата публикации: 2023-10-12.

Methods for treating alzheimer's disease

Номер патента: EP4351643A2. Автор: Karen SMIRNAKIS,Patrick Ryland BURKETT,Kimberly UMANS. Владелец: Biogen MA Inc. Дата публикации: 2024-04-17.

Compounds for use in the treatment of alzheimer's disease

Номер патента: US20160361413A1. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2016-12-15.

Methods for treating alzheimer's disease

Номер патента: WO2022261026A3. Автор: Karen SMIRNAKIS,Patrick Ryland BURKETT,Kimberly UMANS. Владелец: Biogen MA Inc.. Дата публикации: 2023-01-19.

Method for treating alzheimer’s disease

Номер патента: NZ731520A. Автор: James Ferrero,Jeffrey SEVIGNY,Leslie Williams. Владелец: Biogen Int Neuroscience Gmbh. Дата публикации: 2021-08-27.

Methods for treating alzheimer's disease

Номер патента: US20180333487A1. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2018-11-22.

Method for treating Alzheimer's disease

Номер патента: AU2015356773B2. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2021-09-09.

Method for treating alzheimer's disease

Номер патента: EP3227329A2. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH. Дата публикации: 2017-10-11.

Diagnostic drug and diagnostic method for Alzheimer's disease

Номер патента: US12000844B2. Автор: Atsushi Ono,Masakazu Hashimoto,Yasuhiro Teranishi,Maki Hashimoto,Masanori Kusumoto,Shoji KASHIWABARA. Владелец: Sumitomo Pharma Co Ltd. Дата публикации: 2024-06-04.

Hyperforin derivatives and their use in Alzheimer's disease

Номер патента: US09556099B2. Автор: Paolo Morazzoni,Gabriele Fontana,Antonella Riva. Владелец: Indena SpA. Дата публикации: 2017-01-31.

Phosphinic acid derivatives, beta-secretase inhibitors for treating alzheimer's disease

Номер патента: RU2367666C2. Автор: Ханс ХИЛЬПЕРТ,Роланд ХУММ,Петер ВАЙСС,Дитмар КНОПП,Ханс ХИЛЬПЕРТ (CH),Роланд ХУММ (DE),Дитмар КНОПП (CH),Петер ВАЙСС (CH). Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2009-09-20.

Protected amino acid derivatives for the treatment of alzheimer's disease

Номер патента: GB2392443A. Автор: Robert Gordon,Henriette Willems. Владелец: De Novo Pharmaceuticals Ltd. Дата публикации: 2004-03-03.

Compounds useful in the therapy of alzheimer's disease and formulations containing them

Номер патента: EP1638914A2. Автор: Ezio Bombardelli,Gabriele Fontana,Luisella Univers. degli Studi di Milano VEROTTA. Владелец: Indena SpA. Дата публикации: 2006-03-29.

Compounds useful in the therapy of alzheimer’s disease and formulations containing them

Номер патента: WO2004106275A2. Автор: Ezio Bombardelli,Gabriele Fontana,Luisella Verotta. Владелец: INDENA S.P.A.. Дата публикации: 2004-12-09.

Poly-ga proteins in alzheimer's disease

Номер патента: EP4427049A1. Автор: Laura Ranum,Lien Nguyen. Владелец: University Of Florida. Дата публикации: 2024-09-11.

Sorla mini-receptor for treatment of alzheimer's disease

Номер патента: CA3219014A1. Автор: Olav Michael Andersen,Anne Mette GISSEL JENSEN. Владелец: AARHUS UNIVERSITET. Дата публикации: 2023-01-05.

Sorla mini-receptor for treatment of alzheimer's disease

Номер патента: AU2022305119A1. Автор: Olav Michael Andersen,Anne Mette GISSEL JENSEN. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-02-01.

Zinc-charged peptides for the treatment of cancer and alzheimer's disease

Номер патента: US20240199712A1. Автор: Men Hwei Tsai. Владелец: Individual. Дата публикации: 2024-06-20.

Zinc-charged peptides for the treatment of cancer and alzheimer's disease

Номер патента: US12065470B2. Автор: Men Hwei Tsai. Владелец: Individual. Дата публикации: 2024-08-20.

Method for in vitro diagnosis of alzheimer's disease using monoclonal antibody

Номер патента: RU2416619C2. Автор: Энрике МЕНДЕС. Владелец: Консехо Супериор Де Инвестигасионес Сьентификас. Дата публикации: 2011-04-20.

Method of in-vitro diagnosis of alzheimer's disease by means of a monoclonal antibody

Номер патента: CA2601550C. Автор: Enrique Mendez. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2014-11-18.

Sorla mini-receptor for treatment of alzheimer's disease

Номер патента: EP4363440A1. Автор: Olav Michael Andersen,Anne Mette GISSEL JENSEN. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-05-08.

Methods and system for detecting living, non-demented patients who have alzheimer's disease neuropathology for alzheimer's disease

Номер патента: WO2019099431A1. Автор: Gregory B. Mills. Владелец: Inspired Life Medical Inc.. Дата публикации: 2019-05-23.

Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom

Номер патента: EP1481007B1. Автор: Paul Averback. Владелец: Nymox Corp. Дата публикации: 2007-01-24.

Methods for treating Alzheimer's disease

Номер патента: US11781135B2. Автор: C. Frank Bennett,Timothy M. Miller,Frank Rigo,Sarah Devos. Владелец: Biogen MA Inc. Дата публикации: 2023-10-10.

Blood-based diagnostic assays for alzheimer's disease

Номер патента: CA3226615A1. Автор: Ian Pike,George Thornton,Michael BREMANG. Владелец: Cassava Sciences Inc. Дата публикации: 2023-03-30.

Alzheimer’s disease model

Номер патента: WO2003046172A3. Автор: Karl Peter Giese,Marco Angelo. Владелец: Marco Angelo. Дата публикации: 2003-07-17.

Biofluid-based methods for diagnosing alzheimer's disease-associated conditions

Номер патента: EP4307988A1. Автор: Hugo Vanderstichele,Leyla ANDERSON,Steven R. Verdooner. Владелец: Neurovision Imaging Inc. Дата публикации: 2024-01-24.

Biofluid-Based Methods for Diagnosing Alzheimer’s Disease-Associated Conditions

Номер патента: US20240159777A1. Автор: Hugo Vanderstichele,Leyla ANDERSON,Steven R. Verdooner. Владелец: Neurovision Imaging Inc. Дата публикации: 2024-05-16.

Neural thread protein gene expression and detection of alzheimer's disease

Номер патента: AU674581B2. Автор: Jack R. Wands,Suzanne M. De La Monte. Владелец: General Hospital Corp. Дата публикации: 1997-01-02.

Alzheimer's disease secretase, APP substrates thereof, and uses thereof

Номер патента: US20050196398A1. Автор: Mark Gurney,Michael Bienkowski. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2005-09-08.

Bispecific nanobodies as a therapeutic for alzheimer's disease

Номер патента: WO2011031720A1. Автор: Michael Sierks,Srinath Kasturirangan,Shanta Boddapati. Владелец: Arizona Board of Regents Acting for And on Behalf of Arizona State University. Дата публикации: 2011-03-17.

Methods to treat alzheimer's disease using apoe inhibitors

Номер патента: WO2013181618A3. Автор: Asa Abeliovich. Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2014-03-27.

Biotin complexes for treatment and diagnosis of alzheimer's disease

Номер патента: US09655977B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2017-05-23.

Biotin complexes for treatment and diagnosis of Alzheimer's disease

Номер патента: AU2019203874A1. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2019-06-20.

Method for selecting a transgenic mouse model of alzheimer's disease

Номер патента: US6717031B2. Автор: Kate Dora Games,Russell E. Rydel,Dale Bernard Schenk,Lisa Claire McConlogue,Peter Andrew Seubert. Владелец: Athena Neurosciences Inc. Дата публикации: 2004-04-06.

Method for identifying alzheimer's disease therapeutics using transgenic animal models

Номер патента: WO1996040896A1. Автор: Dale B. Schenk,Peter A. Seubert,Russell E. Rydel,Kate D. Games,Lisa Claire McConlogue. Владелец: Athena Neurosciences, Inc.. Дата публикации: 1996-12-19.

Non-human alzheimer's disease model animal and method for producing same

Номер патента: EP4043568A1. Автор: Hiroyuki Yamazaki,Yuko Sekino,Kenji HANAMURA,Tomoaki Shirao,Noriko Koganezawa. Владелец: Alzmed Inc. Дата публикации: 2022-08-17.

Non-human alzheimer's disease model animal and method for producing same

Номер патента: US20230138759A1. Автор: Hiroyuki Yamazaki,Yuko Sekino,Kenji HANAMURA,Tomoaki Shirao,Noriko Koganezawa. Владелец: Alzmed Inc. Дата публикации: 2023-05-04.

Use of the ornithine transcarbamylase (otc), as a marker for diagnosing a brain alteration including alzheimer's disease or non-alzheimer's dementia

Номер патента: CA2649462A1. Автор: Philippe Amouyel,Stephanie Ferreira,Jean-Charles Lambert. Владелец: Individual. Дата публикации: 2007-10-25.

Transgenic animal models for alzheimer's disease

Номер патента: CA2127450C. Автор: Vermuri B. Reddy,Samuel Wadsworth,Benjamin Snyder,Chamer Wei. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2007-04-17.

Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease

Номер патента: CA2085127C. Автор: Barbara Cordell. Владелец: Scios Nova Inc. Дата публикации: 2002-12-10.

Alzheimer's disease animal model, method for obtaining same and uses thereof

Номер патента: CA2638983A1. Автор: Lluis Montoliu Jose,Fernando Valdivieso Amate,Julio Pozueta Larios. Владелец: Individual. Дата публикации: 2007-06-07.

Wild-derived mouse models of alzheimer's disease

Номер патента: AU2023232109A1. Автор: Gareth Howell,Gregory Carter,Michael SASNER,Kristen ONOS. Владелец: Jackson Laboratory. Дата публикации: 2024-10-10.

Models of Alzheimer's Disease

Номер патента: GB2295395A. Автор: Brian Anderton,Christopher Charles Joh Miller. Владелец: INST OF PSYCHIATRY. Дата публикации: 1996-05-29.

Non-human primate alzheimer's disease model animal and method for producing same

Номер патента: US20230027317A1. Автор: Takashi Yamamoto,Kenichi Nagata,Kenya Sato,Tetsushi Sakuma,Takaomi Saido,Erika Sasaki,Wakako KUMITA,Hiroki SASAGURI. Владелец: Central Institute for Experimental Animals. Дата публикации: 2023-01-26.

USE OF Aß34 TO ASSESS ALZHEIMER’S DISEASE PROGRESSION

Номер патента: US20210285971A1. Автор: Gerhard MULTHAUP,Adeola Shobo. Владелец: Royal Institution for the Advancement of Learning. Дата публикации: 2021-09-16.

Non-human primate alzheimer's disease model animal and method for producing same

Номер патента: EP4079852A1. Автор: Takashi Yamamoto,Kenichi Nagata,Kenya Sato,Tetsushi Sakuma,Takaomi Saido,Erika Sasaki,Wakako KUMITA,Hiroki SASAGURI. Владелец: Central Inst for Experimental Animals. Дата публикации: 2022-10-26.

Wild-derived mouse models of alzheimer's disease

Номер патента: WO2023173009A2. Автор: Gareth Howell,Gregory Carter,Michael SASNER,Kristen ONOS. Владелец: THE JACKSON LABORATORY. Дата публикации: 2023-09-14.

Association between the acid phosphatase (ACP1) gene and Alzheimer's disease

Номер патента: US20030110523A1. Автор: David Comings,James MacMurray. Владелец: Individual. Дата публикации: 2003-06-12.

Animal model for alzheimer's disease

Номер патента: WO2004064768A3. Автор: Tadeusz Wieloch. Владелец: Tadeusz Wieloch. Дата публикации: 2004-09-30.

Compositions and methods using reelin in alzheimer's disease

Номер патента: WO2024081934A1. Автор: Joseph F. Arboleda-Velasquez,Eric Reiman,Francisco LOPERA,Yakeel Tatiana QUIROZ-GAVIRIA. Владелец: Banner Health. Дата публикации: 2024-04-18.

ErbB2 REGULATES AUTOPHAGIC FLUX TO MODULATE THE PROTEOSTASIS OF APP-CTFs IN ALZHEIMER'S DISEASE

Номер патента: US20190209565A1. Автор: Yung-Feng Liao,Bo-Jeng WANG. Владелец: Academia Sinica. Дата публикации: 2019-07-11.

ErbB2 REGULATES AUTOPHAGIC FLUX TO MODULATE THE PROTEOSTASIS OF APP-CTFs IN ALZHEIMER'S DISEASE

Номер патента: WO2018048755A1. Автор: Yung-Feng Liao,Bo-Jeng WANG. Владелец: Shih, Ming-Che. Дата публикации: 2018-03-15.

Method for identifying carbohydrate drug-sensitive patient in patients having alzheimer's disease

Номер патента: CA3148921A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2021-02-11.

Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for preparing therapeutic agents for alzheimer's disease

Номер патента: RU2472513C2. Автор: Сигфридо СКАРПА,Андреа ФУСО,Розеллина ДАМЬЯНИ,Мауро РОССИНИ. Владелец: Гносис С.п.А.. Дата публикации: 2013-01-20.

Process for treatment of amyotrophic lateral sclerosis,rheumatoid arthritis,tremors/parkinson's disease,multiple sclerosis,non-viral based cancers,alzheimer's disease,muscular dystrophy,attention deficit disorder,attention deficit hyperactivity disorder,complex regional pain syndrome,diabetes,neuropathic pain,spider arthritis,west nile virus,fibromyalgia,shingles,gout,migraine headaches,senile dementia,post polio syndrome,central virus deafness,asthma,chronic pain of unknown origin and hepatitis c

Номер патента: SG184564A1. Автор: George Nelson. Владелец: Salubrious Pharmaceutical LLC. Дата публикации: 2012-11-29.

Composition for prevention or treatment of alzheimer's disease comprising lactobacillus sakei probio-65

Номер патента: US20230381250A1. Автор: Yong-Ha Park,Min-Tze Liong. Владелец: Probionic Corp. Дата публикации: 2023-11-30.

Methods of treating alzheimer's disease

Номер патента: WO2023275376A1. Автор: Olav Michael Andersen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2023-01-05.

Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases

Номер патента: WO2005115136A3. Автор: Dale E Bredesen,Veronica Galvan. Владелец: Buck Inst. Дата публикации: 2006-09-14.

Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases

Номер патента: WO2005115136A2. Автор: Veronica Galvan,Dale E. Bredesen. Владелец: Buck Institute. Дата публикации: 2005-12-08.

Transgenic models of alzheimer"s disease and uses thereof in the treatment of a variety of neurodegenerative diseases

Номер патента: EP1744762A2. Автор: Veronica Galvan,Dale E. Bredesen. Владелец: BUCK INSTITUTE FOR RESEARCH ON AGING. Дата публикации: 2007-01-24.

Methods of treating alzheimer's disease

Номер патента: EP4363578A1. Автор: Olav Michael Andersen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-05-08.

Methods of treating alzheimer's disease

Номер патента: US20240279666A1. Автор: Olav Michael Andersen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-08-22.

Composition for preventing or treating alzheimer's disease comprising inhibitor of atlastin 2, and method for diagnosing alzheimer's disease by determining atlastin 2

Номер патента: US20230227828A1. Автор: Dong Gyu Jo,Ji Hoon Han. Владелец: Sungkyunkwan University Research and Business Foundation. Дата публикации: 2023-07-20.

Use of the cyp46a1 gene for the treatment of alzheimer's disease

Номер патента: EP2187898A1. Автор: Patrick Aubourg,Nathalie Cartier-Lacave,Eloise Hudry. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2010-05-26.

A transgenic invertebrate model for alzheimer's disease and use thereof

Номер патента: US20210227814A1. Автор: Katsuhiko Yanagisawa,Yasutoyo YAMASAKI,Leo TSUDA. Владелец: NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY. Дата публикации: 2021-07-29.

Transgenic invertebrate model of alzheimer's disease and utilization thereof

Номер патента: EP3626074A1. Автор: Katsuhiko Yanagisawa,Yasutoyo YAMASAKI,Leo TSUDA. Владелец: NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY. Дата публикации: 2020-03-25.

Rapid high throughput screening system to assess potential treatments for sporadic alzheimer’s disease

Номер патента: US20240093236A1. Автор: David L. Kaplan,Dana Cairns. Владелец: TUFTS UNIVERSITY. Дата публикации: 2024-03-21.

Rapid high throughput screening system to assess potential treatments for sporadic alzheimer's disease

Номер патента: WO2022170072A1. Автор: David L. Kaplan,Dana Cairns. Владелец: TRUSTEES OF TUFTS COLLEGE. Дата публикации: 2022-08-11.

Compositions and methods of detecting and treating alzheimer's disease

Номер патента: AU2024205163A1. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascular Therapeutics LLC. Дата публикации: 2024-08-15.

Therapeutic targets for Alzheimer's disease

Номер патента: US09944986B2. Автор: Zsuzsanna Nagy. Владелец: UNIVERSITY OF BIRMINGHAM. Дата публикации: 2018-04-17.

Treatment with cytokines for alzheimer's disease

Номер патента: CA2487734C. Автор: Mario Clerici,Giorgio Annoni. Владелец: Immunoclin Ltd. Дата публикации: 2012-03-06.

Compositions and methods for preparing an alzheimer's disease animal model using microrna

Номер патента: US20230256119A1. Автор: Hyo Jin Lee,Sang Moo Lee,Jin-Hyeob Ryu,Hyun Su Min. Владелец: Biorchestra Co Ltd. Дата публикации: 2023-08-17.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US20170042990A1. Автор: Bira Arya,Richard Markham. Владелец: Cyvax Inc. Дата публикации: 2017-02-16.

Compounds for use in treating alzheimer's disease in apoe4+/+ patients

Номер патента: EP4289820A2. Автор: Petr Kocis,John Hey,Martin TOLAR,Jeremy Yu. Владелец: Alzheon Inc. Дата публикации: 2023-12-13.

Compositions and methods for treating alzheimer's disease

Номер патента: EP4376824A1. Автор: Li Ouyang,Kit Yu Fu,Nancy Yuk Yu Ip,Fanny Chui Fun Ip,Yuanbing JIANG,Xiaopu ZHOU,Hiu Yi WONG,Yangyang DUAN. Владелец: Hong Kong University of Science and Technology HKUST. Дата публикации: 2024-06-05.

Pharmaceutical composition for treating alzheimer's disease

Номер патента: US20230233615A1. Автор: Yu-Chen Tsai,Chi-Ying Huang,Ming-Hsi Chuang,Po-Cheng Lin. Владелец: Gwo Xi Stem Cell Applied Technology Co Ltd. Дата публикации: 2023-07-27.

Methods of treating alzheimer's disease

Номер патента: WO2018178987A1. Автор: Daniel Offen,Ariel ANGEL. Владелец: Ramot at Tel-Aviv University Ltd.. Дата публикации: 2018-10-04.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US20140199338A1. Автор: Bira Arya,Richard Markham. Владелец: Cyvax Inc. Дата публикации: 2014-07-17.

Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of alzheimer's disease

Номер патента: EP3810142A1. Автор: William J. ROMANOW,Ming-Hsiang Lee,Jerold Chun,Victoria BLAHO. Владелец: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE. Дата публикации: 2021-04-28.

Methods of treating alzheimer's disease

Номер патента: EP3601570A1. Автор: Daniel Offen,Ariel ANGEL. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2020-02-05.

Methods for treating alzheimer's disease

Номер патента: AU2023249247A1. Автор: Stephanie CHERQUI,Priyanka Mishra. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2024-10-24.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US09937248B2. Автор: Bira Arya. Владелец: Cyvax Inc. Дата публикации: 2018-04-10.

Methods for diagnosing and treating alzheimer's disease (AD) using the molecules that stabilize intracellular calcium (Ca2+) release

Номер патента: US09464322B2. Автор: Olivier Thibault,Philip W. Landfield,Kuey-Chu Chen,Eric M. Blalock,John Christopher Gant,Nada Porter. Владелец: University of Kentucky Research Foundation. Дата публикации: 2016-10-11.

Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof

Номер патента: US09463157B2. Автор: Hsin-Yung Lin. Владелец: Individual. Дата публикации: 2016-10-11.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US09433665B2. Автор: Bira Arya,Richard Markham. Владелец: Cyvax Inc. Дата публикации: 2016-09-06.

Method for detecting and treating Alzheimer's disease

Номер патента: US5535760A. Автор: Huntington Potter. Владелец: Harvard College. Дата публикации: 1996-07-16.

Small molecule immunomodulators for alzheimer's disease

Номер патента: CA2746273C. Автор: John R. Cashman,Kenneth J. Abel. Владелец: HUMAN BIOMOLECULAR RESEARCH INSTITUTE. Дата публикации: 2019-04-09.

Cell therapy for alzheimer's disease

Номер патента: WO2023201133A1. Автор: Howard Gendelman,R. Lee Mosley,Pravin YEAPURI,Jatinkumar MACHHI. Владелец: Board of Regents of the University of Nebraska. Дата публикации: 2023-10-19.

Therapeutic targets for alzheimer's disease

Номер патента: EP2872529A2. Автор: Zsuzsanna Nagy. Владелец: UNIVERSITY OF BIRMINGHAM. Дата публикации: 2015-05-20.

Compositions and methods of detecting and treating alzheimer's disease

Номер патента: WO2019191518A1. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascuar Therapeutics Llc. Дата публикации: 2019-10-03.

Bacillus subtilis strain with positive influence on neurodegenerative diseases such as alzheimer's disease

Номер патента: WO2024074556A1. Автор: Stefan Pelzer,Heike Tom Dieck,Michelle DARGATZ,Lisa Guttler,Juliane PETER,Andreas BREMGES. Владелец: EVONIK OPERATIONS GMBH. Дата публикации: 2024-04-11.

Screening platform to identify therapeutic drugs or agents for treatment of alzheimer's disease

Номер патента: ZA202000409B. Автор: QUINTI Luisa,E Tanzi Rudolph,Yeon Kim Doo. Владелец: Massachusetts Gen Hospital. Дата публикации: 2023-10-25.

Antisense oligonucleotides for use in treating alzheimer's disease

Номер патента: AU2022271491A1. Автор: Thomas Petrus Gerardus DE VLAAM,Tsinatkeab Tadesse HAILU,Zhana KARNEVA. Владелец: Academisch Ziekenhuis Leiden Also Acting Under Name Leiden University Medical Centre Lum. Дата публикации: 2023-02-09.

Compositions and methods of detecting and treating alzheimer's disease

Номер патента: EP3773500A1. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascular Therapeutics LLC. Дата публикации: 2021-02-17.

Compositions and methods of detecting and treating Alzheimer's disease

Номер патента: AU2019243579B2. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascular Therapeutics LLC. Дата публикации: 2024-05-09.

Method for identifying carbohydrate drug-sensitive patient in patients having alzheimer's disease

Номер патента: US20220280541A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2022-09-08.

Method for identifying carbohydrate drug-sensitive patient in patients having Alzheimer's disease

Номер патента: AU2020327258A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2022-03-10.

Compositions and methods for treating alzheimer's disease

Номер патента: WO2023005959A1. Автор: Li Ouyang,Kit Yu Fu,Nancy Yuk Yu Ip,Fanny Chui Fun Ip,Yuanbing JIANG,Xiaopu ZHOU,Hiu Yi WONG,Yangyang DUAN. Владелец: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY. Дата публикации: 2023-02-02.

Method for detecting and treating Alzheimer's disease

Номер патента: US5297562A. Автор: Huntington Potter. Владелец: Harvard College. Дата публикации: 1994-03-29.

Screening method for therapeutic agents against Alzheimer's disease

Номер патента: US6071694A. Автор: Kazutomo Imahori,Ken-Ichi Saito,Akihiko Takashima,Toshimitsu Hoshino,Akiko Shiratsuchi,Showbu Sato. Владелец: Mitsubishi Chemical Corp. Дата публикации: 2000-06-06.

Compounds for use in treating alzheimer's disease in apoe4+/+ patients

Номер патента: EP4289820A3. Автор: Petr Kocis,John Hey,Martin TOLAR,Jeremy Yu. Владелец: Alzheon Inc. Дата публикации: 2024-03-13.

Agents, compositions and methods for treating and preventing alzheimer's disease

Номер патента: US20210085692A1. Автор: Roberta Diaz Brinton,Kathleen E. ROGERS. Владелец: University of Southern California USC. Дата публикации: 2021-03-25.

Agents, compositions and methods for treating and preventing alzheimer's disease

Номер патента: WO2019178230A1. Автор: Roberta Diaz Brinton,Kathleen E. ROGERS. Владелец: UNIVERSITY OF SOUTHERN CALIFORNIA. Дата публикации: 2019-09-19.

Methods of diagnosis and treatment of alzheimer's disease

Номер патента: US20200088724A1. Автор: Xinhua Zhan,Boryana S. Stamova-Kiossepacheva,Frank R. Sharp. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2020-03-19.

Methods of diagnosis and treatment of Alzheimer's Disease

Номер патента: US11598774B2. Автор: Xinhua Zhan,Boryana S. Stamova-Kiossepacheva,Frank R. Sharp. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2023-03-07.

Treatment of alzheimer's disease with vascular progenitor-derived exosomes enriched with micrornas or thioredoxin

Номер патента: WO2024039760A2. Автор: Peixin Yang,Wei-bin SHEN. Владелец: University of Maryland, Baltimore. Дата публикации: 2024-02-22.

Methods for treating alzheimer's disease with donepezil transdermal system

Номер патента: US20240156747A1. Автор: Eun Soo Lee,Amit K. Jain,Parminder Singh. Владелец: Corium LLC. Дата публикации: 2024-05-16.

Screening Assays Using Stem Cells and Stem Cell-Derived Neurons from Mouse Models of Alzheimer's Disease

Номер патента: US20140171380A1. Автор: Tae-Wan Kim,Natalie Landman,Laura Beth Johnson MCINTIRE,Gina FINAN. Владелец: Columbia University in the City of New York. Дата публикации: 2014-06-19.

Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies

Номер патента: US20150174150A1. Автор: Seongsoo Lee,Bingwei Lu. Владелец: Leland Stanford Junior University. Дата публикации: 2015-06-25.

Method for treating alzheimer's disease by regulating amino acid level

Номер патента: CA3148926A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2021-02-11.

Method for treating Alzheimer's disease by regulating amino acid level

Номер патента: AU2020327259A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2022-03-10.

Neural-derived human exosomes for alzheimer's disease and co-morbidities thereof

Номер патента: WO2021096929A1. Автор: Rene ANAND,Susan MCKAY. Владелец: Anand Rene. Дата публикации: 2021-05-20.

Instant diagnostic test for alzheimer's disease

Номер патента: RU2426130C2. Автор: Томас АРЕНДТ,Дженс СТИЛЕР. Владелец: Лейпцигский Университет. Дата публикации: 2011-08-10.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: EP1556703A2. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2005-07-27.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: EP1556703B1. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2008-10-22.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: AU2003286144A1. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2004-05-13.

Biomarkers for the progression of alzheimer's disease

Номер патента: CA2657980A1. Автор: Yunsheng He,Baltazar Gomez-Mancilla,Joanne Meyer,Giorgio Rovelli,Rainer R. Kuhn,Graeme Bilbe. Владелец: Individual. Дата публикации: 2007-12-27.

Diagnosis of alzheimer's disease using ldl receptor protein-1

Номер патента: EP1290451A2. Автор: Berislav V. Zlokovic. Владелец: University of Southern California USC. Дата публикации: 2003-03-12.

Diagnosis of alzheimer's disease using ldl receptor protein-1

Номер патента: EP1290451B1. Автор: Berislav V. Zlokovic. Владелец: University of Southern California USC. Дата публикации: 2005-12-07.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: WO2004038422A2. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA S.A.. Дата публикации: 2004-05-06.

Inhibitors of Src kinase for use in alzheimer's disease

Номер патента: US20040176313A1. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2004-09-09.

Method for manifestation of alzheimer's disease

Номер патента: RU2380423C2. Автор: Лоран Прадье,Жан-Франсуа ДЕЛЕЗ,Сильвен РИКАР,Сандрин МАС,Эмманюэль КУЗЕН,Хесус Бенавидес. Владелец: Авентис Фарма С.А.. Дата публикации: 2010-01-27.

Devices, kits, and methods for determining increased susceptibility to and treatment and prevention of periodontitis, alzheimer's disease, and other conditions

Номер патента: WO2023283021A9. Автор: Martin Levine,Zsolt M. LOHINAI. Владелец: Martin Levine. Дата публикации: 2023-11-02.

Microrna biomarkers indicative of alzheimer's disease

Номер патента: US09771617B2. Автор: Pavan Kumar,Zoltan Dezso. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2017-09-26.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: EP3551051A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2019-10-16.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: US20190300960A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2019-10-03.

Methods of diagnosing Alzheimer's disease and risk of progression to Alzheimer's disease

Номер патента: AU2017371071B2. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2023-06-15.

Method for diagnosing alzheimer's disease spectrum neurocognitive disorders from tear sample, and solution and diagnostic kit useful in the method

Номер патента: WO2021130508A3. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2021-08-05.

Method for diagnosing alzheimer's disease spectrum neurocognitive disorders from tear sample, and solution and diagnostic kit useful in the method

Номер патента: EP4081797A2. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2022-11-02.

Method for diagnosing alzheimer's disease spectrum neurocognitive disorders from tear sample, and solution and diagnostic kit useful in the method

Номер патента: WO2021130508A2. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2021-07-01.

Apoe promoter single nucleotide polymorphism associated with alzheimer's disease risk and use thereof

Номер патента: EP3626830A1. Автор: Jang Jae Lee,Kun Ho Lee,Kyu Yeong Choi. Владелец: Infomeditech Co ltd. Дата публикации: 2020-03-25.

Micro-rna-biomarkers indicating alzheimer's disease

Номер патента: RU2639509C2. Автор: Золтан ДЕЗСО,Паван КУМАР. Владелец: Эйсай Ар Энд Ди Менеджмент Ко., Лтд.. Дата публикации: 2017-12-21.

Quick test for the diagnosis of alzheimer's disease

Номер патента: RS52875B. Автор: Thomas Arendt,Jens Stieler. Владелец: Universität Leipzig. Дата публикации: 2013-12-31.

Alzheimer's disease-specific alterations of protein kinase c epsilon (pkc-epsilon) protein levels

Номер патента: CA2790680C. Автор: Daniel L. Alkon,Tapan K. Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2019-02-19.

Quick test for the diagnosis of alzheimer's disease

Номер патента: CA2540841A1. Автор: Thomas Arendt,Jens Stieler. Владелец: Jens Stieler. Дата публикации: 2005-06-02.

Devices, kits, and methods for determining increased susceptibility to and treatment and prevention of periodontitis, alzheimer's disease, and other conditions

Номер патента: EP4367261A1. Автор: Martin Levine,Zsolt M. LOHINAI. Владелец: Individual. Дата публикации: 2024-05-15.

Extracellular targets for alzheimer's disease

Номер патента: WO2009043922A2. Автор: Bart De Strooper,Tomoko Wakabayashi. Владелец: Katholieke Universiteit Leuven, K.U. Leuven R & D. Дата публикации: 2009-04-09.

Methods for detecting alzheimer's disease

Номер патента: IL195288A. Автор: . Владелец: ExonHit Therapeutics SA. Дата публикации: 2013-10-31.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: WO2018107059A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY HEALTH. Дата публикации: 2018-06-14.

Method For Diagnosing Alzheimer's Disease Spectrum Neurocognitive Disorders From Tear Sample, And Solution And Diagnostic Kit Useful In The Method

Номер патента: US20230024661A1. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2023-01-26.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: US20240026452A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2024-01-25.

Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof

Номер патента: US20100196400A1. Автор: Yonghong Li,Andrew Grupe. Владелец: Celera Corp. Дата публикации: 2010-08-05.

Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof

Номер патента: CA2626086A1. Автор: Yonghong Li,Andrew Grupe. Владелец: Individual. Дата публикации: 2007-05-03.

Ntrk1 genetic markers associated with age of onset of alzheimer's disease

Номер патента: WO2005037204A2. Автор: Richard S. Judson,Jeroen Aerssens,Maria Athanasiou,Carlos Brain,Nadine Cohen,Bradley Dain,R. Rex Denton,Vural Ozdemir,Carol R. Reed. Владелец: Genaissance Pharmaceuticals, Inc.. Дата публикации: 2005-04-28.

Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)

Номер патента: US09556487B2. Автор: Samuil R. Umansky,Kira S. Sheinerman,Vladimir Tsivinsky. Владелец: DiamiR LLC. Дата публикации: 2017-01-31.

Variants of clu/apoj, picalm, abca7, cr1 and bin1 gene loci and the ms4a gene cluster for the diagnosis of alzheimer's disease

Номер патента: CA2766876C. Автор: Julie Williams,Michael John Owen. Владелец: University College Cardiff Consultants Ltd. Дата публикации: 2020-01-28.

Procedure and methods for detecting alzheimer's disease

Номер патента: NZ573505A. Автор: Fabien Schweighoffer,Laurent Bracco. Владелец: ExonHit Therapeutics SA. Дата публикации: 2011-04-29.

Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants

Номер патента: CA2735578C. Автор: Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2018-10-23.

Treatment of alzheimer's disease

Номер патента: US20230348978A1. Автор: Roman Urfer,Anne URFER-BUCHWALDER. Владелец: Selonterra Inc. Дата публикации: 2023-11-02.

Use of apoe4 motif-mediated genes for diagnosis and treatment of alzheimer's disease

Номер патента: EP3555629A2. Автор: Roman Urfer,Anne URFER-BUCHWALDER. Владелец: Selonterra Inc. Дата публикации: 2019-10-23.

Treatment of alzheimer's disease

Номер патента: WO2021142163A1. Автор: Roman Urfer,Anne URFER-BUCHWALDER. Владелец: Selonterra, Inc.. Дата публикации: 2021-07-15.

Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease

Номер патента: WO2000063441A3. Автор: Corinna Herrnstadt,Robert E Davis. Владелец: Robert E Davis. Дата публикации: 2002-03-14.

Clonal hematopoiesis of indeterminate potential and protection from alzheimer's disease

Номер патента: WO2023034096A1. Автор: Siddhartha Jaiswal,Hind BOUZID. Владелец: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY. Дата публикации: 2023-03-09.

Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof

Номер патента: US20140134186A1. Автор: Yonghong Li,Andrew Grupe. Владелец: Celera Corp. Дата публикации: 2014-05-15.

INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT

Номер патента: WO2004041211A3. Автор: Pavel Petukhov,Alan P Kozikowski,Paul S Aisen. Владелец: Paul S Aisen. Дата публикации: 2004-09-10.

BACE1 inhibitors for the treatment of Alzheimer's disease

Номер патента: US12043631B2. Автор: Arun K. Ghosh,Andrew Mesecar,Margherita Brindisi,Emilio Leal Cardenas. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2024-07-23.

Benfotiamine derivatives in the treatment of alzheimer's disease

Номер патента: US11820787B2. Автор: Huan ZHANG,Chunjiu Zhong. Владелец: Shanghai Raising Pharmaceutical Co Ltd. Дата публикации: 2023-11-21.

Diagnostic tests for alzheimer's disease

Номер патента: WO1999058981A2. Автор: Daniel L. Alkon,Maurizio Grimaldi,Antonella R. Favit. Владелец: The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services. Дата публикации: 1999-11-18.

Diagnostic tests for alzheimer's disease

Номер патента: EP1078259A2. Автор: Daniel L. Alkon,Maurizio Grimaldi,Antonella R. Favit. Владелец: US Department of Health and Human Services. Дата публикации: 2001-02-28.

Negative correlation between irp-2 and transferrin receptor expression as a diagnostic of alzheimer's disease

Номер патента: US20100143924A1. Автор: Wolff M. Kirsch. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2010-06-10.

Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck) -molecules, corresponding substances and detection reagents

Номер патента: WO2005038463A8. Автор: Hans-Dieter Zucht,Hartmut Selle,Jens Lamerz,Thomas Moehring. Владелец: Thomas Moehring. Дата публикации: 2006-02-16.

Methods for diagnosing and treating alzheimer's disease and parkinson's disease

Номер патента: CA2493718A1. Автор: Paul F. Good,D. Stave Kohtz. Владелец: Individual. Дата публикации: 2003-01-30.

Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease

Номер патента: CA2781952A1. Автор: Alice Yam,Xuemei Wang,David Peretz,Man Gao (Carol),Sophie Allauzen,Joseph Fedynyshyn. Владелец: NOVARTIS AG. Дата публикации: 2011-06-03.

Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Номер патента: WO2009043858A9. Автор: Emmanuelle Liaudet,Christine Prebois,Danielle Derocq,Mélanie Beaujoin. Владелец: Mélanie Beaujoin. Дата публикации: 2009-07-09.

Diagnostic agent and method for alzheimer's disease

Номер патента: WO2024049357A1. Автор: Chin Tong ONG,Zhen Kai NGIAN,Yow Yong TAN. Владелец: TEMASEK LIFE SCIENCES LABORATORY LIMITED. Дата публикации: 2024-03-07.

Synaptic protein biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: EP3452828A1. Автор: Edward J. Goetzl. Владелец: Nanosomix Inc. Дата публикации: 2019-03-13.

Biological devices and methods of use thereof for the study and control of alzheimer's disease

Номер патента: US09890201B2. Автор: Raul CUERO RENGIFO,Diana Marcela VASQUEZ FORERO. Владелец: INTERNATIONAL PARK OF CREATIVITY Co. Дата публикации: 2018-02-13.

Diagnostic drug and diagnostic method for alzheimer's disease

Номер патента: CA2823286C. Автор: Hiroyuki Nakagawa,Mikio Aoki,Masakazu Hashimoto,Lars O. Tjernberg,Bengt Winblad. Владелец: Sumitomo Dainippon Pharma Co Ltd. Дата публикации: 2020-01-28.

Compositions and methods for diagnosing alzheimer's disease

Номер патента: US6495335B2. Автор: Mario Chojkier,Martina Buck. Владелец: Individual. Дата публикации: 2002-12-17.

Polypeptide marker for alzheimer's disease and its use for diagnosis

Номер патента: CA1268131A. Автор: George G. Glenner,Caine W. Wong. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 1990-04-24.

p53 Peptides as Markers in the Diagnosis and Prognosis of Alzheimer's Disease

Номер патента: US20240060994A1. Автор: Maurizio Memo,Daniela Letizia UBERTI. Владелец: Diadem Spa. Дата публикации: 2024-02-22.

Compositions, kits, and methods for detecting preclinical alzheimer's disease

Номер патента: CA3228621A1. Автор: Xin Huang,James Doecke,Yihan Li,Baijun GU. Владелец: NEUROQUEST Ltd. Дата публикации: 2023-02-16.

Cell test for Alzheimer's disease

Номер патента: AU689776B2. Автор: Ito Etsuro,Daniel L. Alkon,Rene Etcheberrigaray,Gary E Gibson. Владелец: Cornell Research Foundation Inc. Дата публикации: 1998-04-09.

Compositions, kits, and methods for detecting preclinical alzheimer's disease

Номер патента: EP4384831A1. Автор: Xin Huang,James Doecke,Yihan Li,Baijun GU. Владелец: NEUROQUEST Ltd. Дата публикации: 2024-06-19.

Cell test for alzheimer's disease

Номер патента: WO1994025872A1. Автор: Ito Etsuro,Daniel L. Alkon,Gary E. Gibson,Rene Etcheberrigaray. Владелец: Conell Research Foundation, Inc.. Дата публикации: 1994-11-10.

The application of antibodies for detecting protein biomarker group in the preparation of kits for diagnosing Alzheimer's disease, mild cognitive impairment and other senile dementia

Номер патента: LU503936B1. Автор: Zhengqian DAI,Bojun Gu. Владелец: Hunan Qiankang Tech Co Ltd. Дата публикации: 2024-07-05.

Polypeptide marker for Alzheimer's disease and its use for diagnosis

Номер патента: US4666829A. Автор: George G. Glenner,Caine W. Wong. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 1987-05-19.

Diagnostic methods for alzheimer's disease

Номер патента: US6287793B1. Автор: Dale B. Schenk,Robin M. Barbour,Kelly L. Johnson. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2001-09-11.

Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)

Номер патента: US6114133A. Автор: Robin Barbour,Dale B. Schenk,Peter A. Seubert,Carmen Vigo-Pelfrey. Владелец: Eli Lilly and Co. Дата публикации: 2000-09-05.

Biomarkers for diagnosing alzheimer's disease

Номер патента: CA2746000C. Автор: Denis François HOCHSTRASSER,Jean-Charles Sanchez,Gerhard Koenig,Oezkan Yalkinoglu,Odile Carrette. Владелец: Bayer Schering Pharma AG. Дата публикации: 2014-10-21.

Protein and its use in diagnosing alzheimer's disease

Номер патента: WO2006089422A1. Автор: Paul Averback,Jack Gemmell. Владелец: NYMOX CORPORATION. Дата публикации: 2006-08-31.

Biomarkers comprising peptide sequence vnhvtlsqpk for diagnosing alzheimer's disease

Номер патента: CA2745724C. Автор: Denis François HOCHSTRASSER,Jean-Charles Sanchez,Gerhard Koenig,Oezkan Yalkinoglu,Odile Carrette. Владелец: Bayer Schering Pharma AG. Дата публикации: 2015-06-02.

Diagnostic method for alzheimer's disease

Номер патента: CA2782432C. Автор: Maria Zellner,Ellen Umlauf. Владелец: Randox Laboratories Ltd. Дата публикации: 2019-01-08.

Biomarkers for diagnosing alzheimer's disease

Номер патента: CA2496321E. Автор: Denis François HOCHSTRASSER,Jean-Charles Sanchez,Gerhard Koenig,Oezkan Yalkinoglu,Odile Carrette. Владелец: Odile Carrette. Дата публикации: 2004-03-04.

Lateral flow device for diagnosing alzheimer's disease using the t14 peptide

Номер патента: WO2024052650A1. Автор: Susan Greenfield,Sara GARCIA-RATES. Владелец: NEURO-BIO LTD. Дата публикации: 2024-03-14.

Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Номер патента: WO2009043858A2. Автор: Emmanuelle Liaudet,Christine Prebois,Danielle Derocq,Mélanie Beaujoin. Владелец: Inserm (Institut National de la Sante et de la Recherche Medicale). Дата публикации: 2009-04-09.

Method for detecting mild cognitive impairment and mild alzheimer's disease

Номер патента: US20230417774A1. Автор: Yoshiya Oda,Suzumi TOKUOKA,Fumie HAMANO. Владелец: University of Tokyo NUC. Дата публикации: 2023-12-28.

Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Номер патента: WO2009043858A3. Автор: Emmanuelle Liaudet,Christine Prebois,Danielle Derocq,Mélanie Beaujoin. Владелец: Mélanie Beaujoin. Дата публикации: 2009-05-28.

Alzheimer's disease, secretase, APP substrates therefor, and uses therefor

Номер патента: US6790610B2. Автор: Mark E. Gurney,Luis A. Parodi,Michael J. Bienkowski,Robert L. Heinrikson,Riqiang Yan. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2004-09-14.

Alzheimer's disease secretase, APP substrates therefor, and uses therefor

Номер патента: US20010018208A1. Автор: Mark Gurney,Riqiang Yan,Robert Heinrikson,Luis Parodi,Michael Bienkowski. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2001-08-30.

CDNA clone encoding brain amyloid of alzheimer's disease

Номер патента: US4912206A. Автор: Dmitry Y. Goldgaber,Michael Lerman,D. Carleton Gajdusek. Владелец: US Department of Health and Human Services. Дата публикации: 1990-03-27.

Methods for the diagnosis of alzheimer's disease

Номер патента: WO1995005604A3. Автор: Carl R Merril,Ginger Johnson,Hossein A Ghanbari,Benjamin Wolozin. Владелец: Molecular Geriatrics Corp. Дата публикации: 2001-09-13.

Compositions, kits, and methods for detecting preclinical alzheimer's disease

Номер патента: AU2022327748A1. Автор: Xin Huang,James Doecke,Yihan Li,Baijun GU. Владелец: NEUROQUEST Ltd. Дата публикации: 2024-02-15.

Radiopharmaceutical ketone and dual tracer imaging in alzheimer's disease, cognitive impairment, and other conditions of altered cerebral metabolism

Номер патента: AU2021381323A1. Автор: Samuel T. Henderson,Judith WALKER,Ernest Wong. Владелец: Cerecin Inc. Дата публикации: 2023-06-22.

Radiopharmaceutical ketone and dual tracer imaging in alzheimer's disease, cognitive impairment, and other conditions of altered cerebral metabolism

Номер патента: AU2021381323A9. Автор: Samuel T. Henderson,Judith WALKER,Ernest Wong. Владелец: Cerecin Inc. Дата публикации: 2024-10-03.

Radiopharmaceutical ketone and dual tracer imaging in alzheimer's disease, cognitive impairment, and other conditions of altered cerebral metabolism

Номер патента: EP4247241A1. Автор: Samuel T. Henderson,Judith WALKER,Ernest Wong. Владелец: Cerecin Inc. Дата публикации: 2023-09-27.

Radiopharmaceutical ketone and dual tracer imaging in alzheimer's disease, cognitive impairment, and other conditions of altered cerebral metabolism

Номер патента: US20240016959A1. Автор: Samuel T. Henderson,Judith WALKER,Ernest Wong. Владелец: Cerecin Inc. Дата публикации: 2024-01-18.

System, software and methods of using software for predicting efficacy of alzheimer's disease treatments

Номер патента: US20240225538A1. Автор: William W. SEELEY,Joon-Kyung SEONG,Whajin Lee,Jesse Aaron BROWN. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2024-07-11.

System, software and methods of using software for predicting efficacy of alzheimer's disease treatments

Номер патента: WO2022072738A9. Автор: William W. SEELEY,Joon-Kyung SEONG. Владелец: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION. Дата публикации: 2023-03-23.

Transgenic animals exhibiting major disorders related to Alzheimer's disease

Номер патента: US20050076400A1. Автор: Laurent Pradier,Patrick Benoit,Gunter Tremp,Veronique Blanchard-Bregeon,Jean-Michel Itier,Caty Casas Louzao. Владелец: AVENTIS PHARMA SA. Дата публикации: 2005-04-07.

Transgenic pig as a model of alzheimer's disease

Номер патента: US20100138940A1. Автор: Arne Lund JØRGENSEN,Ida Elisabeth Holm,Anders Lade Nielsen,Marianne Gregers Johansen,Jannik Ejnar Jakobsen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2010-06-03.

Transgenic pig as a model of alzheimer's disease

Номер патента: WO2008106981A1. Автор: Arne Lund JØRGENSEN,Ida Elisabeth Holm,Anders Lade Nielsen,Marianne Gregers Johansen,Jannik Ejnar Jakobsen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2008-09-12.

Transgenic pig as a model of alzheimer's disease

Номер патента: EP2134846A1. Автор: Arne Lund JØRGENSEN,Ida Elisabeth Holm,Anders Lade Nielsen,Marianne Gregers Johansen,Jannik Ejnar Jakobsen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2009-12-23.

Model animal of alzheimer's disease and use thereof

Номер патента: US20070294779A1. Автор: Takashi Saito,Jiro Takano,Takaomi Saido,Nobuhisa Iwata,Takahiro Suemoto. Владелец: RIKEN Institute of Physical and Chemical Research. Дата публикации: 2007-12-20.

Method of treating alzheimer's disease, progressive multiple sclerosis, severe stroke, cerebral and birth brain injury, parkinsonism and other neurodegenerative diseases

Номер патента: RU2737995C1. Автор: Наталья Вениаминовна Казанцева. Владелец: Наталья Вениаминовна Казанцева. Дата публикации: 2020-12-07.

Application of protein yb-1 and its fragments for production of medications in treatment of alzheimer's disease

Номер патента: RU2561050C2. Автор: Александр Николаевич Самохин,Наталья Викторовна Бобкова,Ирина Юрьевна Александрова,Лев Павлович Овчинников,Наталия Игоревна Медвинская,Сергей Георгиевич Гурьянов,Инна Владимировна Нестерова,Ирина Александровна Елисеева,Павел Валерьевич Некрасов. Владелец: Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН). Дата публикации: 2015-08-20.

Memantine therapy for alzheimer's disease of low and low to moderate severity

Номер патента: RU2371173C2. Автор: Скотт МАКДОНАЛЬД,Айван ГЕРГЕЛ,Альбрехт ШТЕФФЛЕР,Ханс-Йорг МЕБИУС,Ивонне ВИРТ,Стивен ПОТКИН. Владелец: Мерц Фарма Гмбх Унд Ко. Кгаа. Дата публикации: 2009-10-27.

Methods for treating alzheimer's disease and pharmaceutical compositions

Номер патента: RU2675786C2. Автор: Эллен ШМИДТ,Джохан АРЕБЕРГ. Владелец: Х. Лундбекк А/С. Дата публикации: 2018-12-25.

Use of R-(Z) -alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2 oct-3-yl) acetonitrile to reduce amyloid beta A4 formation in Alzheimer's disease

Номер патента: AU3843195A. Автор: Roger Edward Markwell,Carol Wendy Gray,Julie Hawkins. Владелец: SmithKline Beecham Ltd. Дата публикации: 1996-05-15.

Use of R-(Z) -alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2 oct-3-yl) acetonitrile to reduce amyloid beta A4 formation in Alzheimer's disease

Номер патента: AU698695B2. Автор: Roger Edward Markwell,Carol Wendy Gray,Julie Hawkins. Владелец: SmithKline Beecham Ltd. Дата публикации: 1998-11-05.

Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease

Номер патента: WO2009099563A3. Автор: Daniel L. Alkon,Changhai Cui. Владелец: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE. Дата публикации: 2009-10-15.

[r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl) acetonitrile for reducing amyloid beta a4 formation in alzheimer's disease

Номер патента: NZ295155A. Автор: Roger Edward Markwell,Carol Wendy Gray,Julie Hawkins. Владелец: Smithkline Beecham Plc. Дата публикации: 2000-07-28.

Methods for preventing ectopic brain mineralization in alzheimer's disease and dementias

Номер патента: WO2023154860A1. Автор: Erming Tian,Maurizio Zangari. Владелец: Tzerma Llc. Дата публикации: 2023-08-17.

Astrocytic trpa1 channel inhibition as a novel neuroprotective therapeutic target in the prodromal phases of alzheimer's disease

Номер патента: US20230372350A1. Автор: Alain Buisson,Mireille Albrieux,Adrien Paumier,Anthony Bosson,Sylvie Boisseau. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2023-11-23.

A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease

Номер патента: CA2310926C. Автор: Wim Louis Julien Parys,Michael Pontecorvo. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2002-10-15.

Biomarkers for the diagnosis and characterization of alzheimer's disease

Номер патента: WO2018049268A8. Автор: Therese Koal,Matthias Arnold,Will THOMPSON,Rima F. KADDURAH-DAOUK,Xianlin Han,Rebecca A. Baillie,Kwangsik Nho,Andrew J. Saykin,Jon B. TOLEDO,Gabi KASTEMULLER,Lisa ST. JOHN-WILLIAMS,M. Arthur MOSELEY,Pudugramam Murali DORAISWAMY. Владелец: Rosa & Co Llc. Дата публикации: 2019-04-25.

Pharmaceutical composition of naphthalene derivatives as multi-targeted therapeutic agents for the treatment of alzheimer's disease

Номер патента: US20240299334A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro De Neurociencias De Cuba Cneuro. Дата публикации: 2024-09-12.

Biomarkers for the diagnosis and characterization of alzheimer's disease

Номер патента: EP3577455A1. Автор: Therese Koal,Matthias Arnold,Will THOMPSON,Rima F. KADDURAH-DAOUK,Xianlin Han,Rebecca A. Baillie,Kwangsik Nho,Andrew J. Saykin,Jon B. TOLEDO,Gabi KASTEMULLER,Lisa ST. JOHN-WILLIAMS,M. Arthur MOSELEY,Pudugramam Murali DORAISWAMY. Владелец: Rosa and Co LLC. Дата публикации: 2019-12-11.

Method and composition for enhancing cognition in alzheimer's patients

Номер патента: US20140377351A1. Автор: Moshe Laudon,Nava Zisapel. Владелец: Neurim Pharmaceuticals 1991 Ltd. Дата публикации: 2014-12-25.

Method of suppressing beta-amyloid-related changes in alzheimer's disease

Номер патента: AU1709999A. Автор: Howard L. Weiner,Dennis J. Selkoe. Владелец: Janssen Alzheimer Immunotherapy. Дата публикации: 1999-06-16.

Method of suppressing beta-amyloid-related changes in alzheimer's disease

Номер патента: EP1033998A1. Автор: Howard L. Weiner,Dennis J. Selkoe. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2000-09-13.

Pharmaceutical composition of naphthalene derivatives as multi-target therapeutic agents for the treatment of alzheimer's disease

Номер патента: CA3200071A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro de Neurociencias de Cuba. Дата публикации: 2022-06-02.

Pharmaceutical composition of naphthalene derivatives as multi-target therapeutic agents for the treatment of alzheimer's disease

Номер патента: AU2021388673A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro de Neurociencias de Cuba. Дата публикации: 2024-03-28.

Pharmaceutical composition of naphthalene derivatives as multi-target therapeutic agents for the treatment of alzheimer's disease

Номер патента: EP4252749A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro de Neurociencias de Cuba. Дата публикации: 2023-10-04.

Application of Lactoferrin in Prevention and Treatment of Alzheimer's Disease

Номер патента: US20240316163A1. Автор: GUO CHENG,LIN Zhang,Lingli Zhang. Владелец: Hainan Xingzheng Nutrition Engineering Co Ltd. Дата публикации: 2024-09-26.

Compositions of peptide conjugate and methods for prevention and treatment of alzheimer's disease

Номер патента: RU2406529C2. Автор: Джин КИННИ,Джон В. ШИВЕР,Джозеф Дж. ДЖОЙС,Виктор М. ГАРСКИ,Пол М. КЕЛЛЕР,Сяопин ЛЯН. Владелец: Мерк Шарп Энд Домэ Корп.. Дата публикации: 2010-12-20.

Pharmaceutical composition for prevention or treatment of alzheimer's disease, comprising mountain-cultivated ginseng extract

Номер патента: US20210113639A1. Автор: Sang Il Lee,Hyoung Chun Kim,Eun Joo Shin,Sung Kwon KO. Владелец: University Industry Cooperation Foundation of Kangwon National University. Дата публикации: 2021-04-22.

Pharmaceutical composition for prevention or treatment of alzheimer's disease, comprising mountain-cultivated ginseng extract

Номер патента: EP3616704A1. Автор: Sang Il Lee,Hyoung Chun Kim,Eun Joo Shin,Sung Kwon KO. Владелец: University Industry Cooperation Foundation of Kangwon National University. Дата публикации: 2020-03-04.

Therapeutic agent containing carbostiryl derivative and donepezil for treating alzheimer's disease

Номер патента: RU2469723C2. Автор: Хейи АРАИ. Владелец: Дзунтендо Юниверсити. Дата публикации: 2012-12-20.

Methods of diagnosing or treating alzheimer's disease

Номер патента: EP1173769A1. Автор: Roger Nitsch,Christoph Universität Zürich HOCK,Uwe Universität Basel OTTEN. Владелец: Evotec OAI AG. Дата публикации: 2002-01-23.

Liquid-state fermentation broth of Ganoderma lucidum to prepare a combination for amelioration, prevention or treatment of Alzheimer’s disease or other relevant symptoms induced by Alzheimer’s disease

Номер патента: AU2021102478A4. Автор: Wei-Jen Chen,Yu-Shan WEI,Hsin-I Lo,Hui-Fang Chu. Владелец: Syngen Biotech Co Ltd. Дата публикации: 2021-09-30.

Agent for preventing or treating alzheimer's disease

Номер патента: US20200108048A1. Автор: Hiroshi Kobayashi,Yoshihiko Matsumoto. Владелец: Fujifilm Toyama Chemical Co Ltd. Дата публикации: 2020-04-09.

Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders

Номер патента: WO1999048489A9. Автор: Blas Frangione,Jorge Ghiso,Miguel A Pappolla. Владелец: Univ New York. Дата публикации: 2000-07-20.

Composition for the use to treat alzheimer' s disease

Номер патента: EP2367529A1. Автор: Curt Hendrix. Владелец: Concourse Health Sciences LLC. Дата публикации: 2011-09-28.

Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system

Номер патента: US20130123370A1. Автор: Giulio M. Pasinetti. Владелец: Mount Sinai School of Medicine. Дата публикации: 2013-05-16.

Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system

Номер патента: US20150150828A1. Автор: Giulio Maria Pasinetti. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2015-06-04.

Compositions and methods for treating alzheimer`s disease and related disorders and promoting a healthy nervous system

Номер патента: US20160151301A1. Автор: Giulio Maria Pasinetti. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2016-06-02.

Compositions and methods for treating alzheimer’s disease and related disorders and promoting a healthy nervous system

Номер патента: WO2006047544A2. Автор: Giulio Mario Pasinetti. Владелец: Mount Sinai School Of Medecine Of New York University. Дата публикации: 2006-05-04.

Methods for using specific saccharides for treating Alzheimer's disease and other amyloidoses

Номер патента: US20020119934A1. Автор: Gerardo Castillo,Alan Snow. Владелец: Individual. Дата публикации: 2002-08-29.

Masitinib for the treatment of alzheimer's disease

Номер патента: AU2021399925A9. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2024-10-10.

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Номер патента: US09669199B2. Автор: Guy DiPierro,Steven A. Giannos. Владелец: Chrono Therapeutics Inc. Дата публикации: 2017-06-06.

Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease

Номер патента: WO2003094909A2. Автор: Eyal S. Ron. Владелец: Enos Pharmaceuticals, Inc.. Дата публикации: 2003-11-20.

Method of treatment of central nervous system diseases such as alzheimer's disease and parkinson's disease and method of diagnosing alzheimer's disease

Номер патента: CA1323294C. Автор: Chaovanee Aroonsakul. Владелец: Individual. Дата публикации: 1993-10-19.

Alkylating agent and combinations in the treatment of immune-related and liver diseases, alzheimer's diseases and fibrosis diseases

Номер патента: WO2022040110A3. Автор: Sheng Liu. Владелец: Sheng Liu. Дата публикации: 2022-03-31.

Unconjugated plga nanoparticles in the treatment of alzheimer's disease

Номер патента: US20230087306A1. Автор: QI Wu,Satyabrata Kar,Bibin Gnanadhason ANAND,Karthivashan GOVINDARAJAN. Владелец: University of Alberta. Дата публикации: 2023-03-23.

Noble gas treatment of alzheimer's disease and taupathies

Номер патента: US20170196906A1. Автор: Thomas Ichim,Vlad Bogin. Владелец: Noblis Therapeutics Inc. Дата публикации: 2017-07-13.

Use of the chinese medicine composition and dianxianning in the preparation of a medicament for preventing or treating alzheimer's diseases

Номер патента: US20170157192A1. Автор: Yang Li,Dong Wang,Xiaoyu Chen,Hongyu Li,Dejuan Zhi,Yinghui Li. Владелец: LANZHOU UNIVERSITY. Дата публикации: 2017-06-08.

Diagnosing and treating alzheimer's disease

Номер патента: US11719708B2. Автор: Steven William Graves. Владелец: BRIGHAM YOUNG UNIVERSITY. Дата публикации: 2023-08-08.

Composition for treating alzheimer's disease comprising as active ingredient mixed extract of pinellia ternata breitenbach, zizyphus jujuba var. inermis rehder, glycyrrhiza uralensis fischer, panax ginseng, zingiber officinale roscoe, scutellaria baicalensis, and coptis rhizome

Номер патента: EP4410300A1. Автор: Jae Kwang Kim,Jinsoo Seo,Hyein LEE,Tae Woo Oh,Jang-Gi Choi,Younghoon GO,Buyun KIM,Malk Eun PAK,Yeo Jin Park. Владелец: Korea Institute of Oriental Medicine KIOM. Дата публикации: 2024-08-07.

A traditional chinese medicine composition for the treatment of alzheimer's disease

Номер патента: NL2035374B1. Автор: ZHANG Wei,Shao Hui,HUANG PENG,PENG Can,Yang Xuan,LI Junying,Zhang Caiyun,Nian Lizhong,Shan Xiaoxiao,Jin Chuanshan,Du Mingsong. Владелец: Univ Anhui Chinese Medicine. Дата публикации: 2024-06-10.

Treatment of MCI and Alzheimer's disease

Номер патента: US09968574B2. Автор: Mark Lovell,Bert Lynn. Владелец: University of Kentucky Research Foundation. Дата публикации: 2018-05-15.

H3 receptor antagonist for use in the treatment of alzheimer's disease

Номер патента: US09789102B2. Автор: Thomas Rooney,Veronique Mary,Veronique Blanchard-Bregeon,Pascal Barneoud,Philippe Delay-Goyet,Jean Menager,Nathalie SCHUSSLER,Mathilde LOPEZ-GRANCHA. Владелец: SANOFI SA. Дата публикации: 2017-10-17.

New approach to treatment of alzheimer's disease

Номер патента: RU2106864C1. Автор: Сергей Евгеньевич Ткаченко,Светлана Васильевна Афанасьева,Сергей Олегович Бачурин,Марина Абрамовна Юровская,Николай Серафимович Зефиров,Владимир Викторович Григорьев,Валерий Павлович Четвериков,Андрей Захарович Афанасьев,Елизавета Евгеньевна Букатина,Ирина Владимировна Григорьева. Владелец: Ирина Владимировна Григорьева. Дата публикации: 1998-03-20.

Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease

Номер патента: US20240091227A1. Автор: Lucio Claudio Rovati,Gianfranco Caselli,Emanuele SALA. Владелец: Rottapharm Biotech SRL. Дата публикации: 2024-03-21.

Oxafuramine, (1r)-n-ethyl-1-[(2r)-oxolan-2-yl]-2-phenylethanamine, hydrochloride and derivatives thereof for use in treating neurodegenerative diseases with lewy body disease and/or alzheimer's disease

Номер патента: WO2023281109A1. Автор: Eric Konofal. Владелец: NLS Pharmaceutics AG. Дата публикации: 2023-01-12.

Probiotic bacteria for treating alzheimer's disease

Номер патента: US20230190835A1. Автор: Frederikus Gerardus Josephus Maria van de Wiel,Marjolein WILDWATER. Владелец: Individual. Дата публикации: 2023-06-22.

Oxafuramine, (1r)-n-ethyl-1-[(2r)-oxolan-2-yl]-2-phenylethanamine, hydrochloride and derivatives thereof for use in treating neurodegenerative diseases with lewy body disease and/or alzheimer's disease

Номер патента: EP4366725A1. Автор: Eric Konofal. Владелец: NLS Pharmaceutics AG. Дата публикации: 2024-05-15.

Agent For Prevention And/Or Treatment Of Alzheimer's Disease

Номер патента: US20070218031A1. Автор: Toshinori Ozaki,Akira Nakagawara. Владелец: Chiba Prefectural Government. Дата публикации: 2007-09-20.

ANAVEX2-73 for the treatment of Alzheimer's disease

Номер патента: AU2017418247B2. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2023-12-14.

Anavex2-73 for the treatment of alzheimer's disease

Номер патента: WO2018231216A1. Автор: Marco Cecchi. Владелец: ANAVEX LIFE SCIENCES CORP.. Дата публикации: 2018-12-20.

Methods and compositions for treating alzheimer's disease

Номер патента: EP2391370A1. Автор: Itzchak Angel,Tuvia Gilat. Владелец: Galmed International Ltd. Дата публикации: 2011-12-07.

Bambuterol for the treatment of alzheimer's disease

Номер патента: CA3095859C. Автор: Patrick Dallemagne,Christophe Rochais,Anne-Claire GROO,Aurelie Malzert-Freon. Владелец: Université de Caen Normandie. Дата публикации: 2024-04-30.

Pharmaceutical composition for the treatment of alzheimer's disease or dementia

Номер патента: US20240165097A1. Автор: Tim TASKER. Владелец: Allergan Pharmaceuticals International Ltd. Дата публикации: 2024-05-23.

Treatments and methods for treating alzheimer's disease

Номер патента: WO2023039226A3. Автор: Hung Wen LIN (Kevin). Владелец: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College. Дата публикации: 2023-04-20.

N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide for treatment of alzheimer's disease

Номер патента: US20230301982A1. Автор: Nitin Krishnaji Damle,Vikram Krishna Ramanathan,Sanjay Nandlalji MANDHANE,Shakti Kamalchand JAIN,Durgesh Ashok Kumar SONI. Владелец: Sun Pharma Advanced Research Co Ltd. Дата публикации: 2023-09-28.

Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor

Номер патента: EP1131060A2. Автор: Benjamin Nymox Corporation WOLOZIN. Владелец: Nymox Corp. Дата публикации: 2001-09-12.

Pharmaceutical composition for preventing or treating alzheimer's disease

Номер патента: EP4410286A1. Автор: Tao Zhao,Guimin Zhang,Honghua Li,Jingchun YAO,Chenghong SUN. Владелец: Shandong New Time Pharmaceutical Co Ltd. Дата публикации: 2024-08-07.

Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor

Номер патента: WO2000028981A3. Автор: Benjamin Wolozin. Владелец: Benjamin Wolozin. Дата публикации: 2000-11-09.

Treatments and methods for treating alzheimer's disease

Номер патента: US20240238268A1. Автор: Hung Wen (Kevin) Lin. Владелец: Louisiana State University. Дата публикации: 2024-07-18.

Pharmaceutical composition for the treatment of alzheimer's disease, method for producing same and use thereof

Номер патента: EP2556833A4. Автор: Sousa Buck Hudson De,Nunes Marielza Andrade. Владелец: Fundação Arnaldo Vieira De Carvalho. Дата публикации: 2013-09-04.

Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heteroyclic amide bond isostere

Номер патента: US20060116413A1. Автор: VARGHESE John. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2006-06-01.

Anavex2-73 for the treatment of alzheimer's disease

Номер патента: US11103478B2. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2021-08-31.

Methods of treating agitation associated with alzheimer's disease

Номер патента: US20230270738A1. Автор: Sanjay Dube. Владелец: Avanir Phrmaceuticals Inc. Дата публикации: 2023-08-31.

Agent for preventing or ameliorating alzheimer's disease

Номер патента: US11998559B2. Автор: Yasuyuki Igarashi,Kaori Takahashi,Katsuyuki Mukai,Kohei Yuyama. Владелец: Daicel Corp. Дата публикации: 2024-06-04.

Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease

Номер патента: WO2009025571A1. Автор: Igor Anatolievich Pomytkin. Владелец: Buddha Biopharma Oy Ltd. Дата публикации: 2009-02-26.

Synthesis of amino thiol nutraceutical linked antioxidant conjugates for treatment of Alzheimer’s disease

Номер патента: AU2021107264A4. Автор: Dileep Kumar,Neha Vithal Bhilare. Владелец: Bhilare Neha Vithal Dr. Дата публикации: 2021-12-23.

Agent for preventing or ameliorating alzheimer's disease

Номер патента: US20240277741A1. Автор: Yasuyuki Igarashi,Kaori Takahashi,Katsuyuki Mukai,Kohei Yuyama. Владелец: Daicel Corp. Дата публикации: 2024-08-22.

Compounds for treating or preventing alzheimer's disease

Номер патента: US20240269128A1. Автор: Madhav Thambisetty,Myriam Gorospe,Carlos Anerillas. Владелец: US Department of Health and Human Services. Дата публикации: 2024-08-15.

Preventative treatment of alzheimer's disease

Номер патента: US20180133186A1. Автор: Carol A. Colton. Владелец: Duke University. Дата публикации: 2018-05-17.

Methods and compositions for screening and treating alzheimer's disease

Номер патента: US20240310389A1. Автор: Peggy S. Eis,Eli Hatchwell,Edward B. Smith, Iii,Shapour JALILZADEH. Владелец: Population Bio Inc. Дата публикации: 2024-09-19.

Methods and compositions for screening and treating alzheimer's disease

Номер патента: WO2024151904A2. Автор: Peggy S. Eis,Eli Hatchwell,Edward B. Smith III,Shapour JALILZADEH. Владелец: POPULATION BIO, INC.. Дата публикации: 2024-07-18.

Method of treating alzheimer's disease

Номер патента: US20240285680A1. Автор: Peter Y. Novak,Maxim V. Temnikov. Владелец: Vector Vitale IP LLC. Дата публикации: 2024-08-29.

Use of pharmaceutical composition comprising chlorogenic acid in preparation of drug for treating early alzheimer's disease

Номер патента: US20240316001A1. Автор: Min Xu,Jie Zhang,Liang Zhang,Fei Zhang,Ya Zhang,Wenbin Li,Wang HUANG,Yujia HUANG. Владелец: Sichuan Jiuzhang Biotechnology Co Ltd. Дата публикации: 2024-09-26.

Method of treating or preventing Alzheimer's Disease

Номер патента: US11833181B1. Автор: Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Ahmed Mohammed Abu-Dief Mohammed,Hazem Mohamed Shaheen,Gaber Elsaber Abd El-Wanis Batiha,Manal Aly Shalaby,Amany Mabrouk Abd Elhady Alamh. Владелец: King Faisal University SA. Дата публикации: 2023-12-05.

Method for Treating and/or Preventing Alzheimer’s Disease

Номер патента: US20240342219A1. Автор: Chih-Kai Hsu,Han-Chung CHENG,Chi-Tang Tu. Владелец: Taiwan Mitochondrion Application Technology Co Ltd. Дата публикации: 2024-10-17.

Therapeutic agent for Alzheimer's disease

Номер патента: US09980937B2. Автор: Takashi Tanaka,Keiro Shirotani,Nobuhisa Iwata,Masashi Asai. Владелец: Nagasaki University NUC. Дата публикации: 2018-05-29.

Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphin-gosine-1-phosphate

Номер патента: US09757398B2. Автор: Ramon Cacabelos,Carmen Vigo. Владелец: Euroespes Biotecnologia SL. Дата публикации: 2017-09-12.

Multi-component formulations for the treatment of cognitive decline including Alzheimer's disease

Номер патента: US09682048B1. Автор: Gene S. Rosen. Владелец: Individual. Дата публикации: 2017-06-20.

Methods for Alzheimer's disease treatment and cognitive enhancement

Номер патента: US09539235B2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Cognitive Research Enterprises Inc. Дата публикации: 2017-01-10.

Methods for treating Alzheimer's disease

Номер патента: US09522124B2. Автор: Luigi Puglielli. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2016-12-20.

Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity

Номер патента: US7776312B2. Автор: Leah Ranae Bresin Hanson,II William H. Frey,Samuel Scott Panter,Annina Roeytenberg. Владелец: HealthPartners Research Foundation. Дата публикации: 2010-08-17.

Pharmaceutical composite formulation for treating vascular dementia with alzheimer's disease

Номер патента: KR20220083020A. Автор: 나도현. Владелец: 나도현. Дата публикации: 2022-06-20.

Pharmaceutical composite formulation for treating vascular dementia with alzheimer's disease

Номер патента: KR20230090187A. Автор: 전진환,나도현,강경표. Владелец: 메디케어제약 주식회사. Дата публикации: 2023-06-21.

Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad)

Номер патента: WO2010005581A4. Автор: Venkateswarlu Akella,Uday Saxena. Владелец: Kareus Therapeutics, Llc. Дата публикации: 2010-03-04.

Compositions and methods for the treatment of alzheimer's disease and other neurogenerative disease

Номер патента: WO2024044355A2. Автор: Christine Ann DENNY,Briana K. Chen,Holly HUNSBERGER. Владелец: 1/1The Trustees Of Columbia University In The City Of New York. Дата публикации: 2024-02-29.

Use of low volume plasma exchange for treating the early and middle stages of alzheimer's disease

Номер патента: US20240115665A1. Автор: Victor Grifols Roura,Antonio Manuel Paez Regadera,Laura Nunez Domenech. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2024-04-11.

Masitinib for the treatment of alzheimer's disease

Номер патента: EP4262801A1. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2023-10-25.

Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad)

Номер патента: US20110097347A1. Автор: Uday Saxena,Venkateswarulu Akella. Владелец: Venkateswarulu Akella. Дата публикации: 2011-04-28.

Masitinib for the treatment of alzheimer's disease

Номер патента: US20240058328A1. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2024-02-22.

New synthetic drugs for treating alzheimer's disease

Номер патента: WO2024058196A1. Автор: Hiroshi Yamada,Tomoyuki Takahashi,Tetsuya Hori,Zacharie Taoufiq,Kohji TAKEI. Владелец: OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION. Дата публикации: 2024-03-21.

Method and pharmaceutical composition for treating alzheimer's disease and disorders, disturbed or lost memory

Номер патента: RU2603470C2. Автор: Ричард Дж. ВЁРТМАН,Ингрид РИЧАРДСОН. Владелец: Массачусетс Инститьют Оф Текнолоджи. Дата публикации: 2016-11-27.

Composition for treating and preventing neurological diseases, neuroinflammation, and alzheimer's disease

Номер патента: CA3008780A1. Автор: Dan Li,Norman Relkin,John M. Williams,Joshua M. COSTIN. Владелец: Hsrx Group LLC. Дата публикации: 2017-06-22.

Use of Epothilone D in Treating Tau-Associated Diseases Including Alzheimer's Disease

Номер патента: US20110230528A1. Автор: Francis Y. Lee,Charles F. Albright,Donna Marie Barten. Владелец: Bristol Myers Squibb Co. Дата публикации: 2011-09-22.

An oxazine derivative for use in the prevention of alzheimer's disease in at risk patients

Номер патента: WO2018015868A1. Автор: Ulf Neumann,Cristina LOPEZ-LOPEZ. Владелец: NOVARTIS AG. Дата публикации: 2018-01-25.

Protective effects of oil palm composition on alzheimer?s disease

Номер патента: MY179462A. Автор: Rha ChoKyun,Sambanthamurthi Ravigadevi,Yew Ai TAN,P Weinberg Robert,J Sinskey Anthony. Владелец: Malaysian Palm Oil Board. Дата публикации: 2020-11-06.

Identification of granins as the pathogenic factor of alzheimer's disease and compositions and methods for inhibiting granin aggregation and treating alzheimer's disease

Номер патента: EP3773547A1. Автор: Seung Hyun Yoo. Владелец: Individual. Дата публикации: 2021-02-17.

Combination therapy of donepezil and sildenafil for the treatment of alzheimer's disease or cognitive impairment

Номер патента: EP4240359A1. Автор: Sukchan Lee,Yong Ha Chi,Hyun-Hee RYU,Miso JEONG. Владелец: Neurorive Inc. Дата публикации: 2023-09-13.

Composition for preventing Alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt

Номер патента: US10124031B2. Автор: Sun Young PARK,Jeong Yong Cho,Kyung Sik Ham,Promyo KITIONG,JinRui ZHU. Владелец: Industry Academic Cooperation Foundation of Mokpo National University. Дата публикации: 2018-11-13.

Use of artemether in the prevention and treatment of alzheimer's disease

Номер патента: US20210205265A1. Автор: Wenhua Zheng. Владелец: UNIVERSITY OF MACAU. Дата публикации: 2021-07-08.

Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses

Номер патента: EP1014996A1. Автор: Gerardo Castillo,Alan D. Snow. Владелец: UNIVERSITY OF WASHINGTON. Дата публикации: 2000-07-05.

Pharmaceutical preservation of creb activation in the treatment of alzheimer's disease

Номер патента: EP4252750A1. Автор: Guilherme Gomes,Michael Kreutz,Carsten Reissner,Katarzyna Grochowska,Anja Oelschlegel,Anna Karpova. Владелец: Leibniz Institut fuer Neurobiologie. Дата публикации: 2023-10-04.

Combination therapy of donepezil and tadalafil for the treatment of alzheimer's disease or cognitive impairment

Номер патента: US20230405004A1. Автор: Sukchan Lee,Yong Ha Chi,Hyun-Hee RYU,Miso JEONG. Владелец: Neurorive Inc. Дата публикации: 2023-12-21.

Combination therapy of donepezil and sildenafil for the treatment of alzheimer's disease or cognitive impairment

Номер патента: US20230398106A1. Автор: Sukchan Lee,Yong Ha Chi,Hyun-Hee RYU,Miso JEONG. Владелец: Neurorive Inc. Дата публикации: 2023-12-14.

Method of treating alzheimer's disease with se-containing peptide

Номер патента: WO2002099061A2. Автор: SONG Ling,Joseph Holoshitz. Владелец: THE REGENTS OF THE UNIVERSITY OF MICHIGAN. Дата публикации: 2002-12-12.

Formulation and method for treatment of alzheimer's disease, stroke and diabetic retinopathy

Номер патента: WO2024110993A1. Автор: Krishnakumar Menon,Gopi Mohan CHETHAMPADI,Sunitha SUBHRAMANIAN. Владелец: AMRITA VISHWA VIDYAPEETHAM. Дата публикации: 2024-05-30.

Alz-801 for use in treating alzheimer's disease

Номер патента: AU2022405026A1. Автор: John Hey,Martin TOLAR,Susan ABUSHAKRA,Neil William FLANZRAICH. Владелец: Alzheon Inc. Дата публикации: 2024-06-20.

Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product

Номер патента: AU7117596A. Автор: Lawrence R. Williams. Владелец: AMGEN INC. Дата публикации: 1997-04-17.

Composition for treating alzheimer's disease containing glial line-derived neurotrophic factor (GDNF) protein product

Номер патента: NZ319040A. Автор: Lawrence R Williams. Владелец: AMGEN INC. Дата публикации: 2001-02-23.

Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease

Номер патента: EP2403534A1. Автор: Umberto Cornelli. Владелец: Individual. Дата публикации: 2012-01-11.

Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease

Номер патента: US20120064054A1. Автор: Umberto Cornelli. Владелец: COR CON INTERNATIONAL Srl. Дата публикации: 2012-03-15.

Intranasal dantrolene administration for treatment of alzheimer's disease

Номер патента: CA3145528A1. Автор: Ge Liang,Huafeng Wei,Qing Cheng Meng,Maryellen FAZEN ECKENHOLL. Владелец: University of Pennsylvania Penn. Дата публикации: 2020-12-30.

Nanoparticle contrast agent for early diagnosis of alzheimer's disease by magnetic resonance imaging (mri)

Номер патента: US20170196998A1. Автор: Kwok Kin Cheng,Lawrence William Baum,Hee Lum Albert CHOW. Владелец: Chinese University of Hong Kong CUHK. Дата публикации: 2017-07-13.

Gasotransmitter metabolites and alzheimer's disease

Номер патента: US20210285938A1. Автор: Christopher Kevil,Karen Y. STOKES,Johnathan Steven ALEXANDER,Elizabeth DISBROW. Владелец: Louisiana State University. Дата публикации: 2021-09-16.

Materials for preventing or treating Alzheimer's disease and compositions comprising same

Номер патента: US10933080B2. Автор: Keejung Yoon,Juwan KIM. Владелец: Sungkyunkwan University Research and Business Foundation. Дата публикации: 2021-03-02.

Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease

Номер патента: EP2654743A1. Автор: Enrico D'aniello,Antimo D'ANIELLO,Gemma D'ANIELLO. Владелец: Individual. Дата публикации: 2013-10-30.

S-adenosylmethionine and derivatives thereof for the treatment and prevention of alzheimer's disease

Номер патента: EP1326620A1. Автор: Sigfrido Scarpa,Andrea Fuso. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2003-07-16.

Compositions and methods for the diagnosis and treatment of alzheimer's disease

Номер патента: WO2021016551A8. Автор: Rima F. KADDURAH-DAOUK,Rebecca BAILLIE,Xianlin Han,Kwangsik Nho,Andrew J. Saykin,Siamak MAHMOUDIANDEHKORDI,Shahzad AHMAD,Cornelia van Duijin. Владелец: Indiana University School of Medicine. Дата публикации: 2022-01-20.

Use of vitamin composition in preparing drug for preventing, treating, or delaying alzheimer's disease

Номер патента: US20200030358A1. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2020-01-30.

Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease

Номер патента: AU2024202678A1. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2024-05-16.

Use of vitamin composition in preparing drug for preventing, treating, or delaying alzheimer's disease

Номер патента: US20230248756A1. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2023-08-10.

Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease

Номер патента: AU2018229920B2. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2024-02-08.

Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease

Номер патента: US11464797B2. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2022-10-11.

Tau phosphorylation inhibitors and methods for treating or preventing alzheimer's disease

Номер патента: EP3634410A1. Автор: Rudolph E. Tanzi,Doo Yeon KIM,Stephen T.C. Wong,Xiaofeng XIA,Xiaoyun Xu. Владелец: Methodist Hospital System. Дата публикации: 2020-04-15.

Method for treating and preventing alzheimer's disease

Номер патента: WO1996001114A1. Автор: Gerald D. Fasman. Владелец: BRANDEIS UNIVERSITY. Дата публикации: 1996-01-18.

Materials for preventing or treating alzheimer's disease and compositions comprising same

Номер патента: US20200000838A1. Автор: Keejung Yoon,Juwan KIM. Владелец: Sungkyunkwan University Research and Business Foundation. Дата публикации: 2020-01-02.

Method of preventing and treating alzheimer's disease and related dementias with drugs inhibiting the interaction between 14-3-3g protein and hexokinase-1 protein

Номер патента: WO2024155781A1. Автор: Srinivas Ayyadevara,Meenakshisundaram BALASUBRAMANIAM,Akshatha GANNE,Srikanth VALLURUPALLI. Владелец: BioVentures, LLC. Дата публикации: 2024-07-25.

Leptin as an anti- amyloidogenic biologic and methods for delaying the onset and reducing alzheimer's disease-like pathology

Номер патента: US20120244156A1. Автор: Nikolaos Tezapsidis. Владелец: Individual. Дата публикации: 2012-09-27.

Use of 6-hydroxy-2-(4-methoxyphenyl)-3-[4-(2-piperidinoethoxy)-phenoxy]benzo[b]thiophene or 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)-phenoxy]benzo[b]thiophene for treating Alzheimer's disease

Номер патента: NZ500175A. Автор: Henry Uhlman Bryant,Kelly Renee Bales,Steven Marc Paul,Mary Patricia Knadler. Владелец: Eli Lili And Company. Дата публикации: 2001-10-26.

Compositions and methods for the diagnosis and treatment of alzheimer's disease

Номер патента: WO2021016466A1. Автор: Matthias Arnold,John Q. Trojanowski,Leslie M. Shaw,Rima F. KADDURAH-DAOUK,Xianlin Han,Kwangsik Nho,Andrew J. Saykin,Gregory Louie,Gabi KASTENMÜLLER,Siamak MAHMOUDIANDEHKORDI,Shahzad AHMAD,Cornelia van Duijin,Shannon L. RISACHER,Colette BLACH,Rebecca BALLIE,Michael W WEINER,P. Murali DORAISWAMY. Владелец: Indiana University School of Medicine. Дата публикации: 2021-01-28.

Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease

Номер патента: WO2014039138A1. Автор: Ta-Yuan Chang,Maximillian A. ROGERS,Elena Bryleva,Stephanie Murphy,Catherine C.Y. Chang. Владелец: Trustees of Dartmouth College. Дата публикации: 2014-03-13.

Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease

Номер патента: EP2892618A1. Автор: Ta-Yuan Chang,Maximillian A. ROGERS,Elena Bryleva,Stephanie Murphy,Catherine C.Y. Chang. Владелец: Dartmouth College. Дата публикации: 2015-07-15.

Fragments, Mutants and Chimeric Fusion Proteins of Leptin For Treating Alzheimer's Disease

Номер патента: US20130183309A1. Автор: Nikolaos Tezapsidis. Владелец: Neurotez Inc. Дата публикации: 2013-07-18.

Methods for detecting and/or predicting age-related macular degeneration and/or alzheimer's disease

Номер патента: US20210283275A1. Автор: Henryk Szmacinski,Richard Thompson,Imre Lengyel,Hui Hui ZENG. Владелец: Queens University of Belfast. Дата публикации: 2021-09-16.

Methods for detecting and/or predicting age-related macular degeneration and/or alzheimer's disease

Номер патента: EP3504554A1. Автор: Henryk Szmacinski,Richard Thompson,Imre Lengyel,Hui Hui ZENG. Владелец: University of Maryland at Baltimore. Дата публикации: 2019-07-03.

Preparation method of1,6-o,o-diacetylbritannilactone and application of preparation anti-alzheimer's disease drug

Номер патента: AU2021104523A4. Автор: Ping Xiang,Jinming Gao,Cong GUO,Jiangjiang Tang,Lanfang Huang. Владелец: NORTHWEST A&F UNIVERSITY. Дата публикации: 2021-10-21.

Method of upregulating sorla for the treatment of alzheimer's disease

Номер патента: US20110104165A1. Автор: Thomas Willnow. Владелец: H Lundbeck AS. Дата публикации: 2011-05-05.

Inhibition of beta-2 nicotinic acetylcholine receptors to treat alzheimer's disease pathology

Номер патента: US20220226307A1. Автор: Uwe Maskos,Sylvia LOMBARDO,Julie CATTEAU,Morgane BESSON,Fani KOUKOULI. Владелец: Institut Pasteur de Lille. Дата публикации: 2022-07-21.

Methods for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild cognitive impairment

Номер патента: WO2019241329A3. Автор: Michael R. D'andrea. Владелец: Dandrea Michael R. Дата публикации: 2020-01-23.

Compounds for treatment of alzheimer's disease

Номер патента: ZA202206837B. Автор: Krenning Guido,Henk Henning Robert,Cornelis Van Der Graaf Adrianus,Henri Swart Daniël,Françoise De Veij Mestdagh Christina,Cornelis Vogelaar Pieter. Владелец: Sulfateq Bv. Дата публикации: 2023-11-29.

Method of upregulating sorla for the treatment of alzheimer's disease

Номер патента: WO2010028651A3. Автор: Thomas Willnow. Владелец: H. Lundbeck A/S. Дата публикации: 2010-05-06.

Method of upregulating sorla for the treatment of alzheimer's disease

Номер патента: EP2323687A2. Автор: Thomas Willnow. Владелец: H Lundbeck AS. Дата публикации: 2011-05-25.

Dosing regimen for the treatment of alzheimer's disease with sulfonyl fluorides

Номер патента: WO2010115177A1. Автор: Federica Pericle,Enrico Braglia. Владелец: The Board of Regents of the University of Texas System. Дата публикации: 2010-10-07.

Inhibition of beta-2 nicotinic acetylcholine receptors to treat alzheimer's disease pathology

Номер патента: EP3454904A1. Автор: Uwe Maskos,Sylvia LOMBARDO,Julie CATTEAU,Morgane BESSON,Fani KOUKOULI. Владелец: Institut Pasteur de Lille. Дата публикации: 2019-03-20.

Methods for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild cognitive impairment

Номер патента: EP3806956A2. Автор: Michael R. D'andrea. Владелец: Dandrea Michael R. Дата публикации: 2021-04-21.

Alz-801 for use in treating alzheimer's disease

Номер патента: EP4444286A1. Автор: John Hey,Martin TOLAR,Susan ABUSHAKRA,Neil William FLANZRAICH. Владелец: Alzheon Inc. Дата публикации: 2024-10-16.

Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease

Номер патента: WO2010042292A8. Автор: Ta-Yuan Chang,Catherine C. Y. Chang. Владелец: Trustees of Dartmouth College. Дата публикации: 2010-07-15.

Compositions and methods for the treatment and/or prevention of alzheimer's disease

Номер патента: US20240293431A1. Автор: Chuanhai Cao. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2024-09-05.

Methods for detecting and preventing alzheimer's disease and mild cognitive impairment

Номер патента: US20240325760A1. Автор: Inna Slutsky,Shiri SHOOB,Nadav BUCHBINDER,Daniel ZARHIN. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2024-10-03.

Medicament for treatment of Alzheimer's disease

Номер патента: US09861640B2. Автор: Koichi Shudo,Kohichi KAWAHARA,Michita SUENOBU. Владелец: KEMPHYS Ltd. Дата публикации: 2018-01-09.

Method of treating, delaying and/or preventing Alzheimer's Disease

Номер патента: US09717704B2. Автор: Janne Sande Mathisen,Henrik Mathisen. Владелец: SMARTFISH AS. Дата публикации: 2017-08-01.

Hyperspectral imaging for early detection of Alzheimer'S Disease

Номер патента: US09585558B2. Автор: Robert Vince,Swati Sudhakar MORE. Владелец: University of Minnesota. Дата публикации: 2017-03-07.

Nanoparticles of cerium oxide targeted to an amyloid beta antigen of alzheimer's disease and associated methods

Номер патента: US09463253B2. Автор: Sudipta Seal,Soumen Das,Annamaria Cimini,Barbara D'Angelo. Владелец: University Of Central Florida Research Foundation Inc. Дата публикации: 2016-10-11.

Ocular diagnosis of alzheimer's disease

Номер патента: EP1420830B1. Автор: Lee E. Goldstein,Leo T. Chylack, Jr.. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2011-03-09.

Ocular diagnosis of alzheimer's disease

Номер патента: CA2458961C. Автор: Lee E. Goldstein,Leo T. Chylack, Jr.. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2008-07-08.

Ocular diagnosis of Alzheimer's disease

Номер патента: NZ545889A. Автор: Lee E Goldstein,Leo T Chylack. Владелец: Brigham & Womens Hospital. Дата публикации: 2006-06-30.

Ocular diagnosis of alzheimer's disease

Номер патента: NZ531337A. Автор: Lee E Goldstein,Leo T Chylack. Владелец: Brigham & Womens Hospital. Дата публикации: 2006-05-26.

Agents for use in the treatment of Alzheimer's disease

Номер патента: US6323218B1. Автор: Xudong Huang,Ashley I. Bush,Craig S. Atwood,Rudolph E. Tanzi. Владелец: General Hospital Corp. Дата публикации: 2001-11-27.

Method for treating alzheimer's disease

Номер патента: CA2311356C. Автор: Charles Larry Bisgaier,Mark Richard Emmerling. Владелец: Warner Lambert Co LLC. Дата публикации: 2004-07-13.

Biomarkers for alzheimer's disease progression

Номер патента: WO2008024677A1. Автор: Jonathan Bejamin Singer. Владелец: Novartis Pharma Gmbh. Дата публикации: 2008-02-28.

Methods for Alzheimer'S disease treatment and cognitive enhancement

Номер патента: US9446020B2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2016-09-20.

Methods and combination therapies for treating alzheimer's disease

Номер патента: CA2667553A1. Автор: David T. Hung,Andrew Asher Protter. Владелец: Medivation Neurology, Inc.. Дата публикации: 2008-05-02.

Method of treating Alzheimer's disease

Номер патента: US4897388A. Автор: Hartmut H. Malluche. Владелец: Geriatric Research Institute Inc. Дата публикации: 1990-01-30.

Use of a composition comprising a cytokine encoding nucleic acid for treating alzheimer's disease

Номер патента: CA2677273A1. Автор: Tai-June Yoo. Владелец: Individual. Дата публикации: 2008-08-14.

Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease

Номер патента: EP1450795A1. Автор: John Varghese. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2004-09-01.

Nadh and nadph as drugs for treating alzheimer's disease

Номер патента: CA2105912C. Автор: Jorg Birkmayer. Владелец: Individual. Дата публикации: 2000-11-14.

A composition comprising an extract of red mold rice for treatment of alzheimer's disease

Номер патента: CA2616971C. Автор: Tzu-Ming Pan,Chun-Lin Lee. Владелец: Sunway Biotech Co Ltd. Дата публикации: 2012-11-20.

1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease

Номер патента: US20050203191A1. Автор: Scott Mcdonald,Albrecht STÖFFLER,Hans-Joerg Moebius,Barry Reisberg,Steven Ferris. Владелец: Forest Laboratories LLC. Дата публикации: 2005-09-15.

Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies

Номер патента: EP2797591A1. Автор: Ubaldo Armato,Ilaria Pierpaola DAL PRA',Anna Maria CHIARINI. Владелец: Individual. Дата публикации: 2014-11-05.

Methods for Alzheimer's Disease treatment and cognitive enhancement

Номер патента: US6825229B2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2004-11-30.

Peptide composition for prevention or treatment of alzheimer's disease

Номер патента: CA3190919C. Автор: Sung Min Kim,Seung Jun Lee,Yong Joo Kim,Jae-Yong Park,Seung-Hyun Lee,Sujin Kim,Mi Suk Lee,Kun Ho Lee,Yeong Min Park,Wahn Soo Choi,Minho Moon,Yong Ho Park,In Duk Jung,Hee Jo Park,Seung Pyo Choi,Soo Jung Shin. Владелец: HLB Science Inc. Дата публикации: 2023-12-19.

Method of treating alzheimer's disease

Номер патента: EP4313080A1. Автор: Peter Y. Novak,Maxim V. Temnikov. Владелец: Vector Vitale IP LLC. Дата публикации: 2024-02-07.

Pharmaceutical composition for preventing or treating alzheimer's disease

Номер патента: CA3232946A1. Автор: Tao Zhao,Guimin Zhang,Honghua Li,Jingchun YAO,Chenghong SUN. Владелец: Shandong New Time Pharmaceutical Co Ltd. Дата публикации: 2023-04-06.

Use of aprepitant for treating alzheimer's disease

Номер патента: EP4297868A1. Автор: Robb Knie. Владелец: Hoth Therapeutics Inc. Дата публикации: 2024-01-03.

Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction

Номер патента: US20130011468A1. Автор: Morten Bryhn. Владелец: Pronova Biopharma Norge AS. Дата публикации: 2013-01-10.

Anavex2-73 for the Treatment of Alzheimer's Disease

Номер патента: US20200022943A1. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2020-01-23.

Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin

Номер патента: US20100184725A1. Автор: Anil Gulati. Владелец: University of Illinois. Дата публикации: 2010-07-22.

Pharmaceutical composition for the treatment of alzheimer's disease or dementia

Номер патента: EP4304591A1. Автор: Tim TASKER. Владелец: Heptares Therapeutics Ltd. Дата публикации: 2024-01-17.

ANAVEX2-73 for the treatment of Alzheimer's disease

Номер патента: AU2024201661A1. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2024-04-04.

Peptide composition for prevention or treatment of Alzheimer's disease

Номер патента: AU2021331859A1. Автор: Sung Min Kim,Seung Jun Lee,Yong Joo Kim,Jae-Yong Park,Seung-Hyun Lee,Sujin Kim,Mi Suk Lee,Kun Ho Lee,Yeong Min Park,Wahn Soo Choi,Minho Moon,Yong Ho Park,In Duk Jung,Hee Jo Park,Seung Pyo Choi,Soo Jung Shin. Владелец: HLB Science Inc. Дата публикации: 2023-03-16.

Non-productive angiogenesis inhibitor for use in the treatment of alzheimer's disease

Номер патента: EP3900788A1. Автор: Alberto Pascual Bravo,Alicia Elena ROSALES NIEVES,María Isabel ÁLVAREZ VERGARA. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2021-10-27.

Method of treating alzheimer's disease

Номер патента: CA3212905A1. Автор: Peter Y. Novak,Maxim V. Temnikov. Владелец: Vector Vitale IP LLC. Дата публикации: 2022-09-29.

6-Substituted Estradiol Derivatives for the Treatment of Alzheimer's Disease

Номер патента: US20150265630A1. Автор: James G. Yarger,Steven H. Nye. Владелец: Endece LLC. Дата публикации: 2015-09-24.

Valacyclovir and celecoxib for the treatment of alzheimer's disease and covid-19

Номер патента: WO2024059247A2. Автор: William Langley PRIDGEN. Владелец: Virios Therapeutics, Inc. Дата публикации: 2024-03-21.

Valacyclovir and celecoxib for the treatment of alzheimer's disease and covid-19

Номер патента: WO2024059247A3. Автор: William Langley PRIDGEN. Владелец: Virios Therapeutics, Inc. Дата публикации: 2024-05-10.

Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis

Номер патента: US20200237739A1. Автор: James M. Youakim,Srdjan R. STANKOVIC,James Randall OWEN,Bruce Duane Coate,Mark Donald Knowles. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2020-07-30.

Anavex2-73 for the Treatment of Alzheimer's Disease

Номер патента: US20180360796A1. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2018-12-20.

Salivary abeta42 levels as prognostic indicators for alzheimer's disease

Номер патента: EP3491383A1. Автор: Edith G. Mcgeer,Patrick L. Mcgeer,Moonhee Lee,Jian-Ping Guo,Krista Kennedy. Владелец: Aurin Biotech Inc. Дата публикации: 2019-06-05.

Composition for the treatment of alzheimer's disease and process for preparing the same

Номер патента: WO1992000737A1. Автор: Peter Literati Nagy,Sziveszter Vizi,Jeno^' SZILBEREKY. Владелец: Biorex Kutató-Fejleszto^' Kft.. Дата публикации: 1992-01-23.

Composition for the treatment of alzheimer's disease and¹process for preparing the same

Номер патента: IE912431A1. Автор: . Владелец: Biorex Kutato Fejleszto Kft. Дата публикации: 1992-01-15.

Preparation of drug for treating Alzheimer's disease

Номер патента: AU2020358184B2. Автор: Tony Chunglit CHOI. Владелец: Plantarx Ltd. Дата публикации: 2024-06-20.

Composition for preventing or treating alzheimer's disease comprising phospholipase c activator as an active ingredient

Номер патента: US20230118869A1. Автор: Jaedong Lee,Jeehyun KWAG. Владелец: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION. Дата публикации: 2023-04-20.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: CA2264097C. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 2007-11-27.

Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease

Номер патента: EP3702470A2. Автор: Eric A. Schon,Estela Area-Gomez. Владелец: Columbia University of New York. Дата публикации: 2020-09-02.

Combination therapy for the prevention or treatment of alzheimer's disease as well as kit therefor

Номер патента: CA2577332C. Автор: Frank Mattner,Walter Schmidt. Владелец: Affiris Forschungs Und Entwicklungs Gmbh. Дата публикации: 2014-12-09.

Preventive or therapeutic drug for alzheimer's disease

Номер патента: CA2213794A1. Автор: Ikuro Maruyama,Kazuhiro Abeyama,Hiroyuki Masayasu. Владелец: A. Nattermann & Cie. Gmbh. Дата публикации: 1998-02-27.

Pharmaceutical composition containing mitochondrial division inhibitor for preventing or treating alzheimer's disease

Номер патента: KR20160121295A. Автор: 정재인,조동규,김학균,반가히. Владелец: 성균관대학교산학협력단. Дата публикации: 2016-10-19.

Use of mnk inhibitors for the treatment of alzheimer's disease

Номер патента: US20100247517A1. Автор: Martin Schneider,Matthias Austen,Marcus Geese. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2010-09-30.

Methods for treating mild cognitive impairment and alzheimer's disease

Номер патента: US20050059743A1. Автор: Jeroen Verheijen,Mel Epstein,Kjesten Wiig. Владелец: Sention Inc. Дата публикации: 2005-03-17.

Preventive or therapeutic drug for alzheimer's disease

Номер патента: CA2213794C. Автор: Ikuro Maruyama,Kazuhiro Abeyama,Hiroyuki Masayasu. Владелец: A Natterman und Cie GmbH. Дата публикации: 2006-10-03.

Compositions for treatment of alzheimer's disease

Номер патента: WO2010114636A1. Автор: Javier Llompart,Jorge Galvez,David Land,Giulio Pasinetti. Владелец: Medisyn Technologies, Inc.. Дата публикации: 2010-10-07.

Method of medical treatment of Alzheimer's disease

Номер патента: US4950658A. Автор: Robert E. Becker,Ezio Giacobini. Владелец: Southern Illinois University System. Дата публикации: 1990-08-21.

Vaccine for alzheimer's disease

Номер патента: US20110076323A1. Автор: Irun R. Cohen,Alon Monsonego. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2011-03-31.

APPLICATION OF COMPOUND IN INHIBITING Aβ ACCUMULATION AND TREATING ALZHEIMER'S DISEASE

Номер патента: WO2019205748A1. Автор: 李江,李晓萌,王立春,李佳乐,汪小莞,兰传健. Владелец: 东北师范大学. Дата публикации: 2019-10-31.

Composition and methods for treating alzheimer's disease and other amyloidoses

Номер патента: CA2289531C. Автор: Gerardo Castillo,Alan D. Snow. Владелец: UNIVERSITY OF WASHINGTON. Дата публикации: 2009-09-29.

Compounds for the treatment of alzheimer's disease

Номер патента: CA2652164C. Автор: Jeremy Turnbull,Edwin Yates,Susannah Patey. Владелец: Ulive Enterprises Ltd. Дата публикации: 2015-09-01.

Methods for treating Alzheimer's disease

Номер патента: US11925659B2. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cyclo Therapeutics Inc. Дата публикации: 2024-03-12.

Method of treating alzheimer's disease

Номер патента: EP4340834A1. Автор: Sharon L. Rogers. Владелец: Amyriad Pharma Inc. Дата публикации: 2024-03-27.

Hyperspectral imaging for early detection of Alzheimer's disease

Номер патента: US11819276B2. Автор: Robert Vince,Swati Sudhakar MORE. Владелец: University of Minnesota. Дата публикации: 2023-11-21.

Improved use of cannabinoids in the treatment of alzheimer's disease

Номер патента: US20240000808A1. Автор: Mark RIDALL,Vincent T. MILETO. Владелец: Orcosa Inc. Дата публикации: 2024-01-04.

Use of riluzole prodrugs to treat alzheimer's disease

Номер патента: US20210212999A1. Автор: Vladimir Coric,Robert Berman,Irfan QURESHI. Владелец: Biohaven Therapeutics Ltd. Дата публикации: 2021-07-15.

Donepezil compositions and methods of treating alzheimer's disease

Номер патента: CA3214846A1. Автор: Mahendra G. Dedhiya,Kavita Vermani,Ashok Katdare. Владелец: Forest Laboratories Holdings ULC. Дата публикации: 2015-08-13.

Medicament for treatment of alzheimer's disease

Номер патента: US20160206624A1. Автор: Koichi Shudo,Kohichi KAWAHARA,Michita SUENOBU. Владелец: KEMPHYS Ltd. Дата публикации: 2016-07-21.

Method to Treat Alzheimer`s Disease

Номер патента: US20220008502A1. Автор: Chi Zhang,Luwen Zhang. Владелец: NuTech Ventures Inc. Дата публикации: 2022-01-13.

Clomipramine for the treatment of alzheimer's disease

Номер патента: US20230372356A1. Автор: Pushkar SHARMA,Monika CHAUHAN. Владелец: National Institute of Immunology. Дата публикации: 2023-11-23.

Lachnospiraceae spp and ruminococcus lactaris strains for the treatment and prevention of alzheimer's disease and aging

Номер патента: WO2023222924A1. Автор: Christiane Bouchier,Damien REI,Dominique CLERMONT,Gérald TOUAK. Владелец: INSTITUT PASTEUR. Дата публикации: 2023-11-23.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: US20230414658A1. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2023-12-28.

Methods of treating and/or preventing alzheimer’s disease with r-carvedilol

Номер патента: US20230381139A1. Автор: Sui Rong Wayne CHEN,Jinjing YAO,BACK Thomas. Владелец: UTI LIMITED PARTNERSHIP. Дата публикации: 2023-11-30.

Treatment of alzheimer's disease with allogeneic mesenchymal stem cells

Номер патента: EP4210719A1. Автор: Joshua M. Hare,Anthony A. OLIVA. Владелец: Longeveron Inc. Дата публикации: 2023-07-19.

Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells

Номер патента: US20230310509A1. Автор: Joshua M. Hare,Anthony A. OLIVA. Владелец: Longeveron Inc. Дата публикации: 2023-10-05.

Use of riluzole prodrugs to treat alzheimer's disease

Номер патента: US20240082340A1. Автор: Vladimir Coric,Robert Berman. Владелец: Biohaven Therapeutics Ltd. Дата публикации: 2024-03-14.

Chlorogenic acid composition and method for its use in the treatment of alzheimer's disease

Номер патента: US20200237702A1. Автор: Kodimule Shyam Prasad. Владелец: Individual. Дата публикации: 2020-07-30.

Method of treating alzheimer's disease

Номер патента: AU2022275939A1. Автор: Sharon L. Rogers. Владелец: Amyriad Pharma Inc. Дата публикации: 2023-11-16.

Lithium cholesterol compositions, including, but not limited to lithium cholesterol sulfate compositions, and methods of treatment for alzheimer's disease and neurological disorders

Номер патента: US20200129527A1. Автор: Jun Tan,Roland Douglas Shytle,Darrell Sawmiller,Jinhua WEN. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2020-04-30.

Apilimod compositions and methods for using same in the treatment of alzheimer's disease

Номер патента: AU2017342262B2. Автор: Jonathan M. Rothberg,Henri Lichenstein,Chris Conrad,Marylens HERNANDEZ. Владелец: Orphai Therapeutics Inc. Дата публикации: 2023-09-28.

Hyperspectral imaging for early detection of alzheimer's disease

Номер патента: US20240156342A1. Автор: Robert Vince,Swati Sudhakar MORE. Владелец: University of Minnesota. Дата публикации: 2024-05-16.

Improved use of cannabinoids in the treatment of alzheimer's disease

Номер патента: EP4243602A1. Автор: Mark RIDALL,Vincent T. MILETO. Владелец: Orcosa Inc. Дата публикации: 2023-09-20.

Pharmaceutical compositions active in preventing, stabilizing and treating Alzheimer's disease

Номер патента: US9198967B2. Автор: Umberto Cornelli. Владелец: COR CON INTERNATIONAL Srl. Дата публикации: 2015-12-01.

Riluzole for the treatment of alzheimer's disease

Номер патента: EP4240308A1. Автор: Ana PEREIRA. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2023-09-13.

Riluzole for the treatment of alzheimer's disease

Номер патента: US20240016783A1. Автор: Ana PEREIRA. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2024-01-18.

Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

Номер патента: US11510932B2. Автор: Robert Sabin. Владелец: Individual. Дата публикации: 2022-11-29.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: US11779600B2. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2023-10-10.

Clomipramine for the treatment of Alzheimer's Disease

Номер патента: US11957692B2. Автор: Pushkar SHARMA,Monika CHAUHAN. Владелец: National Institute of Immunology. Дата публикации: 2024-04-16.

Method of treating alzheimer’s disease

Номер патента: US20240156812A1. Автор: Sharon L. Rogers. Владелец: Amyriad Pharma Inc. Дата публикации: 2024-05-16.

Methods for treating early alzheimer's disease

Номер патента: WO2024073409A1. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cyclo Therapeutics, Inc.. Дата публикации: 2024-04-04.

Methods for treating alzheimer's disease

Номер патента: CA3114021A1. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cyclo Therapeutics Inc. Дата публикации: 2021-05-07.

Methods for treating alzheimer's disease

Номер патента: EP3873604A1. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cycol Therapeutics Inc. Дата публикации: 2021-09-08.

Method of treating alzheimer's disease

Номер патента: CA3217579A1. Автор: Sharon L. Rogers. Владелец: Individual. Дата публикации: 2022-11-24.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: US20190290687A1. Автор: Yosef Koronyo,Maya Koronyo,Keith Black,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2019-09-26.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: EP3458036A1. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2019-03-27.

Method of treating alzheimer's disease

Номер патента: AU2021435291A1. Автор: Peter Y. Novak,Maxim V. Temnikov. Владелец: Vector Vitale IP LLC. Дата публикации: 2023-10-05.

Isolated mitochondria for use in the treatment and/or prevention of alzheimer s disease

Номер патента: EP3714892A1. Автор: Chih-Kai Hsu,Han-Chung CHENG,Chi-Tang Tu. Владелец: Taiwan Mitochondrion Application Technology Co Ltd. Дата публикации: 2020-09-30.

Use of nod2 agonist for the treatment, prophylaxis and/or delay of the onset of multiple sclerosis and alzheimer's disease

Номер патента: EP3793583A1. Автор: Jean Gosselin,Serge Rivest. Владелец: UNIVERSITE LAVAL. Дата публикации: 2021-03-24.

Diagnostic and therapeutic use of kcnj6 for alzheimer's disease

Номер патента: EP1745296A2. Автор: Heinz Von Der Kammer,Johannes Pohlner. Владелец: Evotec Neurosciences GmbH. Дата публикации: 2007-01-24.

Phospho-tau aggregation-based biomarkers for alzheimer's disease diagnosis, differentiation, and treatment

Номер патента: WO2024097164A1. Автор: Bin Xu,Ling Wu,Shih-Hsiu Wang,Nailya GILYAZOVA,John F. ERVIN,Andrew J. LIU. Владелец: NORTH CAROLINA CENTRAL UNIVERSITY. Дата публикации: 2024-05-10.

Csf-based prognostic biomarkers in alzheimer's disease and methods of use thereof

Номер патента: US20230003744A1. Автор: William T. Hu. Владелец: Rutgers State University of New Jersey. Дата публикации: 2023-01-05.

System and a method for detecting and quantifying electroencephalographic biomarkers in alzheimer's disease

Номер патента: US20240021313A1. Автор: Jacob A. Donoghue,Matthew S. Alkaitis,Jarrett Revels,Jay Srirarm Pathmanathan. Владелец: Beacon Biosignals Inc. Дата публикации: 2024-01-18.

Methods and compositions relating to Alzheimer's disease

Номер патента: AU2005288689A1. Автор: Stefan Kienle,Richard Joubert,Helen Byers,Karsten Kuhn,Juergen Schaefer,Christian Baumann,Malcolm Ward,Simon Lovestone,Jules Westbrook,Petra Prefot,Abdul Hye,Stephen Lynham,Thorsten Prinz. Владелец: Proteome Sciences PLC. Дата публикации: 2006-04-06.

Methods and compositions relating to alzheimer's disease

Номер патента: CA2580532A1. Автор: Stefan Kienle,Richard Joubert,Helen Byers,Karsten Kuhn,Juergen Schaefer,Christian Baumann,Malcolm Ward,Simon Lovestone,Jules Westbrook,Petra Prefot,Abdul Hye,Stephen Lynham,Thorsten Prinz. Владелец: Individual. Дата публикации: 2006-04-06.

Methods and compositions relating to Alzheimer`s disease

Номер патента: EP2354795B1. Автор: Richard Joubert,Malcom Ward,Helen Byers,Karsten Kuhn,Juergen Schaefer,Christian Baumann,Simon Lovestone,Jules Westbrook,Petra Prefot,Abdul Hye,Stephen Lynham,Thorsten Prinz,Stefan Kielne. Владелец: Proteome Sciences PLC. Дата публикации: 2014-12-17.

Methods and compositions relating to alzheimer's disease

Номер патента: EP1794594B1. Автор: Malcolm Proteome Sciences plc Ward,Helen Proteome Sciences plc BYERS,Jules Proteome Sciences plc WESTBROOK,Simon King's College London LOVESTONE,Abdul King's College London HYE,Stephen King's College London LYNHAM,Richard Proteome Sciences R&D GmbH&Co.KG JOUBERT,Petra Proteome Sciences R&D GmbH&Co. KG PREFOT,Karsten Proteome Sciences R&D GmbH&Co. KG KUHN,Christian Proteome Sci. R&D GmbH&Co KG BAUMANN,Juergen Proteome Sci. R&D GmbH&CO KG SCHAEFER,Thorsten Proteome Sciences R&D GmbH&Co. KG PRINZ,Stefan Proteome Sciences R&D GmbH&Co. KG KIENLE. Владелец: Proteome Sciences PLC. Дата публикации: 2011-01-12.

Method for monitoring a patient having a neurological and/or progressive disease, such as multiple sclerosis, parkinson's disease or alzheimer's disease

Номер патента: EP4341962A1. Автор: Johannes Weda,Frank DE GRAAF,Pim Petrus Cornelius VAN OIRSCHOT. Владелец: Sherpa BV. Дата публикации: 2024-03-27.

Method for monitoring a patient having a neurological and/or progressive disease, such as multiple sclerosis, parkinson's disease or alzheimer's disease

Номер патента: US20240242844A1. Автор: Johannes Weda,Frank DE GRAAF,Pim Petrus Cornelius VAN OIRSCHOT. Владелец: Sherpa BV. Дата публикации: 2024-07-18.

Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio - alzheimer's disease-specific molecular biomarkers (adsmb)

Номер патента: CA2625300C. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2018-01-02.

Biomarkers for detecting and/or determining a treatment regimen for alzheimer's disease

Номер патента: WO2024049764A1. Автор: Jeff Olson,Sarah Bacus,Christopher Hamm. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-03-07.

Method for diagnosing alzheimer´s disease

Номер патента: EP3465163A1. Автор: Carlo Zanotti,Alejandro Catala Espi,Gloria VENEGAS DEL VALLE. Владелец: Raman Health Technologies SL. Дата публикации: 2019-04-10.

Methods and compositions for screening and treating alzheimer's disease

Номер патента: WO2024151904A3. Автор: Peggy S. Eis,Eli Hatchwell,Edward B. Smith III,Shapour JALILZADEH. Владелец: POPULATION BIO, INC.. Дата публикации: 2024-08-22.

Component assay for alzheimer's disease in a living subject

Номер патента: CA3227341A1. Автор: Hoau-Yan Wang,George B. Thornton. Владелец: Cassava Sciences Inc. Дата публикации: 2023-01-26.

Component assay for alzheimer's disease in a living subject

Номер патента: AU2022313196A1. Автор: Hoau-Yan Wang,George B. Thornton. Владелец: Cassava Sciences Inc. Дата публикации: 2024-02-15.

Component assay for alzheimer's disease in a living subject

Номер патента: EP4374175A1. Автор: Hoau-Yan Wang,George B. Thornton. Владелец: Cassava Sciences Inc. Дата публикации: 2024-05-29.

System and Method for Detecting Alzheimer's Disease

Номер патента: US20210353207A1. Автор: Sandeep Chakraborty,Chi-Kuang Sun. Владелец: National Taiwan University NTU. Дата публикации: 2021-11-18.

Hyperspectral Image-Guided Ocular Imager for Alzheimer's Disease Pathologies

Номер патента: US20240341668A1. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2024-10-17.

Apparatus and method for detecting amyloid in a retina in a diagnosis, advancement, and prognosing of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative dissorders, and ocular diseases

Номер патента: US09730580B2. Автор: Steven Roger Verdooner. Владелец: Neurovision Imaging Inc. Дата публикации: 2017-08-15.

Systems and methods for moving and circulating fluid to treat alzheimer's disease

Номер патента: US09421348B2. Автор: Tim Lenihan,Bruce Meadows. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2016-08-23.

Phototherapy apparatus for treating alzheimer's disease

Номер патента: WO2024022381A1. Автор: Daifa Wang. Владелец: Danyang Huichuang Medical Equipment Co., Ltd.. Дата публикации: 2024-02-01.

Methods of diagnosing or prognosing alzheimer's disease

Номер патента: EP1123509A2. Автор: Roger Nitsch,John Growdon. Владелец: Roger Nitsch. Дата публикации: 2001-08-16.

Non-invasive method for diagnosing alzheimer's disease in a patient

Номер патента: CA2195877C. Автор: Leonard Scinto,Kirk R. Daffner. Владелец: Beth Israel Hospital Association. Дата публикации: 2000-12-05.

Compositions and methods for treating alzheimer's disease utilizing a transcriptional master regulator of the retromer complex

Номер патента: WO2023201219A1. Автор: Ulrich Hengst,Claudio Andre Gouveia Martins ROQUE,Jimena BALERIOLA. Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2023-10-19.

Fragment of neurosecretory protein VGF as a biomarker for Alzheimer's disease

Номер патента: US20070015221A1. Автор: Huw Davies,Kaj Blennow,Vladimir Podust,James McGuire,Anja Simonsen. Владелец: Ciphergen Biosystems Inc. Дата публикации: 2007-01-18.

Predictive neuromarkers of alzheimer's disease

Номер патента: EP3451903A1. Автор: Quentin BARTHELEMY,Louis MAYAUD,David OJEDA. Владелец: Mensia Technologies. Дата публикации: 2019-03-13.

Micro device of nerve signal recording and stimulating for diagnosis and treatment of chronic pain or alzheimer's disease

Номер патента: US20220184398A1. Автор: Jae Suk Sung,Heon Jin Choi,Youngcheol Chae. Владелец: Nformare Inc. Дата публикации: 2022-06-16.

Head worn device for treating alzheimer's disease

Номер патента: US20180333590A1. Автор: Matthew D. Millard,David A. Gonzales. Владелец: Individual. Дата публикации: 2018-11-22.

Low Level Laser Therapy for Alzheimer's Disease

Номер патента: US20160325115A1. Автор: Dan Frenkel,Dorit Farfara,Uri Oron,Hana Tuby. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2016-11-10.

Method of providing diagnostic information on alzheimer's disease using brain network

Номер патента: US20230148955A1. Автор: Goo-Rak KWON. Владелец: Industry Academic Cooperation Foundation of Chosun National University. Дата публикации: 2023-05-18.

Diagnosis and treatment of alzheimer's disease

Номер патента: CA2587601A1. Автор: Suzanne Marie De La Monte,Jack Raymond Wands. Владелец: Individual. Дата публикации: 2006-06-08.

Diagnosis and treatment of alzheimer's disease

Номер патента: EP1817050A2. Автор: Suzanne Marie De La Monte,Jack Raymond Wands. Владелец: RHODE ISLAND HOSPITAL. Дата публикации: 2007-08-15.

Methods for treating alzheimer's disease

Номер патента: US20230218812A1. Автор: John O. Tate. Владелец: Individual. Дата публикации: 2023-07-13.

Explainable cnn-attention network (c-attention network) architecture for automated detection of alzheimer's disease

Номер патента: US20240023876A1. Автор: Ning Wang,Koduvayur P. Subbalakshmi,Mingxuan Chen. Владелец: Stevens Institute of Technology . Дата публикации: 2024-01-25.

Explainable cnn-attention network (c-attention network) architecture for automated detection of alzheimer's disease

Номер патента: WO2022046793A1. Автор: Ning Wang,Koduvayur P. Subbalakshmi,Mingxuan Chen. Владелец: The Trustees of the Stevens Institute of Technology. Дата публикации: 2022-03-03.

Acousto-optic therapeutic equipment for improving cognitive function of alzheimer's disease

Номер патента: LU502659B1. Автор: Dongsheng Zhou. Владелец: Ninbo Kangning Hospital Ningbo Center For Mental Disease Prevention And Control. Дата публикации: 2023-02-13.

Hyperspectral image-guided raman ocular imager for Alzheimer's Disease pathologies

Номер патента: AU2018372578B2. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2024-11-07.

Targeted immunization and plaque destruction against Alzheimer's disease

Номер патента: US09907485B2. Автор: Christoph Pedain,Andreas Hartlep. Владелец: BRAINLAB AG. Дата публикации: 2018-03-06.

Detection of early stage alzheimer's disease and mild cognitive impairment

Номер патента: US09872647B2. Автор: Peter Koulen. Владелец: University of Missouri System. Дата публикации: 2018-01-23.

Electrical treatment of alzheimer's disease

Номер патента: US09775996B2. Автор: Yossi Gross. Владелец: Rainbow Medical Ltd. Дата публикации: 2017-10-03.

Electrical substance clearance from the brain for treatment of Alzheimer's disease

Номер патента: US09724515B2. Автор: Yossi Gross,Gideon Fostick. Владелец: Rainbow Medical Ltd. Дата публикации: 2017-08-08.

Low level laser therapy for Alzheimer's disease

Номер патента: US09649507B2. Автор: Dan Frenkel,Dorit Farfara,Uri Oron,Hana Tuby. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2017-05-16.

Electrical treatment of Alzheimer's disease

Номер патента: US09616221B2. Автор: Yossi Gross. Владелец: Rainbow Medical Ltd. Дата публикации: 2017-04-11.

Accelerated evaluation of treatments to prevent clinical onset of alzheimer's disease

Номер патента: US09492114B2. Автор: Eric M. Reiman. Владелец: Banner Health Systems Inc. Дата публикации: 2016-11-15.

Hyperspectral image-guided ocular imager for alzheimer's disease pathologies

Номер патента: US11896382B2. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2024-02-13.

System and method for Alzheimer's disease prediction using neural network, computer-readable recording medium with stored program, and computer program product

Номер патента: US11813067B2. Автор: Gwo-Giun Lee,Yu-Min Kuo,Yi-Ru Xie. Владелец: National Cheng Kung University NCKU. Дата публикации: 2023-11-14.

Alzheimer's disease personalized medicine

Номер патента: US20220022749A1. Автор: Janos Redei. Владелец: I2DX Inc. Дата публикации: 2022-01-27.

Method for obtaining an indicator of presence for alzheimer's disease using eeg signals

Номер патента: WO2023223140A1. Автор: Pedro Miguel DE LUÍS RODRIGUES,Gabriel Afonso DA ROCHA SILVA. Владелец: Universidade Catolica Portuguesa - Ucp. Дата публикации: 2023-11-23.

Alzheimer's disease treatment with multiple therapeutic agents delivered to the olfactory region through a special delivery catheter and iontophoresis

Номер патента: US20150080785A1. Автор: Totada R. Shantha. Владелец: Wedge Therapeutics LLC. Дата публикации: 2015-03-19.

System and method for alzheimer's disease prediction using neural network, computer-readable recording medium with stored program, and computer program product

Номер патента: US20220378361A1. Автор: Gwo-Giun Lee,Yu-Min Kuo,Yi-Ru Xie. Владелец: National Cheng Kung University NCKU. Дата публикации: 2022-12-01.

Systems and methods for color-coded visualization to aid in diagnosis and prognosis of Alzheimer's disease

Номер патента: US11989932B1. Автор: Malek Adjouadi,Mohammad Eslami,Solale Tabarestani. Владелец: Florida International University FIU. Дата публикации: 2024-05-21.

Method for endovascular treatment of alzheimer's disease

Номер патента: RU2297860C1. Автор: Иван Васильевич Максимович. Владелец: Иван Васильевич Максимович. Дата публикации: 2007-04-27.

Intranasal Red Light Probe For Treating Alzheimer's Disease

Номер патента: US20080221646A1. Автор: Thomas M. DiMauro,Sean Lilienfeld,Mohamed Attawia,Chantal Holy. Владелец: Individual. Дата публикации: 2008-09-11.

Apparatus and method for alzheimer's disease diagnosis using eeg(electroencephalogram) analysis

Номер патента: KR20100032054A. Автор: 이승환,임창환. Владелец: 인제대학교 산학협력단. Дата публикации: 2010-03-25.

Methods and systems for management of alzheimer's disease

Номер патента: CA2489341A1. Автор: Alon Shalev. Владелец: Individual. Дата публикации: 2003-12-24.

Methods for treating Alzheimer's disease

Номер патента: US11944736B2. Автор: John O. Tate. Владелец: Individual. Дата публикации: 2024-04-02.

Methods for treating alzheimer's disease

Номер патента: US20230390475A1. Автор: John O. Tate. Владелец: Individual. Дата публикации: 2023-12-07.

Patient with alzheimer's disease positioning and retrieval assembly carrying an original location

Номер патента: US20190388010A1. Автор: Jun Deng,Mengyao Lai. Владелец: Dongguan University of Technology. Дата публикации: 2019-12-26.

Patient with Alzheimer's disease positioning and retrieval assembly carrying an original location

Номер патента: US10694979B2. Автор: Jun Deng,Mengyao Lai. Владелец: Dongguan University of Technology. Дата публикации: 2020-06-30.

Hyperspectral image-guided raman ocular imager for alzheimer's disease pathologies

Номер патента: EP3716838A1. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2020-10-07.

Detecting longitudinal progression of alzheimer's disease (ad) based on speech analyses

Номер патента: WO2023250326A1. Автор: Edmond Huatung Teng,Laurence Kahn,Jessica Robin. Владелец: Genentech, Inc.. Дата публикации: 2023-12-28.

Systems and methods to characterize individual response to brain perturbation in patients with alzheimer's disease

Номер патента: WO2024006939A2. Автор: Emiliano Santarnecchi,Giacomo Koch. Владелец: Sinaptica Therapeutics, Inc.. Дата публикации: 2024-01-04.

Detection of Early Stage Alzheimer's Disease and Mild Cognitive Impairment

Номер патента: US20160302712A1. Автор: Peter Koulen. Владелец: University of Missouri System. Дата публикации: 2016-10-20.

Detection of early stage alzheimer's disease and mild cognitive impairment

Номер патента: US20180125410A1. Автор: II Peter Koulen. Владелец: University of Missouri System. Дата публикации: 2018-05-10.

Electrical treatment of Alzheimer's disease

Номер патента: US11819685B2. Автор: Yossi Gross. Владелец: Rainbow Medical Ltd. Дата публикации: 2023-11-21.

Method and apparatus for diagnosing Alzheimer's disease using PET-CT image

Номер патента: US11756193B2. Автор: Sang Won Seo,Soo Jong Kim. Владелец: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION. Дата публикации: 2023-09-12.

Upregulation of Adamts4 Protease Activity for the Treatment of Alzheimer's Disease

Номер патента: US20090305314A1. Автор: Dirk Beher,Jonathon Wrigley. Владелец: Individual. Дата публикации: 2009-12-10.

Method for determining probability of subject with mild cognition impairment developing alzheimer's disease within predetermined time period

Номер патента: US20240156417A1. Автор: Albert Chihchieh YANG,Jong-Ling FUH,Shih-Yu Fang. Владелец: National Yang Ming Chiao Tung University NYCU. Дата публикации: 2024-05-16.

Systems, methods, and media for predicting a conversion time of mild cognitive impairment to alzheimer's disease in patients

Номер патента: US20230225668A1. Автор: Chris Peter Tsokos,Mohamed Ali M Abu Sheha. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2023-07-20.

Methods for diagnosing alzheimer's disease

Номер патента: EP1372468A1. Автор: Martin H. Teicher,Steven B. Lowen,David G. Harper,Janet M. Lawrence,Sumer D. Verma. Владелец: Mclean Hospital Corp. Дата публикации: 2004-01-02.

Methods for diagnosing alzheimer's disease

Номер патента: EP1372468A4. Автор: Martin H Teicher,Steven B Lowen,David G Harper,Sumer D Verma,Janet M Lawrence. Владелец: Mclean Hospital Corp. Дата публикации: 2006-06-28.

Prevention and treatment of alzheimer's disease through electromagnetic field exposure

Номер патента: US20120065456A1. Автор: Chuanhai Cao,Jun Tan,Gary W. Arendash. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2012-03-15.

System and method for alzheimer?s disease risk quantification utilizing interferometric micro - doppler radar and artificial intelligence

Номер патента: US20230078905A1. Автор: Yuan-Ming Fleming Lure,Shuchuan Jack Cheng. Владелец: MS Technologies LLC. Дата публикации: 2023-03-16.

Methods for detecting and preventing alzheimer's disease and mild cognitive impairment

Номер патента: WO2023112030A1. Автор: Inna Slutsky,Shiri SHOOB,Nadav BUCHBINDER,Daniel ZARHIN. Владелец: Ramot at Tel-Aviv University Ltd.. Дата публикации: 2023-06-22.

Set of oligonucleotide primers and probes for genetic typing of polymorphous dna loci associated with a risk of progression of sporadic form of alzheimer's disease in russian populations

Номер патента: RU2600874C2. Автор: Александр Сергеевич Заседателев,Татьяна Васильевна Наседкина,Ольга Алексеевна Гра,Игорь Игоревич Низамутдинов. Владелец: Федеральное государственное бюджетное учреждение науки Российской академии наук Институт молекулярной биологии им. В.А. Энгельгардта Российской академии наук (ИМБ РАН). Дата публикации: 2016-10-27.

Mitochondrial preproteins as markers for alzheimer's disease

Номер патента: EP3114486A2. Автор: Caroline Graff,Chris MEISINGER,Nora VÖGTLE,Dirk MOSSMANN,Elzbieta GLASER,René P. ZAHEDI. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2017-01-11.

Abnormalities of phosphatase 2a (pp2a) for diagnosis and treatment of alzheimer's disease

Номер патента: CA2582270A1. Автор: Daniel L. Alkon,Wei-Qin Zhao. Владелец: Wei-Qin Zhao. Дата публикации: 2006-05-26.

Compositions and methods for assessing risk factors in Alzheimer's disease

Номер патента: US6136530A. Автор: Shirley E. Poduslo. Владелец: Texas Tech University Health Sciences Center. Дата публикации: 2000-10-24.

Determination of platelet-mirnas in alzheimer's disease

Номер патента: EP3083987A2. Автор: Markus Beier. Владелец: Hummingbird Diagnostics GmbH. Дата публикации: 2016-10-26.

Gene expression profiling of endothelium in alzheimer's disease

Номер патента: WO2002057496A3. Автор: Howard J Federoff,Berislav V Zlokovic. Владелец: Berislav V Zlokovic. Дата публикации: 2004-03-25.

Determination of platelet-mirnas in alzheimer's disease

Номер патента: US20170002411A1. Автор: Markus Beier. Владелец: Hummingbird Diagnostics GmbH. Дата публикации: 2017-01-05.

tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease

Номер патента: US20220195508A1. Автор: Xiang Fang,Xiaoyong Bao. Владелец: University of Texas System. Дата публикации: 2022-06-23.

Specialized excitatory synaptic protein biomarkers of plasma neuronal exosomes for prediction and staging of alzheimer's disease

Номер патента: US20190011460A1. Автор: Edward J. Goetzl. Владелец: Individual. Дата публикации: 2019-01-10.

Plasma cell-free rna and methods of use thereof as non-invasive biomarkers for alzheimer's disease

Номер патента: US20240167096A1. Автор: Carlos Cruchaga,Laura IBANEZ,Alejandro Cisterna Garcia. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2024-05-23.

Method for diagnosis of Alzheimer's disease using microrna

Номер патента: US12084718B2. Автор: Jin-Hyeob Ryu,Hyun-Jeong CHO. Владелец: Biorchestra Co Ltd. Дата публикации: 2024-09-10.

Peripheral blood mononuclear cells (pbmc) phenotypes as biomarkers for patients with alzheimer's disease and/or mild cognitive impairment (mci)

Номер патента: US20240327913A1. Автор: Philip DENNER,Anja Schneider,Eugenio FAVA,Wera ROTH,Pranjal DHOLE,Josephine BLERSCH. Владелец: Deutsches Zentrum fuer Neurodegenerative Erkrankungen eV. Дата публикации: 2024-10-03.

Composition for predicting clinical stage of Alzheimer's disease and kit using the same

Номер патента: US20220091138A1. Автор: Myeong Ok Kim. Владелец: Industry Academic Cooperation Foundation of GNU. Дата публикации: 2022-03-24.

Composition and method of using mir-302 precursors as drugs for treating alzheimer's diseases

Номер патента: US20170218362A1. Автор: Shi-Lung Lin,Hsin-Hua Li,Chih-Li LIN,Te-Jen LAI. Владелец: MELLO BIOTECHNOLOGY Inc. Дата публикации: 2017-08-03.

U-p53 peptides as markers in the rate of progression of cognitive decline to alzheimer's disease

Номер патента: WO2024148357A2. Автор: Paul Kinnon,Simona Piccirella. Владелец: Diadem Spa. Дата публикации: 2024-07-11.

U-p53 peptides as markers in the rate of progression of cognitive decline to alzheimer's disease

Номер патента: WO2024148357A3. Автор: Paul Kinnon,Simona Piccirella. Владелец: Diadem Spa. Дата публикации: 2024-08-08.

Method for diagnosis of alzheimer's disease using microrna

Номер патента: US20220170095A1. Автор: Jin-Hyeob Ryu,Hyun-Jeong CHO. Владелец: Biorchestra Co Ltd. Дата публикации: 2022-06-02.

Detection of alzheimer's disease (ad), frontotemporal lobar degeneration (ftld), amyotrophic lateral schlerosis (als), parkinson's disease (pd), and dementia with lewy bodies (dlb) indicated by phosphorylation of marcks

Номер патента: EP3764102A1. Автор: Hitoshi Okazawa. Владелец: Tokyo Medical and Dental University NUC. Дата публикации: 2021-01-13.

Olfactory receptor copy number association with age at onset of alzheimer's disease

Номер патента: WO2011163607A3. Автор: Kinga Szigeti,Chad A. Shaw,Joanna Wiszniewska. Владелец: Baylor College of Medicine. Дата публикации: 2013-09-06.

Biosensor for diagnosing alzheimer's disease using rayleigh scattering and colorimetric assay of gold nanoparticle and multi-detection method using the biosensor

Номер патента: US20190338360A1. Автор: SangJun SIM. Владелец: Pharmaworks Co Ltd. Дата публикации: 2019-11-07.

Circulating miRNAs as biomarkers for diagnosis of mild cognitive impairment and Alzheimer's disease

Номер патента: US12054779B2. Автор: Jose Rodriguez Alvarez,Alfredo Jesus Miñano Molina,Dolores Siedlecki Wullich. Владелец: Centro Investigacion Biomedica En Red Enfermedades Neurodegenerativas (ciberned). Дата публикации: 2024-08-06.

Method for determining the risk of occurrence of alzheimer's disease

Номер патента: WO2011024082A3. Автор: Philippe Amouyel,Jean-Charles Lambert,Mark Lathrop. Владелец: Institut National De La Sante Et De La Recherche Medicale (Inserm) (Epst). Дата публикации: 2011-04-21.

Method for determining the risk of occurrence of alzheimer's disease

Номер патента: US20120238461A1. Автор: Philippe Amouyel,Jean-Charles Lambert,Mark Lathrop. Владелец: Universite Lille 2 Droit et Sante. Дата публикации: 2012-09-20.

Method for determining the risk of occurrence of alzheimer's disease

Номер патента: WO2011024082A2. Автор: Philippe Amouyel,Jean-Charles Lambert,Mark Lathrop. Владелец: Institut National De La Sante Et De La Recherche Medicale (Inserm) (Epst). Дата публикации: 2011-03-03.

Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders

Номер патента: US09958460B2. Автор: Edward J. Goetzl. Владелец: Nanosomix Inc. Дата публикации: 2018-05-01.

Biomarkers for alzheimer's disease

Номер патента: CA2718392A1. Автор: Philippe Amouyel,Stephanie Ferreira,Jean-Charles Lambert. Владелец: Genoscreen. Дата публикации: 2009-09-17.

Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism

Номер патента: US20030059824A1. Автор: Samuel Henderson. Владелец: Accera Inc. Дата публикации: 2003-03-27.

Cortical neuron cell model of alzheimer's disease based on bmi1 deficiency, and uses thereof

Номер патента: US20190203254A1. Автор: Gilbert Bernier,Anthony Flamier. Владелец: 9636137 Canada Inc. Дата публикации: 2019-07-04.

Prediction of alzheimer's disease

Номер патента: WO2023225004A1. Автор: Uppala RadhaKrishna,Ray BAHADO-SINGH,Stewart F. GRAHAM,Sangeetha VISHWESWARAIAH. Владелец: Bioscreening & Diagnostics LLC. Дата публикации: 2023-11-23.

Cortical neuron cell model of alzheimer's disease based on bmi1 deficiency, and uses thereof

Номер патента: EP3494212A1. Автор: Gilbert Bernier,Anthony Flamier. Владелец: 9636137 Canada Inc. Дата публикации: 2019-06-12.

Cortical neuron cell model of alzheimer's disease based on bmi1 deficiency, and uses thereof

Номер патента: WO2018025098A1. Автор: Gilbert Bernier,Anthony Flamier. Владелец: 9636137 Canada Inc.. Дата публикации: 2018-02-08.

Diagnostics for determining the onset of alzheimer's disease

Номер патента: US20180057879A1. Автор: William P. Macconnell,Harold Amogan. Владелец: Macconnell Research Corp. Дата публикации: 2018-03-01.

Composition for diagnosing Alzheimer's disease using methylation status of HMOX1 gene and method for diagnosing Alzheimer's disease using the same

Номер патента: US20140162252A1. Автор: Jung-Hyuck AHN,Hye-Youn Sung. Владелец: Industry Collaboration Foundation of Ewha University. Дата публикации: 2014-06-12.

Methods for assessing risk of alzheimer's disease in a patient

Номер патента: US20130102692A1. Автор: Craig S. Atwood. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2013-04-25.

Methods for Assessing Risk of Alzheimer's Disease in a Patient

Номер патента: US20100035266A1. Автор: Craig S. Atwood. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2010-02-11.

Methods for assessing risk of alzheimer's disease in a patient

Номер патента: US20170016072A1. Автор: Craig S. Atwood. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2017-01-19.

Microrna biomarkers in blood for diagnosis of alzheimer's disease

Номер патента: US20190136320A1. Автор: Urszula Wojda,Katarzyna Laskowska-Kaszub,Tomasz Gabryelewicz,Jacek Kuznicki. Владелец: Biotech Innovations Spolka Z Ograniczona Odpowiedziainoscia. Дата публикации: 2019-05-09.

Mirnas as biomarkers for alzheimer's disease

Номер патента: WO2019081497A1. Автор: Andreas Keller,Markus Beier. Владелец: Universität des Saarlandes. Дата публикации: 2019-05-02.

Method of determining alzheimer's disease risk using apolipoprotein e4 genotype analysis in combination with decreased estrogen levels

Номер патента: US20020098481A1. Автор: Donald E. Schmechel,Gillian Einstein,Laura W. Shaughnessy. Владелец: Individual. Дата публикации: 2002-07-25.

Microrna biomarkers in blood for diagnosis of alzheimer's disease

Номер патента: EP3449009A1. Автор: Urszula Wojda,Katarzyna Laskowska-Kaszub,Tomasz Gabryelewicz,Jacek Kuznicki. Владелец: Instytut Biologii Doswiadczalnej Pan Im M Nenckiego. Дата публикации: 2019-03-06.

Composition and method of using mir-302 precursors as drugs for treating alzheimer's diseases

Номер патента: US20200071700A1. Автор: Shi-Lung Lin,Hsin-Hua Li,Chih-Li LIN,Te-Jen LAI. Владелец: Individual. Дата публикации: 2020-03-05.

Methods and compositions for diagnosing, preventing, and treating Alzheimer's disease

Номер патента: US20040219610A1. Автор: Rudolph Tanzi,Giuseppina Tesco,Young Koh. Владелец: General Hospital Corp. Дата публикации: 2004-11-04.

Reagents and methods for alzheimer's disease and comorbidities thereof

Номер патента: WO2020227084A3. Автор: Rene ANAND,Susan MCKAY. Владелец: Anand Rene. Дата публикации: 2020-12-17.

Methods of Diagnosis of Alzheimer's Disease by Monitoring STING Signaling Activation

Номер патента: US20230313306A1. Автор: Feng Xue. Владелец: Individual. Дата публикации: 2023-10-05.

Methods for diagnosing alzheimer's disease and other neurological disorders

Номер патента: WO2022133107A8. Автор: Desheng Xu,Paul F. Worley,Meifang Xiao. Владелец: Cognext Diagnostics LLC. Дата публикации: 2022-08-18.

Reagents and methods for alzheimer's disease and comorbidities thereof

Номер патента: WO2020227084A2. Автор: Rene ANAND,Susan MCKAY. Владелец: Anand Rene. Дата публикации: 2020-11-12.

Methods for diagnosing alzheimer's disease and other neurological disorders

Номер патента: EP4264277A1. Автор: Desheng Xu,Paul F. Worley,Meifang Xiao. Владелец: Cognext Diagnostics LLC. Дата публикации: 2023-10-25.

Vps35-based assays and methods for treating alzheimer’s disease

Номер патента: WO2005046585A3. Автор: Tae-Wan Kim,Scott A Small. Владелец: Univ Columbia. Дата публикации: 2006-03-23.

Methods and compositions for treating alzheimer's disease

Номер патента: US20110165598A1. Автор: Henry W. Querfurth. Владелец: Individual. Дата публикации: 2011-07-07.

Markers associated with alzheimer's disease

Номер патента: US20110263439A1. Автор: Eric M. Reiman,Matt HUENTELMAN. Владелец: Translational Genomics Research Institute TGen. Дата публикации: 2011-10-27.

Markers associated with alzheimer's disease

Номер патента: WO2011113004A3. Автор: Eric M. Reiman,Matt HUENTELMAN. Владелец: TRANSLATIONAL GENOMICS RESEARCH INSTITUTE. Дата публикации: 2012-04-12.

Methods and compositions for treating alzheimer's disease

Номер патента: US20150247857A1. Автор: Henry W. Querfurth. Владелец: Individual. Дата публикации: 2015-09-03.

Method for determining a predisposition to or prognosis of alzheimer's disease based on angiotensin-converting enzyme dna polymorphisms

Номер патента: WO2000000640A3. Автор: Julie Williams,Michael John Owen,Patrick Gavin Kehoe. Владелец: Patrick Gavin Kehoe. Дата публикации: 2000-05-25.

Method for diagnosis of alzheimer's disease

Номер патента: US20180113129A1. Автор: Chai-Ching Lin,Chen-Wei Tsai. Владелец: Dr Power Stem Biomedicai Research Inc Ltd. Дата публикации: 2018-04-26.

Methods and compositions for treating alzheimer's disease

Номер патента: US09618511B2. Автор: Henry W. Querfurth. Владелец: Individual. Дата публикации: 2017-04-11.

Screening for alzheimer's disease

Номер патента: US20060183117A1. Автор: Jeffery Vance,Margaret Pericak-Vance,Johathan Haines. Владелец: Duke University. Дата публикации: 2006-08-17.

Screening for alzheimer's disease

Номер патента: WO2004005534A2. Автор: Margaret A. Pericak-Vance,Jeffrey M. Vance,Jonathan L. Haines. Владелец: Duke University. Дата публикации: 2004-01-15.

Human induced pluripotent stem cell lines for modeling Alzheimer's disease and usage thereof

Номер патента: US11834648B2. Автор: BO Yang,Min Zhou,Jian Fu,Yuqing Liu,Lixiang Jiang,Yubo YAN,Jiayin YANG. Владелец: Shenzhen Cell Inspire Biotechnology Co ltd. Дата публикации: 2023-12-05.

Methods of determining the risk of developing alzheimer's disease dementia

Номер патента: WO2023170307A1. Автор: Marta Barrachina Castillo,Marta BLANCH LOZANO,Jose Luis MOSQUERA MAYO. Владелец: Admit Therapeutics Sl. Дата публикации: 2023-09-14.

Methods for diagnosing and/or treating alzheimer's disease

Номер патента: WO2023129531A2. Автор: Sarah S. Bacus. Владелец: Seq Biomarque, Llc.. Дата публикации: 2023-07-06.

Novel human induced pluripotent stem cell lines for modeling alzheimer's disease and usage thereof

Номер патента: EP3707263A1. Автор: BO Yang,Min Zhou,Jian Fu,Yuqing Liu,Lixiang Jiang,Yubo YAN,Jiayin YANG. Владелец: Shenzhen Cell Inspire Biotechnology Co ltd. Дата публикации: 2020-09-16.

Olfactory receptor copy number association with age at onset of alzheimer's disease

Номер патента: WO2011163607A2. Автор: Kinga Szigeti,Chad A. Shaw,Joanna Wiszniewska. Владелец: Baylor College of Medicine. Дата публикации: 2011-12-29.

Differentially expressed biomarkers for alzheimer's disease

Номер патента: EP2992111A2. Автор: Graham Ball. Владелец: NOTTINGHAM TRENT UNIVERSITY. Дата публикации: 2016-03-09.

Methods for diagnosing and/or treating alzheimer's disease

Номер патента: AU2022429793A1. Автор: Sarah S. Bacus. Владелец: Seq Biomarque LLC. Дата публикации: 2024-06-27.

Methods for detection of cell-free dna (cfdna) and uses thereof for diagnosing, treating, and/or monitoring alzheimer's disease

Номер патента: WO2024098003A1. Автор: Victor Velculescu,Sarah Bacus,Jillian PHALLEN,Christopher A. Hamm,Robert Scharpf,Akshaya ANNAPRAGADA. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-05-10.

Methods for diagnosing and/or treating alzheimer's disease

Номер патента: WO2023129531A3. Автор: Sarah S. Bacus. Владелец: Seq Biomarque, Llc.. Дата публикации: 2023-08-10.

LYMPHOCYTE-BASED PKCepsilon TEST FOR ALZHEIMER'S DISEASE

Номер патента: EP3601601A1. Автор: Daniel L. Alkon,Florin Valentin Chirila. Владелец: NeuroDiagnostics LLC. Дата публикации: 2020-02-05.

Methods and compositions for pre-symptomatic or post-symptomatic diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: EP1769089A2. Автор: Douglas C. Wallace,Pinar E. Coskun. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2007-04-04.

Methods and compositions for pre-symptomatic or post-symptomatic diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: US20090111093A1. Автор: Douglas C. Wallace,Pinar E. Coskun. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2009-04-30.

Methods and compositions for diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: WO2007011322A2. Автор: Douglas C. Wallace,Pinar E. Coskun. Владелец: The Regents of the University of California. Дата публикации: 2007-01-25.

Method of diagnosing Alzheimer's disease by detecting the level of cathepsin D in cerebrospinal fluid

Номер патента: US5686269A. Автор: Ralph A. Nixon. Владелец: Mclean Hospital Corp. Дата публикации: 1997-11-11.

Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis

Номер патента: EP4289970A3. Автор: Simon Geir MØLLER,Ketan Patil,Guido Werner Alves. Владелец: St Johns University. Дата публикации: 2024-03-13.

VPS35-based assays and methods for treating Alzheimer's disease

Номер патента: US20050176668A1. Автор: Tae-Wan Kim,Scott Small. Владелец: Individual. Дата публикации: 2005-08-11.

Biomarker panels, systems, and methods for risk stratification of a subject for alzheimer's disease

Номер патента: US20230340597A1. Автор: Sasidhar Venkata MANDA,Sai Krishnaveni CHEVOORU,Subhashani PRABHAKAR,Anusha TUMMALA. Владелец: Urvogelbio Private Ltd. Дата публикации: 2023-10-26.

Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis

Номер патента: US20200190588A1. Автор: Simon Geir MØLLER,Ketan Shirish Patil,Guido Werner Alves. Владелец: St Johns University USA. Дата публикации: 2020-06-18.

Minimal biomarkers and related next-generation sequencing kit for diagnosing alzheimer's disease from intestinal microbiome

Номер патента: WO2020117164A9. Автор: Özkan Ufuk Nalbantoglu,Aycan Gündogdu,Emel KÖSEOĞLU. Владелец: T.C. Erciyes Universitesi. Дата публикации: 2021-04-15.

Protein markers for assessing alzheimer's disease

Номер патента: US20230213535A1. Автор: Nancy Yuk-yu Ip,Fanny Chui-Fun Ip,Kit Yu Fu,Yuanbing JIANG,Xiaopu ZHOU. Владелец: Hong Kong University of Science and Technology HKUST. Дата публикации: 2023-07-06.

Screening method for agents suitable for therapy of alzheimer's disease

Номер патента: EP2222869A1. Автор: Gerd Multhaup,Lisa-Marie MÜNTER. Владелец: FREIE UNIVERSITAET BERLIN. Дата публикации: 2010-09-01.

Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis

Номер патента: EP4289970A2. Автор: Simon Geir MØLLER,Ketan Patil,Guido Werner Alves. Владелец: St Johns University. Дата публикации: 2023-12-13.

Protein markers for assessing alzheimer's disease

Номер патента: EP4150120A1. Автор: Nancy Yuk-yu Ip,Fanny Chui-Fun Ip,Kit Yu Fu,Yuanbing JIANG,Xiaopu ZHOU. Владелец: Hong Kong University of Science and Technology HKUST. Дата публикации: 2023-03-22.

Screening method for agents suitable for therapy of alzheimer's disease

Номер патента: WO2009068269A1. Автор: Gerd Multhaup,Lisa-Marie MÜNTER. Владелец: Fu Berlin. Дата публикации: 2009-06-04.

Health-care food for preventing and assisting treatment of alzheimer's disease, and preparation method thereof

Номер патента: AU2020202884A1. Автор: Shuiming Zhou,Yi-Hsuan Pan. Владелец: Visdon Pty Ltd. Дата публикации: 2021-10-14.

Late-onset alzheimer's disease animal model and uses thereof

Номер патента: US20190387723A1. Автор: Hiroshi Yamada,Chinthalapally Rao. Владелец: University of Oklahoma . Дата публикации: 2019-12-26.

Late-onset Alzheimer's disease animal model and uses thereof

Номер патента: US12004493B2. Автор: Hiroshi Yamada,Chinthalapally Rao. Владелец: University of Oklahoma . Дата публикации: 2024-06-11.

Method for predicting the likelihood of developing alzheimer's disease (ad)

Номер патента: RU2663451C1. Автор: Татьяна Павловна Клюшник,Любовь Васильевна Андросова,Анатолий Никифорович Симонов,Наталия Михайловна Михайлова. Владелец: Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья". Дата публикации: 2018-08-06.

Biomarkers of Alzheimer's Disease Progression

Номер патента: US20160252531A1. Автор: Morten Karsdal,Kim Henriksen. Владелец: Nordic Bioscience AS. Дата публикации: 2016-09-01.

Methods for identifying and targeting the molecular subtypes of alzheimer's disease

Номер патента: US20230395255A1. Автор: Bin Zhang,Lap Ho,Ryan A NEFF,Vahram HAROUTUNIAN,Xianxiao ZHOU. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2023-12-07.

Diagnostic assay for alzheimer's disease

Номер патента: CA2037105A1. Автор: Hossein A. Ghanbari,Peter Davies. Владелец: Individual. Дата публикации: 1991-08-27.

Methods of diagnosing alzheimer's disease

Номер патента: CA2574825A1. Автор: Michael R. D'andrea. Владелец: Michael R. D'andrea. Дата публикации: 2006-02-09.

Methods of diagnosing alzheimer's disease

Номер патента: EP1776590A1. Автор: Michael R. D'andrea. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2007-04-25.

Methods of diagnosing alzheimer's disease

Номер патента: WO2006014876A1. Автор: Michael R. D'andrea. Владелец: Janssen Pharmaceutica N.V.. Дата публикации: 2006-02-09.

Stratification by sex and apoe genotype identifies metabolic heterogeneity in alzheimer's disease

Номер патента: WO2020185563A1. Автор: Matthias Arnold,Rima F. KADDURAH-DAOUK,Gabi KASTENMÜLLER. Владелец: Duke University. Дата публикации: 2020-09-17.

Novel biomarker for diagnosis of alzheimer's disease, discovered from blood-derived exosomes, and method for diagnosing alzheimer's disease using same

Номер патента: US20240053365A1. Автор: So Youn Kim,Gunjoo Park. Владелец: PCL Inc. Дата публикации: 2024-02-15.

Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)

Номер патента: US09797913B2. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2017-10-24.

Biomarker and methods for early diagnosis of alzheimer's disease

Номер патента: RU2687272C2. Автор: Аннегрет ФОЙЕРХЕЛЬМ-ХАЙДЛЬ. Владелец: Предемтек Аг. Дата публикации: 2019-05-13.

Method for in vitro diagnosing of alzheimer's disease on basis of albumin redox-status in cerebrospinal fluid

Номер патента: RU2696485C2. Автор: ГАМОН Сальвадор ГРАНЧА,РЬЕРОЛА Монтсеррат КОСТА,ФЕРНАНДЕС Ана Мария ОРТИС. Владелец: Грифольс Уорлдуайд Оперейшнс Лимитед. Дата публикации: 2019-08-02.

Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology

Номер патента: US6787318B1. Автор: Jun Tan,Terrence Town,Michael Mullan. Владелец: ROSKAMP RESEARCH INSTITUTE LLC. Дата публикации: 2004-09-07.

Intelligent early screening model and construction method thereof for alzheimer’s disease

Номер патента: US20240233962A9. Автор: Chun Chen,Qingren Yang. Владелец: Wenzhou Medical University. Дата публикации: 2024-07-11.

Catecholamine concentrations in a blood sample and arterial hypertension status in a subject for a differential diagnosis of neurodegenerative diseases including alzheimer's disease

Номер патента: EP3959522A1. Автор: Romain VERPILLOT,Hervé THIRIEZ,Rudy BEAUJEAN. Владелец: Sas Alzohis. Дата публикации: 2022-03-02.

Alzheimer's disease biomarker, and screening method therefor and application thereof

Номер патента: US20240369583A1. Автор: YU Chen,Yijing Chen,Yingying Fan. Владелец: Shenzhen Institute of Advanced Technology of CAS. Дата публикации: 2024-11-07.

Spectroscopic method for Alzheimer's disease diagnosis

Номер патента: US09891108B2. Автор: Igor K. Lednev. Владелец: Research Foundation of State University of New York. Дата публикации: 2018-02-13.

Methods and systems for identifying patients with mild cognitive impairment with risk of transition to alzheimer's disease

Номер патента: RU2603601C2. Автор: Кейтлин Мари ЧИОУФОЛО,Джейм Дэвид ШАФФЕР. Владелец: КОНИНКЛЕЙКЕ ФИЛИПС ЭЛЕКТРОНИКС Н.В.. Дата публикации: 2016-11-27.

Catecholamine concentrations in a blood sample and arterial hypertension status in a subject for a differential diagnosis of neurodegenerative diseases including alzheimer's disease

Номер патента: WO2020216689A1. Автор: Romain VERPILLOT,Hervé THIRIEZ,Rudy BEAUJEAN. Владелец: Sas Alzohis. Дата публикации: 2020-10-29.

Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders

Номер патента: EP1423704A1. Автор: Rainer Hipfel,Heinz Von Der Kammer,Johannes Pohlner. Владелец: Evotec Neurosciences GmbH. Дата публикации: 2004-06-02.

Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders

Номер патента: US20040241694A1. Автор: Rainer Hipfel,Heinz Von Der Kammer,Johannes Pohlner. Владелец: Evotec Neurosciences GmbH. Дата публикации: 2004-12-02.

Detection of Beta Amyloid Protein as Alzheimer's Disease-Causing Factor in Palatine Tonsil and Use Thereof

Номер патента: US20240329057A1. Автор: Do Hyun Kim,Jung Eun Lee,Jung Yeon Lim,Seung Ho Yang,Sung Won Kim,Il Hwan LEE,Jung Ho CHUN. Владелец: Industry Academic Cooperation Foundation of Catholic University of Korea. Дата публикации: 2024-10-03.

Detection of fragments of nectin-1 for the diagnosis of alzheimer's disease

Номер патента: WO2008148098A3. Автор: Howard J Federoff,Seung T Lim. Владелец: Seung T Lim. Дата публикации: 2009-04-30.

Neurofilamental proteins as biomarker for alzheimer's disease

Номер патента: WO2008148492A8. Автор: Bernd Bohrmann,Peter Berndt. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2009-11-05.

Diagnostic method for Alzheimer's disease

Номер патента: US09625474B2. Автор: Kaj Blennow,Tormod Fladby,Lisbeth Johnsen. Владелец: INVEN2 AS. Дата публикации: 2017-04-18.

Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (adsmb)

Номер патента: US20140031245A1. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2014-01-30.

A biomarker for determining alzheimer's disease

Номер патента: WO2023198960A1. Автор: Rashid Giniatullin,Tarja Malm,Ilpo Kuronen,Ilkka FAGERLUND,Dilyara NURKHAMETOVA. Владелец: University Of Eastern Finland. Дата публикации: 2023-10-19.

Screening of agents for treatment of alzheimer's disease

Номер патента: US6245575B1. Автор: Michael John Smith,Masato Hasegawa,Michel Goedert,Ross Jakes,Maria Grazia Spillantini,Richard Anthony Crowther. Владелец: Medical Research Council. Дата публикации: 2001-06-12.

Method for Differentiation of Alzheimer's Disease into Subgroups

Номер патента: US20080070263A1. Автор: Inge Grundke-Iqbal,Khalid Iqbal,Michael Flory. Владелец: Research Foundation for Mental Hygiene Inc. Дата публикации: 2008-03-20.

Method for detecting alzheimer's disease, and detection reagent

Номер патента: EP4400841A1. Автор: Koji Ueda,Kohei Yuyama,Yukifusa IGETA. Владелец: Tosoh Corp. Дата публикации: 2024-07-17.

Materials and methods relating to alzheimer's disease

Номер патента: EP3004894A1. Автор: Malcolm Andrew Ward,Ian Hugo Pike,Hans Dieter ZUCHT. Владелец: Electrophoretics Ltd. Дата публикации: 2016-04-13.

Biosensor using cell that expresses chemosensory receptor that can detect sugar, and alzheimer's disease diagnostic apparatus comprising same

Номер патента: US09846166B2. Автор: Jeong Ok Lim,JEUNG SOO HUH,Won Ju Cho. Владелец: Industry Academic Cooperation Foundation of KNU. Дата публикации: 2017-12-19.

Detection of Alzheimer's disease and other diseases using a photoaffinity labeling method

Номер патента: US5272055A. Автор: Boyd Haley. Владелец: University of Kentucky Research Foundation. Дата публикации: 1993-12-21.

Cell cycle-based blood test to diagnose alzheimer's disease

Номер патента: WO2008003516A1. Автор: Thomas Arendt,Jens Stieler,F. Randall Grimes,William J. Gartner,Donald F. Weber. Владелец: Universität Leipzig. Дата публикации: 2008-01-10.

Intelligent early screening model and construction method thereof for alzheimer's disease

Номер патента: LU504548B1. Автор: Chun Chen. Владелец: Univ Wenzhou Medical. Дата публикации: 2023-12-20.

Spectroscopic method for alzheimer's disease diagnosis

Номер патента: US20150276482A1. Автор: Igor K. Lednev. Владелец: Research Foundation of State University of New York. Дата публикации: 2015-10-01.

Peripheral blood mononuclear cells (pbmc) phenotypes as biomarkers for patients with alzheimer's disease and/or mild cognitive impairment (mci)

Номер патента: WO2023012064A1. Автор: Philip DENNER,Anja Schneider,Eugenio FAVA,Wera ROTH,Pranjal DHOLE,Josephine BLERSCH. Владелец: Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (Dzne). Дата публикации: 2023-02-09.

Intelligent early screening model and construction method thereof for alzheimer’s disease

Номер патента: US20240136071A1. Автор: Chun Chen,Qingren Yang. Владелец: Wenzhou Medical University. Дата публикации: 2024-04-25.

Novel biomarker for diagnosis of Alzheimer's disease, discovered from blood-derived exosomes, and method for diagnosing Alzheimer's disease using same

Номер патента: GB2616796A. Автор: Youn Kim So,Park Gunjoo. Владелец: PCL Inc. Дата публикации: 2023-09-20.

Peripheral blood mononuclear cells (pbmc) phenotypes as biomarkers for patients with alzheimer's disease and/or mild cognitive impairment (mci)

Номер патента: EP4377695A1. Автор: Philip DENNER,Anja Schneider,Eugenio FAVA,Wera ROTH,Pranjal DHOLE,Josephine BLERSCH. Владелец: Deutsches Zentrum fuer Neurodegenerative Erkrankungen eV. Дата публикации: 2024-06-05.

Deep learning and self-assembled-monolayer-based alzheimer's disease diagnosis method, and sers substrate therefor

Номер патента: EP4372759A1. Автор: Min Young Lee,Sungho Jo,Minjoon Kim,Yeonsik JUNG,Hyung Joon Park,Sejoon HUH. Владелец: Korea Institute of Materials Science KIMS. Дата публикации: 2024-05-22.

Diagnostic Screens for Alzheimer's Disease

Номер патента: US20110045483A1. Автор: Zsuzsanna Nagy. Владелец: Oxford University Innovation Ltd. Дата публикации: 2011-02-24.

Phage mediated immuno-pcr for the diagnosis of alzheimer's disease

Номер патента: WO2023144765A1. Автор: Salvatore Cuzzocrea,Emanuela ESPOSITO,Sabrina Conoci,Salvatore Guglielmino,Laura Maria DE PLANO,Domenico FRANCO,Maria Giovanna Rizzo,Irene Paterniti,Michela Campolo. Владелец: Universita’ Degli Studi Di Messina. Дата публикации: 2023-08-03.

Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same

Номер патента: EP1109929A1. Автор: John K. Apartment 11D MAESAKA. Владелец: Winthrop University Hospital. Дата публикации: 2001-06-27.

Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same

Номер патента: US20020197652A1. Автор: John Maesaka. Владелец: Winthrop University Hospital. Дата публикации: 2002-12-26.

Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same

Номер патента: US20010021508A1. Автор: John K. Maesaka. Владелец: Individual. Дата публикации: 2001-09-13.

Biomarkers and methods for determining risk factors for alzheimer's disease

Номер патента: EP3674711A3. Автор: Steven W. Graves,John S.K. Kauwe. Владелец: Individual. Дата публикации: 2020-10-28.

Method of diagnosing on increased risk of alzheimer's disease

Номер патента: EP2718729A1. Автор: Matej Oresic,Hilkka Soininen,Tuulia HYÖTYLÄINEN. Владелец: Eastern Finland, University of. Дата публикации: 2014-04-16.

Diagnostic assay for alzheimer's disease

Номер патента: US20150212098A1. Автор: Richard O'Brien,Jennifer Van Eyk,Xiaogian Liu. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2015-07-30.

Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: US20160363599A1. Автор: Edward J. Goetzl. Владелец: Nanosomix Inc. Дата публикации: 2016-12-15.

Alzheimer's disease diagnostic panels and methods for their use

Номер патента: US20150198618A1. Автор: Paul Edward Kearney,Xiao-jun LI. Владелец: Integrated Diagnostics Inc. Дата публикации: 2015-07-16.

Generating image-based biomarkers for alzheimer's disease and related dementias

Номер патента: EP4414998A1. Автор: Eli Gibson,Long Xie. Владелец: Siemens Healthineers AG. Дата публикации: 2024-08-14.

Cell model for alzheimer's disease pathology

Номер патента: WO2008002620A3. Автор: George S Bloom,Michelle E King. Владелец: Michelle E King. Дата публикации: 2008-12-11.

Generating image-based biomarkers for alzheimer's disease and related dementias

Номер патента: US20240273727A1. Автор: Eli Gibson,Long Xie. Владелец: Siemens Healthineers AG. Дата публикации: 2024-08-15.

Diagnostic assay for Alzheimer's disease

Номер патента: US09678086B2. Автор: Richard O'Brien,Jennifer Van Eyk,Xiaogian Liu. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2017-06-13.

Biomarkers for prediction, diagnosis, and monitoring of Alzheimer's disease

Номер патента: US09529002B2. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Individual. Дата публикации: 2016-12-27.

Cellular markers for diagnosis of alzheimer's disease and for alzheimer's disease progression

Номер патента: EP2831584A1. Автор: Michal Eisenbach-Schwartz,Ester Yoles. Владелец: NEUROQUEST Ltd. Дата публикации: 2015-02-04.

Novel blood cell biomarker for late onset alzheimer's disease

Номер патента: US20230333091A1. Автор: Christopher Wheeler. Владелец: Cedars Sinai Medical Center. Дата публикации: 2023-10-19.

Detection of fragments of nectin-1 for the diagnosis of alzheimer's disease

Номер патента: US20100285597A1. Автор: Howard Federoff,Seung T. Lim. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2010-11-11.

Methods and materials for identifying biomarkers and/or pathways associated with alzheimer's disease

Номер патента: WO2024015951A3. Автор: Sarah S. Bacus,Jeff Olson,Christopher A. Hamm. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-04-04.

Process for detection of alzheimer's disease from a serum sample

Номер патента: US9835621B2. Автор: Mark A. Lovell,Bert C. Lynn. Владелец: University of Kentucky Research Foundation. Дата публикации: 2017-12-05.

Detection of alzheimer's disease and other diseases using a photoaffinity labeling method

Номер патента: AU3324593A. Автор: Boyd E Haley. Владелец: University of Kentucky Research Foundation. Дата публикации: 1993-07-28.

Lymphocyte-based morphometric test for alzheimer's disease

Номер патента: WO2018183703A1. Автор: Daniel L. Alkon,Florin Valentin Chirila. Владелец: NeuroDiagnostics LLC. Дата публикации: 2018-10-04.

Methods and kits for assessing alzheimer's disease

Номер патента: WO2023196927A1. Автор: Christopher Campbell,Martin Stengelin,Steven E. ARNOLD,Pia Kivisakk WEBB. Владелец: MESO SCALE TECHNOLOGIES, LLC.. Дата публикации: 2023-10-12.

Saposin d and fam3c are biomarkers for alzheimer's disease

Номер патента: EP1877416A2. Автор: Kaj Blennow,Huw Alun Davies,Anja Hviid Simonsen,James Norton Mcguire,Vladimir N. Podust. Владелец: Vermillion Inc. Дата публикации: 2008-01-16.

A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects

Номер патента: US20220260595A1. Автор: Thomas Arendt,Elise Brownell,Herman Weiss,Paula TRZEPACZ,Gerald COMMISSIONG. Владелец: Todos Medical Ltd. Дата публикации: 2022-08-18.

Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject

Номер патента: WO2006110621A3. Автор: Norman R. Relkin,Erin Finehout,Kelvin H. Lee. Владелец: Cornell Research Foundation, Inc.. Дата публикации: 2011-05-26.

Diagnosis of alzheimer's disease by detecting auto-antibodies against y-box binding protein-1 (yb-1)

Номер патента: EP4314834A1. Автор: Harald Heidecke,Peter Mertens. Владелец: CELLTREND GMBH. Дата публикации: 2024-02-07.

Screening of agents for treatment of alzheimer's disease

Номер патента: WO1997044669A1. Автор: Michael John Smith,Masato Hasegawa,Michel Goedert,Ross Jakes,Maria Grazia Spillantini,Richard Anthony Crowther. Владелец: Medical Research Council. Дата публикации: 1997-11-27.

Saposin d and fam3c are biomarkers for alzheimer's disease

Номер патента: US20090226897A1. Автор: Kaj Blennow,Huw Alun Davies,Anja Hviid Simonsen,James Norton Mcguire,Vladimir N. Podust. Владелец: Vermillion Inc. Дата публикации: 2009-09-10.

Protein Biomarkers for Alzheimer's Disease Detection

Номер патента: US20110091991A1. Автор: Chun-Chia Cheng,Shui-Cheng Lee,Shiau-Shiun Guan. Владелец: Institute of Nuclear Energy Research. Дата публикации: 2011-04-21.

Multi-modality neural network for alzheimer's disease classifcation

Номер патента: US20240233945A1. Автор: Rishabh Sharma,Rachid Fahmi,Ludovic Sibille. Владелец: Siemens Medical Solutions USA Inc. Дата публикации: 2024-07-11.

A diagnostic blood test method for the detection of alzheimer's disease

Номер патента: US20230296629A1. Автор: Anett Hudák,Tamás Letoha. Владелец: Pharmacoidea Kft. Дата публикации: 2023-09-21.

Early-stage alzheimer's disease autoantibody biomarkers, target antigens and diagnostic uses thereof

Номер патента: US20200340990A1. Автор: Robert G. Nagele. Владелец: ROWAN UNIVERSITY. Дата публикации: 2020-10-29.

Multi-modality neural network for alzheimer's disease classification

Номер патента: EP4399721A1. Автор: Rishabh Sharma,Rachid Fahmi,Ludovic Sibille. Владелец: Siemens Medical Solutions USA Inc. Дата публикации: 2024-07-17.

A diagnostic blood test method for the detection of alzheimer's disease

Номер патента: EP4185874A1. Автор: Anett Hudák,Tamás Letoha. Владелец: Pharmacoidea Kft. Дата публикации: 2023-05-31.

A diagnostic blood test method for the detection of alzheimer's disease

Номер патента: WO2022018468A1. Автор: Anett Hudák,Tamás Letoha. Владелец: Pharmacoidea Kft. Дата публикации: 2022-01-27.

Method for diagnosis of alzheimer's disease

Номер патента: EP1177447A1. Автор: Allen B. Reitz,Carlos R. Plata Salaman,Adrian Dawkes,Haou-Yan Wang. Владелец: Ortho McNeil Pharmaceutical Inc. Дата публикации: 2002-02-06.

Treatment of vascular dysfunction and alzheimer's disease

Номер патента: EP1532258A1. Автор: Berislav V. Zlokovic. Владелец: Socratech LLC. Дата публикации: 2005-05-25.

Assay for non-familial alzheimer's disease

Номер патента: WO1994001579A1. Автор: Elizabeth R. Simons,Theresa A. Davies. Владелец: Boston University. Дата публикации: 1994-01-20.

Bioassay to detect compounds to treat alzheimer's disease

Номер патента: WO1999027370A1. Автор: Ling Sun Jen,Ambrish Janardanbhai Patel. Владелец: IMPERIAL COLLEGE INNOVATIONS LIMITED. Дата публикации: 1999-06-03.

Methods and compositions for the diagnosis and prognosis of Alzheimer's disease

Номер патента: US09726678B2. Автор: Stephen Peter Fitzgerald,John V. Lamont,Paul Innocenzi,Massimiliano Corsi. Владелец: Randox Laboratories Ltd. Дата публикации: 2017-08-08.

Method for diagnosing alzheimer's disease (AD)

Номер патента: US09625459B2. Автор: Frank Mattner,Walter Schmidt,Andreas Mairhofer,Achim Schneeberger,Martina LUTTEROVA,Guenther Staffler. Владелец: Affiris AG. Дата публикации: 2017-04-18.

Method for diagnosing alzheimer's disease

Номер патента: EP1031034A1. Автор: Jeffrey K. Aronson,Asita H. De Silva,David G. Grahame-Smith. Владелец: Bristol Myers Squibb Co. Дата публикации: 2000-08-30.

Method for diagnosis and monitoring of Alzheimer's disease

Номер патента: EP2211183A1. Автор: Sandip Ray,Anton Wyss-Coray. Владелец: Satoris Inc. Дата публикации: 2010-07-28.

Fibroblast growth patterns for diagnosis of alzheimer's disease

Номер патента: CA2776501C. Автор: Daniel L. Alkon,Tapan Kumar Khan,Florin Valentin Chirila. Владелец: WEST VIRGINIA UNIVERSITY. Дата публикации: 2022-04-19.

Non-invasive assessment of alzheimer's disease

Номер патента: US20240003918A1. Автор: Thomas H. Tulip,Michael Reitermann,Mathotaarachchilage Sulantha Sanjeewa MATHOTAARACHCHI. Владелец: Enigma Biointelligence Inc. Дата публикации: 2024-01-04.

Methods for monitoring disease progression of alzheimer's disease using csf markers from longitudinal samples

Номер патента: WO2008106076A3. Автор: Viswanath Devanarayan,Adam J Simon. Владелец: Adam J Simon. Дата публикации: 2008-11-20.

Systems, assays, and methods for determining risk factors for Alzheimer's disease

Номер патента: US10761100B2. Автор: Steven W. Graves,John S. K. Kauwe, III. Владелец: BRIGHAM YOUNG UNIVERSITY. Дата публикации: 2020-09-01.

Methods for detecting alzheimer's disease

Номер патента: EP1869474A1. Автор: Doris Damian,Aram Adourian,Amir Handzel. Владелец: Bg Medicine Inc. Дата публикации: 2007-12-26.

Blood indicators of alzheimer's disease

Номер патента: WO2022168006A1. Автор: Paul Alan Cox,Sandra Anna BANACK. Владелец: The Institute for Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2022-08-11.

Non-invasive assessment of alzheimer's disease

Номер патента: EP4252243A2. Автор: Michael Reitermann,Thomas TULIP,Mathotaarachchilage S. S. MATHOTAARACHCHI. Владелец: Mathotaarachchi Mathotaarachchilage. Дата публикации: 2023-10-04.

Methods, systems, and kits for prediction, detection, monitoring, and treatment of alzheimer's disease

Номер патента: EP4237857A1. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Baseline Global Inc. Дата публикации: 2023-09-06.

Methods and materials for identifying biomarkers and/or pathways associated with alzheimer's disease

Номер патента: WO2024015951A2. Автор: Sarah S. Bacus,Jeff Olson,Christopher A. Hamm. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-01-18.

Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers

Номер патента: US8753607B2. Автор: Manuela G. Neuman. Владелец: Individual. Дата публикации: 2014-06-17.

Systems, assays, and methods for determining risk factors for alzheimer's disease

Номер патента: EP3164703A1. Автор: Steven W. Graves,John S.K. Kauwe. Владелец: Individual. Дата публикации: 2017-05-10.

Systems, Assays, and Methods for Determining Risk Factors for Alzheimer's Disease

Номер патента: US20170138964A1. Автор: Steven W. Graves,John S.K. Kauwe. Владелец: BRIGHAM YOUNG UNIVERSITY. Дата публикации: 2017-05-18.

Biomarkers for prediction, diagnosis, and monitoring of alzheimer's disease

Номер патента: US20170067913A1. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Individual. Дата публикации: 2017-03-09.

Blood indicators of alzheimer's disease

Номер патента: EP4287941A1. Автор: Paul Alan Cox,Sandra Anna BANACK. Владелец: Institute For Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2023-12-13.

Blood indicators of alzheimer's disease

Номер патента: AU2022216529A1. Автор: Paul Alan Cox,Sandra Anne Banack. Владелец: Inst For Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2023-08-17.

Blood indicators of alzheimer's disease

Номер патента: CA3207470A1. Автор: Paul Alan Cox,Sandra Anna BANACK. Владелец: Institute For Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2022-08-11.

Innovative blood platelets biomarker for early diagnosis of alzheimer's disease

Номер патента: US20120058573A1. Автор: Ricardo B. Maccioni,Gonzalo Farias. Владелец: Servicios Cientificos Neuroinnovation Ltda. Дата публикации: 2012-03-08.

Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers

Номер патента: EP2279420A1. Автор: Manuela G. Neuman,Morris Freedman. Владелец: Individual. Дата публикации: 2011-02-02.

Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers

Номер патента: WO2009114945A9. Автор: Manuela G. Neuman,Morris Freedman. Владелец: Neuman Manuela G. Дата публикации: 2010-01-21.

Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers

Номер патента: US20120015381A1. Автор: Manuela G. Neuman. Владелец: Individual. Дата публикации: 2012-01-19.

Methods for diagnosis and prognosis of alzheimer's disease

Номер патента: EP4332575A1. Автор: Cristina María PEDRERO PRIETO,Juan Ramón PEINADO MENA,Yoana RABANAL RUIZ. Владелец: UNIVERSIDAD DE CASTILLA LA MANCHA. Дата публикации: 2024-03-06.

Diagnostic method for Alzheimer's disease: examination of non-neural tissue

Номер патента: US5262332A. Автор: Dennis J. Selkoe. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 1993-11-16.

Diagnostic assay for alzheimer's disease

Номер патента: US5234814A. Автор: John P. Card,Leonard G. Davis,Robert G. Siman. Владелец: DuPont Merck Pharmaceutical Co. Дата публикации: 1993-08-10.

Method for detecting alzheimer's disease

Номер патента: CA2360219A1. Автор: Eleftherios Diamandis. Владелец: Eleftherios Diamandis. Дата публикации: 2002-04-27.

Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases

Номер патента: EP2052255A2. Автор: Michael G. Harrington,Alfred N. Fonteh. Владелец: Huntington Medical Research Institute. Дата публикации: 2009-04-29.

Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease

Номер патента: WO2013010003A1. Автор: Robert G. Nagele. Владелец: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY. Дата публикации: 2013-01-17.

Method of diagnosing alzheimer's disease

Номер патента: EP1543331B1. Автор: Yadong Huang. Владелец: J David Gladstone Institutes. Дата публикации: 2009-02-11.

Use of Alzheimer's disease marker

Номер патента: CN105353135A. Автор: 刘璐,府伟灵,刘跃平,余抒. Владелец: First Affiliated Hospital of TMMU. Дата публикации: 2016-02-24.

Multi-modality neural network for alzheimer's disease classification

Номер патента: WO2023063969A1. Автор: Rishabh Sharma,Rachid Fahmi,Ludovic Sibille. Владелец: SIEMENS MEDICAL SOLUTIONS USA, INC.. Дата публикации: 2023-04-20.

Companion diagnostic for nsaids and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease

Номер патента: EP3740761A1. Автор: Sid E. O'bryant. Владелец: University of North Texas Health Science Center. Дата публикации: 2020-11-25.

Companion diagnostic for nsaids and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease

Номер патента: CA3088512C. Автор: Sid E. O'bryant. Владелец: University of North Texas Health Science Center. Дата публикации: 2023-09-19.

Companion diagnostic for nsaids and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease

Номер патента: WO2019143562A1. Автор: Sid E. O'bryant. Владелец: University of North Texas Health Science Center at Fort Worth. Дата публикации: 2019-07-25.

METHOD FOR DETECTION OF PrP-INTERACTING Aβ OLIGOMERIC SPECIES IN BIOLOGICAL MATERIALS AS A DIAGNOSIS OF ALZHEIMER'S DISEASE

Номер патента: WO2013173699A3. Автор: Stephen M. Strittmatter,Mikhail KOSTYLEV. Владелец: YALE UNIVERSITY. Дата публикации: 2014-01-03.

Diagnostic for early stage alzheimer's disease

Номер патента: EP1461611B1. Автор: Xianlin Han,David M. D. M. Holtzman. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2010-03-03.

Cell-Based Biosensor for Early Alzheimer's Disease Detection

Номер патента: US20210109080A1. Автор: Melissa A. Moss,Brittany E. Watson. Владелец: UNIVERSITY OF SOUTH CAROLINA. Дата публикации: 2021-04-15.

Biomarkers for alzheimer's disease

Номер патента: EP4370931A1. Автор: Reinhold Schmidt,Andrea Armirotti,Gianfranco SPALLETTA,Giuliana Ottonello,Pietro Franceschi. Владелец: FONDAZIONE SANTA LUCIA. Дата публикации: 2024-05-22.

Mass spectrometry analysis of markers for alzheimer's disease

Номер патента: WO2024044763A1. Автор: Allan Levey,Duc Duong,James Lah,Nicholas Seyfried,Caroline WATSON. Владелец: EMORY UNIVERSITY. Дата публикации: 2024-02-29.

Method for differential diagnosis of alzheimer's disease, vascular and mixed dementia

Номер патента: RU2578188C1. Автор: Степан Григорьевич Григорьев,Лидия Аркадьевна Алексеева,Владимир Юрьевич Лобзин,Андрей Юрьевич Емелин. Владелец: Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА). Дата публикации: 2016-03-20.

Aspartic proteases, termed aspartyl protease 1 and 2 (ASP1 and ASP2) and gene variants thereof and their role in Alzheimer's disease

Номер патента: NZ517297A. Автор: Mark Gurney,Michael Jerome Bienkowski. Владелец: Upjohn Co. Дата публикации: 2004-04-30.

METHODS FOR ASSESSING RISK OF ALZHEIMER'S DISEASE IN A PATIENT

Номер патента: US20120003649A1. Автор: Atwood Craig S.. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2012-01-05.

G PROTEIN-COUPLED RECEPTOR ANTAGONIST AND ITS USE FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE

Номер патента: US20120004254A1. Автор: Pei Gang,Ni Yanxiang,Zhao Xiaohui. Владелец: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Дата публикации: 2012-01-05.

Therapy of alzheimer's disease with using amyloid-beta peptide antibodies, and mixtures thereof

Номер патента: RU2353389C2. Автор: Арнон Розенталь,Джил ЛЕВКОВИЦ. Владелец: Ринат Ньюросайенс Корп.. Дата публикации: 2009-04-27.

Medication for treating alzheimer's disease and method of treating alzheimer's disease

Номер патента: RU2542445C2. Автор: Олег Ильич Эпштейн. Владелец: Олег Ильич Эпштейн. Дата публикации: 2015-02-20.

Compositions and methods for treating alzheimer's disease

Номер патента: WO2024192296A1. Автор: Ottavio Arancio,Luana Fioriti,Paul Edward FRASER. Владелец: Teh Trustees Of Columbia University In The City Of New York. Дата публикации: 2024-09-19.

Therapeutic agent for alzheimer's disease and method of treating alzheimer's disease

Номер патента: RU2536232C2. Автор: Олег Ильич Эпштейн. Владелец: Олег Ильич Эпштейн. Дата публикации: 2014-12-20.

Peptide with protective action against alzheimer's disease

Номер патента: RU2372355C1. Автор: Наталья Викторовна Бобкова,Татьяна Даниловна Волкова,Ольга Марковна Вольпина,Дмитрий Отарович Короев,Виктор Ионович Цетлин,Наталья Игоревна Медвинская,Ирина Юрьевна Александрова. Владелец: Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН. Дата публикации: 2009-11-10.

Protein markers for mild cognitive impairment and alzheimer's disease

Номер патента: WO2024213092A1. Автор: Nancy Yuk-yu Ip,Kit Yu Fu,Yuanbing JIANG,Hyebin UHM,Chui Fun Fanny IP. Владелец: Hong Kong Center For Neurodegenerative Diseases Limited. Дата публикации: 2024-10-17.

N'-(2-Chloro-6-Methylbenzoyl)-4-Methyl-3[2-(3-Quinolyl) Ethynyl]-Benzohydrazide for treatment of Alzheimer's disease.

Номер патента: OA21248A. Автор: Nitin Krishnaji Damle,Vikram Krishna Ramanathan,Shakti Kamalchand JAIN,Sanjay Nandlalhi MANDHANE,Durgesh Ashokkumar SONI. Владелец: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED. Дата публикации: 2024-03-18.

Biomarkers of mild cognitive impairment and Alzheimer's disease

Номер патента: AU2013205062A1. Автор: Mark A. Lovell,Bert C. Lynn. Владелец: University of Kentucky Research Foundation. Дата публикации: 2013-05-16.

Method for diagnosis of alzheimer's disease

Номер патента: TWI622771B. Автор: 林佳靜,蔡澄偉. Владелец: 百威研發股份有限公司. Дата публикации: 2018-05-01.

Compounds for treatment of alzheimer's disease.

Номер патента: OA21243A. Автор: Robert Henk Henning,Guido Krenning,Adrianus Cornelis Van Der Graaf,Daniël Henri SWART,Pieter Cornelis VOGELAAR,Christina Françoise DE VEIJMESTDAGH. Владелец: SULFATEQ B.V.. Дата публикации: 2024-03-18.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.